584
Q1Official Cancer Control PlanYes, distinct CCP (55%)Does your country have a written and official cancer control plan?NC_CancerPlan
1[3 pts]Yes, as part of NCD Plan
2[5 pts]Yes, as a distinct Cancer Control Plan
3[0 pts]No
4[0 pts]Do not know
1
27 (23%) — Yes, NCD Plan [3 pts]
2
65 (55%) — Yes, distinct CCP [5 pts]
3
14 (12%) — No [0 pts]
4
12 (10%) — Don't know [0 pts]
Q2Pediatric Cancer ComponentYes (91%)Is there a pediatric cancer component to the cancer control plan?NC_CancerComponent
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
Conditional: only if Q1 = Yes.
1
84 (91%) — Yes [5 pts]
2
5 (5%) — No [0 pts]
3
3 (3%) — Don't know [0 pts]
Q3PCC OperabilityYes (70%)Is the pediatric cancer component of the cancer control plan operational?NC_OperationalCCP1
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
Conditional: only if Q1 = Yes.
1
64 (70%) — Yes [5 pts]
2
11 (12%) — No [0 pts]
3
17 (19%) — Don't know [0 pts]
Q4PCC Monitoring & EvaluationYes (67%)Does the pediatric cancer plan include scheduled monitoring and evaluation?NC_OperationalCCP2
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
Conditional: only if Q1 = Yes.
1
62 (67%) — Yes [5 pts]
2
14 (15%) — No [0 pts]
3
16 (17%) — Don't know [0 pts]
Q5Plan TimelineNumberBeginning and ending year of most recent cancer control plan?NC_PlanBegin, NC_PlanEnd
Numeric (YYYY). Free-text year fields. Not scored.
Q6Plan Status CommentsFree textAdditional information on past, present, or future cancer control plans?NC_YesPlanComments
Open text field. Not scored.
Q7Past Cancer PlanDon't know (50%)Given no current plan, has there ever been one in the past?NC_PastCCP
1[3 pts]Yes
2[0 pts]No
3[0 pts]Do not know
Conditional: only if Q1 = No/Don't know.
1
9 (35%) — Yes [3 pts]
2
4 (15%) — No [0 pts]
3
13 (50%) — Don't know [0 pts]
Q8Plan in DevelopmentDon't know (85%)Given no current plan, is there one in progress or development?NC_ProgressCCP
1[3 pts]Yes
2[0 pts]No
3[0 pts]Do not know
Conditional: only if Q1 = No/Don't know.
1
3 (12%) — Yes [3 pts]
2
1 (4%) — No [0 pts]
3
22 (85%) — Don't know [0 pts]
Q9No-Plan CommentsFree textAdditional information on status of past/present/future plans?NC_NoPlanComments
Open text field. Conditional: only if Q1 = No/Don't know. Not scored.
Q10Children's Treatment RightsYes (86%)Does your country have laws to protect children's right to essential treatment?NC_ChildLaws
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
102 (86%) — Yes [5 pts]
2
6 (5%) — No [0 pts]
3
10 (9%) — Don't know [0 pts]
Q11Law EnforcementAlways (74%)Are children's rights laws enforced for cancer treatment initiation and adherence?NC_LawEnforced
1[0 pts]Never
2[0 pts]Only as last resource
3[5 pts]Always when relevant
Conditional: only if Q10 = Yes.
1
3 (3%) — Never [0 pts]
2
24 (24%) — Last resource [0 pts]
3
75 (74%) — Always [5 pts]
Q12State Reporting DutyYes (70%)Are providers expected to report when essential treatment is withheld?NC_ReportToState
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
Conditional: only if Q10 = Yes.
1
71 (70%) — Yes [5 pts]
2
13 (13%) — No [0 pts]
3
18 (18%) — Don't know [0 pts]
Q13Law CommentsFree textAdditional information on children's treatment rights laws?NC_LawComments
Open text field. Not scored.
Q14PHO Facility CountNumberHow many facilities provide PHO services in your country?NC_PHOHosp
Numeric (free entry). Not scored.
Q15Facility AccreditationCyclic, benchmarking (36%)Does your country have a process for accreditation of PHO facilities?NC_AccredPHOHosp
1[N/D]Yes, one-time accreditation
2[3 pts]Yes, cyclic based on quality indicators
3[5 pts]Yes, cyclic with public benchmarking
4[0 pts]No
1
20 (17%) — One-time [N/D]
2
39 (33%) — Cyclic, quality [3 pts]
3
42 (36%) — Cyclic, benchmarking [5 pts]
4
17 (14%) — No [0 pts]
Q16Accreditation Process TypeInternal (87%)Which best describes the PHO facility accreditation process?NC_AccredProcess
1[0 pts]Not available
2[3 pts]Internal (national)
3[4 pts]External (international)
4[5 pts]Both (combination)
5[3 pts]Other
1
2 (2%) — Not available [0 pts]
2
88 (87%) — Internal [3 pts]
3
1 (1%) — External [4 pts]
4
10 (10%) — Both [5 pts]
5
0 (0%) — Other [3 pts]
Q17PHO Provider CountNumberHow many PHO-trained providers are currently practicing in your country?NC_PHOProv
Numeric (free entry). Not scored.
Q18Provider CertificationCyclic (83%)Does your country have accreditation/certification for PHO providers?NC_PHOAccred
1[0 pts]No
2[3 pts]Yes, one-time accreditation
3[5 pts]Yes, cyclic (every X years)
1
9 (8%) — No [0 pts]
2
11 (9%) — One-time [3 pts]
3
98 (83%) — Cyclic [5 pts]
FinancingQ19-Q20 · max 10 pts
Q19Treatment Cost FundingMost covered (49%)Country's funding sources for direct/indirect costs of childhood cancer treatment?NC_TxCostFunding
0[0 pts]No mechanism, families heavily burdened
1[1 pt]No mechanism, but NGO sources available
2[3 pts]Most direct costs covered, indirect gap remains
3[5 pts]Most costs covered, low bankruptcy risk
0
2 (2%) — No mechanism [0 pts]
1
4 (3%) — NGO sources [1 pt]
2
54 (46%) — Direct covered [3 pts]
3
58 (49%) — Most covered [5 pts]
Q20Competing Health PrioritiesModerate, sustain (45%)Status of competing health priorities and capacity to address them nationally?NC_CompetingPriorities
0[0 pts]High burden, dependent on foreign aid
1[1 pt]High burden, increasing national investment
2[3 pts]Moderate burden, can sustain crisis
3[5 pts]Moderate burden, can rapidly mobilize funds
0
8 (7%) — High, foreign aid [0 pts]
1
48 (41%) — High, investing [1 pt]
2
53 (45%) — Moderate, sustain [3 pts]
3
9 (8%) — Moderate, mobilize [5 pts]
Health InformationQ21-Q25 · max 15 pts
Q21New Cases 0-14yrNumberEstimated annual newly diagnosed pediatric cancer patients (0-14)?NC_NewCancer14
Numeric (free entry). Not scored.
Q22New Cases 15-19yrNumberEstimated annual newly diagnosed young adult cancer patients (15-19)?NC_NewCancer15
Numeric (free entry). Not scored.
Q23Vital Statistics RegistrationLow/moderate (64%)Status of national registration of vital statistics?NC_VitalStats
1[0 pts]No registration
2[1 pt]Incomplete or sample
3[3 pts]Low/moderate complete
4[5 pts]High quality complete
1
8 (7%) — None [0 pts]
2
28 (24%) — Incomplete [1 pt]
3
75 (64%) — Low/moderate [3 pts]
4
7 (6%) — High quality [5 pts]
Q24Population Cancer RegistryIncomplete (67%)Status of pediatric population-based cancer registration?NC_CancerReg
0[0 pts]No registry exists
1[1 pt]Agreements in progress
2[3 pts]Exists but incomplete/incidence only
3[5 pts]Established, reliable incidence + outcomes
0
8 (7%) — None [0 pts]
1
13 (11%) — In progress [1 pt]
2
79 (67%) — Incomplete [3 pts]
3
18 (15%) — Established [5 pts]
Q25Research FundingRecognized, unfunded (43%)Status of research activities and financial support for research?NC_ResearchSupport
0[0 pts]Little to none
1[1 pt]Recognized important but no funding
2[3 pts]Supported, limited govt financing
3[5 pts]Govt supports innovation & benchmarking
0
16 (14%) — Little/none [0 pts]
1
51 (43%) — Recognized, unfunded [1 pt]
2
46 (39%) — Limited govt [3 pts]
3
5 (4%) — Govt supports [5 pts]
Service DeliveryQ26-Q28 · max 15 pts
Q26Essential Medicine AccessThird sector (59%)Access to essential medicines and technologies for childhood cancer treatment?NC_EssentialMeds
0[0 pts]Erratic supply (>25% plans affected)
1[1 pt]Improved, dependent on third sector
2[3 pts]Secured (<=1% affected), quality assured
3[5 pts]Strong procurement, overcomes shortages
0
19 (16%) — Erratic supply [0 pts]
1
70 (59%) — Third sector [1 pt]
2
23 (20%) — Secured [3 pts]
3
6 (5%) — Strong [5 pts]
Q27Care ContinuityProvider-dependent (52%)Status of continuity of care in general pediatrics?NC_CareContinuity
0[0 pts]Point-of-care only, no continuity
1[1 pt]Same clinic but rotation impedes continuity
2[3 pts]Primary care continuity, provider-dependent
3[5 pts]Systems integration, effective continuity
0
7 (6%) — No continuity [0 pts]
1
36 (31%) — Rotation impedes [1 pt]
2
61 (52%) — Provider-dependent [3 pts]
3
14 (12%) — Systems integration [5 pts]
Q28Healthcare InfrastructureUpdated, shared (46%)Status of healthcare infrastructure in your country?NC_Infrastructure
0[0 pts]Aged, crowded, >1 patient/bed
1[1 pt]Aged, improved crowding, never >1/bed
2[3 pts]Updated, clean, shared rooms
3[5 pts]Single rooms, parent comfort & privacy
0
11 (9%) — Aged, crowded [0 pts]
1
52 (44%) — Aged, improved [1 pt]
2
54 (46%) — Updated, shared [3 pts]
3
1 (1%) — Single rooms [5 pts]
TrainingQ29-Q35 · max 40 pts
Q29PHO Fellowship ProgramYes (98%)Is there an accredited PHO fellowship program in your country?NC_PHOFellowship
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
116 (98%) — Yes [5 pts]
2
1 (1%) — No [0 pts]
3
1 (1%) — Don't know [0 pts]
Q30Fellowship SubspecialtiesCancer Survivorship (0%)Which subspecialty training opportunities are available? (check all that apply)NC_PHOSubspecialties*
Group A (max 10 pts if all 3 checked): Hem [5], Onco [5], PHO [10]. Group B (max 15 pts if all checked): SCT [5], Neuro [5], CanSurv [5]. Conditional: Q29 = Yes.
0%
Cancer Survivorship (0)
0%
Neuro-Oncology (0)
0%
Pediatric Hematology (0)
0%
Pediatric Hematology/Oncology (0)
0%
Pediatric Oncology (0)
0%
Stem Cell Transplantation (0)
Q31Fellowship DescriptionFree textDescribe available fellowship programs (# programs, years, strengths, challenges)?NC_PHOFellowPrograms
Open text field. Conditional: Q29 = Yes. Not scored.
Q32Training AbroadFree textWhere do providers train? Do they return? Accreditation challenges?NC_NOFellowPrograms
Open text field. Conditional: Q29 = No. Not scored.
Q33Nurse PHO CertificationYes (64%)Is there accredited training/certification for nurses to specialize in PHO?NC_NursePHO
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
76 (64%) — Yes [5 pts]
2
23 (20%) — No [0 pts]
3
19 (16%) — Don't know [0 pts]
Q34Medical Schools CountNumberHow many accredited medical schools are there in the country?NC_MDSchools
Numeric (free entry). Not scored.
Q35Workforce Training & RetentionPhysician + nurse (62%)Status of healthcare workforce training and retention?NC_HCTraining
0[0 pts]No local subspecialty, poor retention
1[1 pt]Minimal local, govt facilitates training abroad
2[3 pts]Local physician + nurse training exists
3[5 pts]Full range: physicians, nurses, pharmacists, etc.
0
6 (5%) — No local, poor [0 pts]
1
20 (17%) — Minimal, abroad [1 pt]
2
73 (62%) — Physician + nurse [3 pts]
3
19 (16%) — Full range [5 pts]
Professional AssociationsQ36-Q37 · max 10 pts
Q36PHO Professional AssociationYes (96%)Nationally recognized professional association for PHO?NC_PHOAssociation
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
113 (96%) — Yes [5 pts]
2
2 (2%) — No [0 pts]
3
3 (3%) — Don't know [0 pts]
Q37Other Discipline AssociationsYes (75%)National associations for nursing, surgery, radiology, social work, etc.?NC_OtherAssociation
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
88 (75%) — Yes [5 pts]
2
6 (5%) — No [0 pts]
3
24 (20%) — Don't know [0 pts]
Care Access & UtilizationQ38-Q43 · max 30 pts
Q38Family Awareness CampaignsYes (98%)Pediatric cancer awareness campaigns targeting families in past 2 years?NC_CampaignsFam
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
115 (98%) — Yes [5 pts]
2
1 (1%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
Q39Provider Awareness CampaignsYes (96%)Awareness or early detection campaigns targeting community health providers?NC_CampaignsMedical
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
113 (96%) — Yes [5 pts]
2
3 (3%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
Q40Recent Policy ChangesYes (70%)Policy changes affecting children's cancer care in past 2 years?NC_PolicyChange
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
82 (70%) — Yes [5 pts]
2
25 (21%) — No [0 pts]
3
11 (9%) — Don't know [0 pts]
Q41Political Events ImpactYes (71%)Social or political events affecting children's cancer care in past 2 years?NC_PoliticalEvents
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
84 (71%) — Yes [5 pts]
2
20 (17%) — No [0 pts]
3
14 (12%) — Don't know [0 pts]
Q42Public Cancer AwarenessImproving (50%)Level of awareness among providers and public about childhood cancer?NC_CancerAwareness
0[0 pts]Mostly unaware, no campaigns
1[1 pt]Moderate among providers, poor public
2[3 pts]Improving, large-scale campaigns
3[5 pts]Common knowledge, campaigns frequent
0
1 (1%) — Unaware [0 pts]
1
47 (40%) — Moderate, poor [1 pt]
2
59 (50%) — Improving [3 pts]
3
11 (9%) — Common knowledge [5 pts]
Q43Alternative Medicine RiskDelays, <25% (41%)Risk of traditional/alternative medicine to diagnosis and treatment compliance?NC_AltMedicine
0[0 pts]Major risk, abandonment >=25%
1[1 pt]Delays diagnosis, abandonment <25%
2[3 pts]Minor risk, abandonment <5%
3[5 pts]Minimal, complement only, <1%
0
9 (8%) — Major risk [0 pts]
1
48 (41%) — Delays, <25% [1 pt]
2
47 (40%) — Minor, <5% [3 pts]
3
14 (12%) — Minimal, <1% [5 pts]
PlanningQ44-Q45 · max 10 pts
Q44Overall PHO Policy RatingScale (6.2)Rate current policies, laws, and regulations for PHO care (0=Weak, 10=Strong)?NC_Impression
Self-assessment scale 0-10. N=118 responses. Mean=6.2, Median=6.5. Not scored.
7
41 (35%)
6
26 (22%)
5
15 (13%)
8
11 (9%)
4
10 (9%)
3
4 (3%)
9
4 (3%)
10
3 (3%)
1
2 (2%)
2
2 (2%)
Q4512-Month Improvement PlansYes (47%)Plans or committed resources to improve PHO care policies in next 12 months?NC_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
55 (47%) — Yes [10 pts]
2
20 (17%) — No [0 pts]
3
43 (36%) — Don't know [0 pts]
Module 2: Facility & Local Context (Institución y Contexto Local)27 questions · max 195 pts
Facility ProfileQ1-Q9 · max 55 pts
Q1Facility TypeGeneral Hospital (64%)Which of the following best describes your facility?FC_TypeofFacility
1PHO Hospital
2Cancer Hospital/Institute
3Children's Hospital
4General Hospital
5Other
1
5 (4%) — PHO Hospital
2
9 (8%) — Cancer Hospital
3
23 (20%) — Children's Hospital
4
76 (64%) — General Hospital
5
5 (4%) — Other
Q2Public vs PrivatePublic (87%)Is your facility public or private?FC_PubvsPriva
1Public
2Private, non-for-profit
3Private, for-profit
4Combination
1
103 (87%) — Public
2
6 (5%) — Private non-profit
3
6 (5%) — Private for-profit
4
3 (3%) — Combination
Q3Teaching FacilityYes (89%)Is your facility a government-designated teaching or training facility?FC_TeachingFacility
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
105 (89%) — Yes [5 pts]
2
12 (10%) — No [0 pts]
3
1 (1%) — Don't know [0 pts]
Q4University AffiliatedYes (92%)Is your facility formally affiliated with a local university or academic program?FC_UnivAffiliated
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
108 (92%) — Yes [5 pts]
2
10 (9%) — No [0 pts]
3
0 (0%) — Don't know [0 pts]
Q5PHO Fellowship ProgramNo (82%)Does your facility have an accredited PHO fellowship program?FC_PHOFellowProgram
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
21 (18%) — Yes [5 pts]
2
97 (82%) — No [0 pts]
3
0 (0%) — Don't know [0 pts]
Q6Fellowship Programs AvailableNone of the above (64%)Which accredited fellowship training programs are available? (check all that apply)FC_FellowTrainAvail___*
Multi-select checkboxes. {N} facilities responded.
64%
None of the above (75)
26%
Pediatric General Surgery (31)
21%
Pediatric Intensive Care (25)
16%
Infectious Diseases (19)
16%
Pediatric Endocrinology (19)
14%
Pediatric Cardiology (16)
14%
Pediatric Nephrology (16)
13%
Pediatric Pulmonary (15)
10%
Pediatric Radiology (12)
9%
Pediatric Orthopedics (11)
8%
Pediatric Neurosurgery (9)
8%
Pediatric Pathology (9)
6%
Pediatric Ophthalmology (7)
Q7Referral FacilityYes (83%)Is your facility a government-designated referral facility?FC_ReferralFacility
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
98 (83%) — Yes [5 pts]
2
18 (15%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
Q8Max Pediatric AgeNumber (17.2)Maximum age (years) for pediatric services at your facility?FC_MaxAge
Numeric (free entry). Not scored. Mean: 17.2, Median: 18. Range: 3–18.
Q9Hospital RenovationsYes (82%)Additions, renovations or upgrading of hospital facilities in past 5 years?FC_RenovationHosp5Y
1[5 pts]Yes
2[0 pts]No
1
97 (82%) — Yes [5 pts]
2
21 (18%) — No [0 pts]
PHO UnitQ10-Q18 · max 80 pts
Q10Separate PHO UnitYes (70%)Is the PHO inpatient care area a separate unit or ward?FC_SeparatePHOUnit
1[5 pts]Yes
2[0 pts]No
If Yes → Q11, Q13-14. If No → Q12.
1
83 (70%) — Yes [5 pts]
2
35 (30%) — No [0 pts]
Q11Inpatient Care Ward TypeExclusive malignant (54%)Which best describes your PHO inpatient care area?FC_InpatientCareWard
1[5 pts]Exclusive for PHO patients with malignant disease
2[3 pts]Combines PHO patients with benign and malignant disease
Conditional: only if Q10 = Yes. n=83
1
45 (54%) — Exclusive malignant [5 pts]
2
38 (46%) — Benign + malignant [3 pts]
Q12Non-Separate SettingGeneral pediatrics (86%)If not a separate PHO unit, which setting?FC_NoSeparatePHOArea
1General pediatrics ward
2General ward (adult + pediatric)
3Oncology ward (adult + pediatric)
4Other
Conditional: only if Q10 = No. n=35. Not scored.
1
30 (86%) — General pediatrics
2
4 (11%) — General adult+ped
3
1 (3%) — Oncology adult+ped
4
0 (0%) — Other
Q13PHO Area Built RecentlyYes (63%)Was the PHO inpatient care area built in the past 10 years?FC_PHOBuilt10y
1[5 pts]Yes
2[0 pts]No
Conditional: only if Q10 = Yes. n=83
1
52 (63%) — Yes [5 pts]
2
31 (37%) — No [0 pts]
Q14PHO Area RenovatedYes (69%)PHO inpatient care areas expanded, renovated or upgraded in past 5 years?FC_RenovationInpatient5Y
1[5 pts]Yes
2[0 pts]No
Conditional: only if Q10 = Yes. n=83
1
57 (69%) — Yes [5 pts]
2
26 (31%) — No [0 pts]
Q15Ambulatory PHO LocationSeparate, same bldg (59%)Where are ambulatory PHO services provided?FC_AmbulatoryServ
1In the PHO inpatient care area
2Separate area, same building
3Separate area, different building
4Other
1
26 (22%) — In PHO inpatient area
2
70 (59%) — Separate, same bldg
3
20 (17%) — Separate, diff bldg
4
2 (2%) — Other
Q16Ambulatory ExclusivityYes, daily (63%)Is the ambulatory area exclusive for PHO patients?FC_ExcluAmbulServ
1Yes, daily
2Yes, on specific days
3No, always shared
4Other
1
74 (63%) — Yes, daily
2
11 (9%) — Yes, specific days
3
30 (25%) — No, shared
4
3 (3%) — Other
Q17Ambulatory PHO ServicesDay Chemotherapy (IV, IM, PO) (95%)Which services are provided in the ambulatory PHO area? (check all that apply)FC_AmbuServices___*
Multi-select checkboxes. {N} facilities responded.
95%
Day Chemotherapy (IV, IM, PO) (112)
64%
Consultation (H and P) (76)
64%
IT Chemotherapy (LP/IT) (75)
64%
Labs/Phlebotomy (75)
64%
Symptom Management (75)
63%
Transfusions (74)
59%
Procedures (BMA/BX) (70)
57%
Procedural Sedation (67)
44%
Pharmacy (Drug dispensing) (52)
42%
Anesthesia (50)
36%
Fever/Neutropenia Management (43)
34%
Patient Triage (40)
Q18CollaborationsNational: Patient-care delivery (54%)PHO collaborations at subnational, national, and international levels?FC_Lb_Subnational/National/Inter___*
Three sub-sections: Subnational, National, International. Each has up to 5 options. {N} facilities responded.
54%
National: Patient-care delivery (64)
53%
National: Education (63)
44%
Subnational: Patient-care delivery (52)
43%
Subnational: Education (51)
42%
National: Research (49)
37%
International: Research (44)
36%
International: Education (43)
35%
International: None of the above (41)
34%
Subnational: None of the above (40)
31%
International: Patient-care delivery (37)
31%
Subnational: Research (37)
25%
National: None of the above (29)
11%
Subnational: Do not know (13)
7%
International: Do not know (8)
3%
National: Do not know (3)
Facility AmenitiesQ19-Q23 · max 25 pts
Q19Electricity 24/7Almost Always (100%)Electricity is available 24 hours a day, 7 days a weekFC_Electricity
1[5 pts]Almost Always
2[4 pts]Frequently
3[3 pts]Sometimes
4[2 pts]Infrequently
5[1 pt]Almost Never
6[0 pts]Not available
6-point frequency scale.
1
118 (100%) — Almost Always [5 pts]
2
0 (0%) — Frequently [4 pts]
3
0 (0%) — Sometimes [3 pts]
4
0 (0%) — Infrequently [2 pts]
5
0 (0%) — Almost Never [1 pt]
6
0 (0%) — Not available [0 pts]
Q20Potable Water 24/7Almost Always (97%)Potable water is available 24 hours a day, 7 days a weekFC_PotableWater
1[5 pts]Almost Always
2[4 pts]Frequently
3[3 pts]Sometimes
4[2 pts]Infrequently
5[1 pt]Almost Never
6[0 pts]Not available
6-point frequency scale.
1
114 (97%) — Almost Always [5 pts]
2
3 (3%) — Frequently [4 pts]
3
1 (1%) — Sometimes [3 pts]
4
0 (0%) — Infrequently [2 pts]
5
0 (0%) — Almost Never [1 pt]
6
0 (0%) — Not available [0 pts]
Q21Sanitation FacilitiesAlmost Always (70%)Adequate sanitation facilities are accessible for patients and familiesFC_SanitationFac
1[5 pts]Almost Always
2[4 pts]Frequently
3[3 pts]Sometimes
4[2 pts]Infrequently
5[1 pt]Almost Never
6[0 pts]Not available
6-point frequency scale.
1
83 (70%) — Almost Always [5 pts]
2
25 (21%) — Frequently [4 pts]
3
9 (8%) — Sometimes [3 pts]
4
0 (0%) — Infrequently [2 pts]
5
1 (1%) — Almost Never [1 pt]
6
0 (0%) — Not available [0 pts]
Q22Internet ConnectivityAlmost Always (32%)Internet available with good connectivity and speedFC_Internet
1[5 pts]Almost Always
2[4 pts]Frequently
3[3 pts]Sometimes
4[2 pts]Infrequently
5[1 pt]Almost Never
6[0 pts]Not available
6-point frequency scale.
1
38 (32%) — Almost Always [5 pts]
2
34 (29%) — Frequently [4 pts]
3
25 (21%) — Sometimes [3 pts]
4
4 (3%) — Infrequently [2 pts]
5
6 (5%) — Almost Never [1 pt]
6
11 (9%) — Not available [0 pts]
Q23Private Consultation SpaceFull privacy (87%)PHO patients have access to spaces for private consultationFC_PrivateConsult
1[5 pts]Full privacy (visual + auditory)
2[3 pts]Visual privacy only (curtains)
3[0 pts]No privacy
1
103 (87%) — Full privacy [5 pts]
2
12 (10%) — Visual only [3 pts]
3
3 (3%) — No privacy [0 pts]
Community DemographicsQ24-Q25 · max 10 pts
Q24Referring NetworkYes (88%)Does your facility have a formal referring network or organized referral pathway for PHO patients?FC_ReferringNetwork
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
104 (88%) — Yes [5 pts]
2
11 (9%) — No [0 pts]
3
3 (3%) — Don't know [0 pts]
Q25Satellite ClinicsNo (77%)Does your facility have satellite clinics for PHO chemo/supportive care?FC_SatelliteClinic
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
25 (21%) — Yes [5 pts]
2
91 (77%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
PlanningQ26-Q27 · max 10 pts
Q26Overall Facility RatingScale (7.3)Rate current status of facility for PHO care (1=Weak, 10=Strong)?FC_Impression
Self-assessment scale 1-10. N=118 responses. Mean=7.3, Median=8. Not scored.
8
38 (32%)
7
23 (20%)
9
17 (14%)
6
16 (14%)
10
9 (8%)
5
6 (5%)
4
4 (3%)
3
3 (3%)
2
2 (2%)
Q2712-Month Improvement PlansYes (64%)Plans and committed resources to improve facility PHO care in next 12 months?FC_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
75 (64%) — Yes [10 pts]
2
23 (20%) — No [0 pts]
3
20 (17%) — Don't know [0 pts]
Module 3: Facility Resources (Recursos de la Institución)34 questions · max 115 pts
Foundation SupportQ1-Q2 · max 10 pts
Q1Local FoundationYes (82%)Is there a local foundation(s) supporting the needs of PHO patients?FR_Foundation
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
97 (82%) — Yes [5 pts]
2
17 (14%) — No [0 pts]
3
4 (3%) — Don't know [0 pts]
Q2Fundraising MechanismsYes, established (33%)Are there mechanisms for fundraising for PHO care locally?FR_Fundraising
1[5 pts]Yes, well established
2[3 pts]Yes, but not well established
3[0 pts]No
4[0 pts]Do not know
1
39 (33%) — Yes, established [5 pts]
2
29 (25%) — Yes, not established [3 pts]
3
39 (33%) — No [0 pts]
4
11 (9%) — Don't know [0 pts]
Families & PatientsQ3-Q11 · max 95 pts
Q3Indigent FamiliesNumber (2.4%)What proportion of families of children with cancer in your facility are indigent?FR_Indigent
Percentage (0-100). N=118 responses. Mean=2.4%, Median=0%, Range=0-100%.
Q4Financial Assistance AccessNumber (51.5%)For patients unable to pay for treatment-associated costs, what percentage have access to financial protection/assistance?FR_FinancialAssistance
Percentage (0-100). N=118 responses. Mean=51.5%, Median=67.5%, Range=0-100%.
Q5Payment Sources: HospitalizationGovernment (84%)Who pays for treatment-associated costs? a. Hospitalization (check all that apply)Hosp___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
84%
Government (99)
14%
Insurance (17)
8%
Family (9)
3%
Foundation (4)
1%
Other (1)
Q6Payment Sources: Ambulatory VisitsGovernment (69%)Who pays for treatment-associated costs? b. Ambulatory visits (check all that apply)Outpatient___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
69%
Government (81)
25%
Family (30)
14%
Insurance (16)
9%
Foundation (11)
3%
Other (3)
Q7Payment Sources: Diagnostic ImagingGovernment (77%)Who pays for treatment-associated costs? c. Diagnostic imaging (check all that apply)DxImaging___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
77%
Government (91)
20%
Foundation (23)
15%
Insurance (18)
10%
Family (12)
2%
Other (2)
Q8Payment Sources: Basic LabsGovernment (82%)Who pays for treatment-associated costs? d. Basic diagnostic laboratories (CBC, chemistries, LFTs, etc.) (check all that apply)Labs___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
82%
Government (97)
15%
Insurance (18)
10%
Family (12)
9%
Foundation (10)
1%
Other (1)
Q9Payment Sources: Specialty LabsGovernment (70%)Who pays for treatment-associated costs? e. Specialty diagnostic laboratories (tumor markers, drug levels, etc.) (check all that apply)SpecLabs___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
70%
Government (83)
20%
Foundation (24)
15%
Insurance (18)
14%
Family (16)
2%
Other (2)
Q10Payment Sources: Basic PathologyGovernment (75%)Who pays for treatment-associated costs? f. Basic pathology (morphology, H&E, etc.) (check all that apply)Path___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
75%
Government (89)
15%
Insurance (18)
12%
Family (14)
10%
Foundation (12)
3%
Other (3)
Q11Payment Sources: Specialty PathologyGovernment (59%)Who pays for treatment-associated costs? g. Specialty pathology (IHC, Flow, FISH, cytogenetics) (check all that apply)SpecPath___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
59%
Government (70)
25%
Foundation (30)
19%
Family (22)
15%
Insurance (18)
3%
Other (4)
Q12Payment Sources: ChemotherapyGovernment (83%)Who pays for treatment-associated costs? h. Chemotherapy (check all that apply)Chemo___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
83%
Government (98)
17%
Foundation (20)
14%
Insurance (17)
9%
Family (10)
1%
Other (1)
Q13Payment Sources: Other MedicationsGovernment (79%)Who pays for treatment-associated costs? i. Other medications (antibiotics, etc.) (check all that apply)Meds___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
79%
Government (93)
20%
Foundation (24)
14%
Insurance (17)
13%
Family (15)
2%
Other (2)
Q14Payment Sources: Supportive CareGovernment (82%)Who pays for treatment-associated costs? j. Supportive care (blood products, etc.) (check all that apply)SupportCare___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
82%
Government (97)
14%
Insurance (17)
14%
Family (16)
6%
Foundation (7)
2%
Other (2)
Q15Payment Sources: SurgeryGovernment (82%)Who pays for treatment-associated costs? k. Surgery (check all that apply)Surgery___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
82%
Government (97)
15%
Insurance (18)
9%
Family (10)
9%
Foundation (10)
2%
Other (2)
Q16Payment Sources: RadiationGovernment (74%)Who pays for treatment-associated costs? l. Radiation (check all that apply)Radiation___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
74%
Government (87)
15%
Insurance (18)
13%
Foundation (15)
7%
Family (8)
4%
Other (5)
Q17Payment Sources: RehabilitationGovernment (75%)Who pays for treatment-associated costs? m. Rehabilitation services (check all that apply)Rehab___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
75%
Government (88)
17%
Family (20)
15%
Insurance (18)
12%
Foundation (14)
2%
Other (2)
Q18Payment Sources: Internal ProsthesisGovernment (42%)Who pays for treatment-associated costs? n. Prosthesis (internal) (check all that apply)IntProsthesis___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
42%
Government (49)
32%
Foundation (38)
23%
Family (27)
15%
Insurance (18)
8%
Other (9)
Q19Payment Sources: External ProsthesisFoundation (39%)Who pays for treatment-associated costs? o. Prosthesis (external) (check all that apply)ExtProsthesis___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
39%
Foundation (46)
32%
Government (38)
29%
Family (34)
14%
Insurance (17)
8%
Other (9)
Q20Payment Sources: Ocular ImplantsGovernment (36%)Who pays for treatment-associated costs? p. Ocular implants (check all that apply)Ocular___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
36%
Government (42)
34%
Foundation (40)
31%
Family (36)
12%
Insurance (14)
9%
Other (11)
Q21Payment Sources: Medical SuppliesFamily (52%)Who pays for treatment-associated costs? q. Medical supplies (crutches, wheelchairs, etc.) (check all that apply)MedSupplies___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
52%
Family (61)
45%
Foundation (53)
18%
Government (21)
10%
Insurance (12)
8%
Other (9)
Q22Payment Sources: Medical DevicesGovernment (76%)Who pays for treatment-associated costs? r. Medical devices (central lines, subcutaneous ports, Hickman, etc.) (check all that apply)MedDevices___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
76%
Government (90)
23%
Foundation (27)
15%
Insurance (18)
13%
Family (15)
2%
Other (2)
Q23Payment Sources: HousingFamily (72%)Who pays for treatment-associated costs? s. Housing (check all that apply)Housing___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
72%
Family (85)
38%
Foundation (45)
14%
Government (17)
3%
Insurance (4)
3%
Other (4)
Q24Payment Sources: MealsFamily (71%)Who pays for treatment-associated costs? t. Meals (check all that apply)Meals___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
71%
Family (84)
28%
Government (33)
26%
Foundation (31)
3%
Insurance (4)
3%
Other (3)
Q25Payment Sources: TransportationFamily (74%)Who pays for treatment-associated costs? u. Transportation (check all that apply)Transport___*
Check all sources that apply. Max 3 pts per category. {N} facilities responded.
74%
Family (87)
30%
Foundation (35)
22%
Government (26)
6%
Insurance (7)
3%
Other (3)
Q26Parent Sleeping SpacesYes (79%)Are there beds, cots, or sleeping spaces designated for parent(s) within your facility?FR_Beds
1[5 pts]Yes
2[0 pts]No
1
93 (79%) — Yes [5 pts]
2
25 (21%) — No [0 pts]
Q27Sleeping Space TypeBed/cot (47%)If yes, please describe the sleeping arrangements:FR_Beds_Yes
1[1 pt]In chair next to child
2[1 pt]In bed or cot next to child
3[2 pts]In separate/private area
4[1 pt]Other
Sub-question of Q26. Only answered when FR_Beds = Yes.
1
38 (41%) — Chair [1 pt]
2
44 (47%) — Bed/cot [1 pt]
3
7 (8%) — Private area [2 pts]
4
4 (4%) — Other [1 pt]
Q28Local HousingYes (75%)Is local housing available within 1 hour away for patients and families who do not live near the facility?FR_Housing
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
88 (75%) — Yes [5 pts]
2
27 (23%) — No [0 pts]
3
3 (3%) — Don't know [0 pts]
Q29Transportation ServicesNo (71%)Does your facility provide transportation services for PHO patients and their families to and from your facility?FR_Transport
1[5 pts]Yes
2[0 pts]No
1
34 (29%) — Yes [5 pts]
2
84 (71%) — No [0 pts]
Q30Meal SupportPatients only (42%)Does your facility provide meal support for PHO patients and their families while inpatient?FR_Meals
1[5 pts]Yes, patients and caregiver(s)
2[3 pts]Yes, patients only
3[0 pts]No
1
42 (36%) — Patients & caregivers [5 pts]
2
50 (42%) — Patients only [3 pts]
3
26 (22%) — No [0 pts]
Q31Health Education ProgramsNo (58%)Are there any formal programs for PHO health education for patients and families at your facility?FR_HealthEdu
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
46 (39%) — Yes [5 pts]
2
68 (58%) — No [0 pts]
3
4 (3%) — Don't know [0 pts]
Q32Cancer Advocacy GroupsYes (53%)Are there any local parent/advocacy groups for children with cancer?FR_CancerAdvocacy
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
62 (53%) — Yes [5 pts]
2
49 (42%) — No [0 pts]
3
7 (6%) — Don't know [0 pts]
Planning & ImprovementQ33-Q34 · max 10 pts
Q33Overall Status RatingScale (7.0)Overall, how would you rate the current status of finances and resources for delivery of PHO care at your facility (1=Weak and 10=Strong)?FR_Impression
Self-assessment scale 1-10. N=118 responses. Mean=7.0, Median=7. Not scored.
7
34 (29%)
8
31 (26%)
6
19 (16%)
9
11 (9%)
5
6 (5%)
10
6 (5%)
4
5 (4%)
3
4 (3%)
2
2 (2%)
Q34Improvement PlansYes (45%)Are there plans and committed resources to improve the current status of your finances and resources for delivery of PHO care in the next 12 months?FR_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
53 (45%) — Yes [10 pts]
2
27 (23%) — No [0 pts]
3
38 (32%) — Don't know [0 pts]
Module 4: Personnel (Personal)84 questions · max 268 pts
Core Team AvailabilityQ1-Q9 · max 45 pts
Q1PHO Specialist AvailabilityExclusive (90%)Availability of pediatric hematologist and/or oncologist for the PHO serviceP_Availability_PHO
1[5 pts]Available, works exclusively with PHO service
2[3 pts]Available, but not exclusive for PHO service
3[2 pts]Moderate availability upon request
4[1 pt]Limited availability
5[0 pts]Not available
1
106 (90%) — Exclusive [5 pts]
2
8 (7%) — Not exclusive [3 pts]
3
2 (2%) — Moderate [2 pts]
4
0 (0%) — Limited [1 pt]
5
2 (2%) — Not available [0 pts]
Q2General Pediatrician AvailabilityNot exclusive (46%)Availability of general pediatrician/practitioner for the PHO serviceP_Availability_GP
1[5 pts]Available, works exclusively with PHO service
2[3 pts]Available, but not exclusive for PHO service
3[2 pts]Moderate availability upon request
4[1 pt]Limited availability
5[0 pts]Not available
1
42 (36%) — Exclusive [5 pts]
2
54 (46%) — Not exclusive [3 pts]
3
4 (3%) — Moderate [2 pts]
4
3 (3%) — Limited [1 pt]
5
15 (13%) — Not available [0 pts]
Q3PHO Fellow AvailabilityNot available (88%)Availability of pediatric hematology/oncology fellow for the PHO serviceP_Availability_Fellow
1[5 pts]Available, works exclusively with PHO service
2[3 pts]Available, but not exclusive for PHO service
3[2 pts]Moderate availability upon request
4[1 pt]Limited availability
5[0 pts]Not available
1
13 (11%) — Exclusive [5 pts]
2
0 (0%) — Not exclusive [3 pts]
3
0 (0%) — Moderate [2 pts]
4
1 (1%) — Limited [1 pt]
5
104 (88%) — Not available [0 pts]
Q4Pediatric Resident AvailabilityNot exclusive (48%)Availability of general pediatric resident for the PHO serviceP_Availability_Resident
1[5 pts]Available, works exclusively with PHO service
2[3 pts]Available, but not exclusive for PHO service
3[2 pts]Moderate availability upon request
4[1 pt]Limited availability
5[0 pts]Not available
1
22 (19%) — Exclusive [5 pts]
2
57 (48%) — Not exclusive [3 pts]
3
4 (3%) — Moderate [2 pts]
4
9 (8%) — Limited [1 pt]
5
26 (22%) — Not available [0 pts]
Q5PHO Nursing Staff AvailabilityExclusive (48%)Availability of professional nursing staff formally trained in PHO careP_Availability_Nurse
1[5 pts]Available, works exclusively with PHO service
2[3 pts]Available, but not exclusive for PHO service
3[2 pts]Moderate availability upon request
4[1 pt]Limited availability
5[0 pts]Not available
1
56 (48%) — Exclusive [5 pts]
2
29 (25%) — Not exclusive [3 pts]
3
4 (3%) — Moderate [2 pts]
4
8 (7%) — Limited [1 pt]
5
21 (18%) — Not available [0 pts]
Q6Nurse Educator AvailabilityNot available (69%)Availability of nurse educator for the PHO serviceP_Availability_NurseEDU
1[5 pts]Available, works exclusively with PHO service
2[3 pts]Available, but not exclusive for PHO service
3[2 pts]Moderate availability upon request
4[1 pt]Limited availability
5[0 pts]Not available
1
18 (15%) — Exclusive [5 pts]
2
16 (14%) — Not exclusive [3 pts]
3
2 (2%) — Moderate [2 pts]
4
1 (1%) — Limited [1 pt]
5
81 (69%) — Not available [0 pts]
Q7Infectious Diseases Physician AvailabilityNot exclusive (40%)Availability of infectious diseases physician for the PHO serviceP_Availability_ID
1[5 pts]Available, works exclusively with PHO service
2[3 pts]Available, but not exclusive for PHO service
3[2 pts]Moderate availability upon request
4[1 pt]Limited availability
5[0 pts]Not available
1
15 (13%) — Exclusive [5 pts]
2
47 (40%) — Not exclusive [3 pts]
3
15 (13%) — Moderate [2 pts]
4
7 (6%) — Limited [1 pt]
5
34 (29%) — Not available [0 pts]
Q8Social Worker AvailabilityExclusive (45%)Availability of social worker for the PHO serviceP_Availability_Social
1[5 pts]Available, works exclusively with PHO service
2[3 pts]Available, but not exclusive for PHO service
3[2 pts]Moderate availability upon request
4[1 pt]Limited availability
5[0 pts]Not available
1
53 (45%) — Exclusive [5 pts]
2
52 (44%) — Not exclusive [3 pts]
3
5 (4%) — Moderate [2 pts]
4
3 (3%) — Limited [1 pt]
5
5 (4%) — Not available [0 pts]
Q9Data Manager AvailabilityNot available (54%)Availability of data manager for the PHO serviceP_Availability_Data
1[5 pts]Available, works exclusively with PHO service
2[3 pts]Available, but not exclusive for PHO service
3[2 pts]Moderate availability upon request
4[1 pt]Limited availability
5[0 pts]Not available
1
26 (22%) — Exclusive [5 pts]
2
15 (13%) — Not exclusive [3 pts]
3
6 (5%) — Moderate [2 pts]
4
7 (6%) — Limited [1 pt]
5
64 (54%) — Not available [0 pts]
StaffingQ10-Q37 · max 50 pts
Q10PHO Staff at FacilityYes (99%)Are pediatric hematologists and/or oncologists available at the facility?P_Facility_PHO
1Yes
2No
3Do not know
1
117 (99%) — Yes
2
1 (1%) — No
3
0 (0%) — Don't know
Q11PHO Staff Other EngagementN/A (40%)Which statement best describes the activities of PHO trained staff dedicating less than 35 hours per week to clinical work at your facility?P_OtherEngagement_PHO
0Engaged in admin/research/educational activities to meet full-time at facility (>35 hrs/wk)
1Engaged in admin/research/educational activities elsewhere (outside PHO service)
2Engaged in clinical activities elsewhere (outside PHO service)
3Other
4Not applicable
0
13 (28%) — Full-time at facility
1
4 (9%) — Admin elsewhere
2
3 (6%) — Clinical elsewhere
3
8 (17%) — Other
4
19 (40%) — N/A
Q12PHO Staff Scope of WorkFree textWhat is the current scope of work for PHO-trained staff at the PHO service?P_Tasks_PHO
Free-text response describing daily tasks and activities.
Q13Fellows at FacilityNo (88%)Are pediatric hematology/oncology fellows available at the facility?P_Facility_Fellow
1Yes
2No
3Do not know
1
14 (12%) — Yes
2
104 (88%) — No
3
0 (0%) — Don't know
Q14Fellow Scope of WorkFree textWhat is the current scope of work for a PHO fellow at the PHO service?P_Tasks_Fellow
Free-text response describing daily tasks and activities.
Q15General Pediatricians at FacilityYes (89%)Are pediatricians and/or general practitioners available at the facility?P_Facility_GP
1Yes
2No
3Do not know
1
105 (89%) — Yes
2
13 (11%) — No
3
0 (0%) — Don't know
Q16General Pediatrician Scope of WorkFree textWhat is the current scope of work for a pediatrician/general practitioner at the PHO service?P_Tasks_GP
Free-text response describing daily tasks and activities.
Q17Specialist Nurses at FacilityYes (75%)Are specialist nurses (formally trained in PHO care) available at the facility?P_Facility_SpecNurse
1Yes
2No
3Do not know
1
88 (75%) — Yes
2
28 (24%) — No
3
2 (2%) — Don't know
Q18Specialist Nurse Scope of WorkFree textWhat is the current scope of work for a specialist nurse at the PHO service?P_Tasks_SpecNurse
Free-text response describing daily tasks and activities.
Q19Professional Nurses at FacilityYes (97%)Are professional nurses available at the facility for the inpatient PHO ward?P_Facility_ProfNurse
1Yes
2No
3Do not know
1
114 (97%) — Yes
2
3 (3%) — No
3
1 (1%) — Don't know
Q20Professional Nurse Scope of WorkFree textWhat is the current scope of work for a professional nurse at the PHO service?P_Tasks_ProfNurse
Free-text response describing daily tasks and activities.
Q21Practical Nurses at FacilityYes (52%)Are practical nurses and/or nurse assistants available at the facility?P_Facility_PractNurse
1Yes
2No
3Do not know
1
61 (52%) — Yes
2
52 (44%) — No
3
5 (4%) — Don't know
Q22Practical Nurse Scope of WorkFree textWhat is the current scope of work for a practical nurse/nurse assistant at the PHO service?P_Tasks_PractNurse
Free-text response describing daily tasks and activities.
Q23Nurse Educators at FacilityNo (68%)Are nurse educators available at the facility?P_Facility_NurseEdu
1Yes
2No
3Do not know
1
37 (31%) — Yes
2
80 (68%) — No
3
1 (1%) — Don't know
Q24Nurse Educator Scope of WorkFree textWhat is the current scope of work for a nurse educator at the PHO service?P_Tasks_NurseEdu
Free-text response describing daily tasks and activities.
Q25Ambulatory Nurses at FacilityYes (81%)Are ambulatory care nurses available at the facility?P_Facility_AmbuNurse
1Yes
2No
3Do not know
1
95 (81%) — Yes
2
23 (20%) — No
3
0 (0%) — Don't know
Q26Ambulatory Nurse Scope of WorkFree textWhat is the current scope of work for most ambulatory PHO care nurses?P_Tasks_AmbuNurse
Free-text response describing daily tasks and activities.
Q27Clerical Staff at FacilityYes (83%)Are clerical healthcare workers available at the facility?P_Facility_Clerical
1Yes
2No
3Do not know
1
98 (83%) — Yes
2
14 (12%) — No
3
6 (5%) — Don't know
Q28Clerical: Administrative SupportAlmost Always (85%)How often are clerical staff available for administrative support?P_Clerical_AdminSupport
1Almost Always
2Frequently
3Sometimes
4Infrequently
5Almost Never
6Not Available
7Do not know
Sub-question of Q27, answered when clerical staff are available.
1
83 (85%) — Almost Always
2
9 (9%) — Frequently
3
3 (3%) — Sometimes
4
0 (0%) — Infrequently
5
2 (2%) — Almost Never
6
0 (0%) — Not Available
7
1 (1%) — Don't know
Q29Clerical: Medical Record ClerksAlmost Always (40%)How often are clerical staff available as medical record clerks?P_Clerical_MRClerk
1Almost Always
2Frequently
3Sometimes
4Infrequently
5Almost Never
6Not Available
7Do not know
Sub-question of Q27.
1
39 (40%) — Almost Always
2
15 (15%) — Frequently
3
15 (15%) — Sometimes
4
3 (3%) — Infrequently
5
14 (14%) — Almost Never
6
4 (4%) — Not Available
7
8 (8%) — Don't know
Q30Clerical: Medical CodersAlmost Never (30%)How often are clerical staff available as medical coders?P_Clerical_Coders
1Almost Always
2Frequently
3Sometimes
4Infrequently
5Almost Never
6Not Available
7Do not know
Sub-question of Q27.
1
19 (19%) — Almost Always
2
8 (8%) — Frequently
3
6 (6%) — Sometimes
4
6 (6%) — Infrequently
5
29 (30%) — Almost Never
6
6 (6%) — Not Available
7
24 (25%) — Don't know
Q31Clerical: Medical TranscriptionistAlmost Never (33%)How often are clerical staff available as medical transcriptionists?P_Clerical_MedTx
1Almost Always
2Frequently
3Sometimes
4Infrequently
5Almost Never
6Not Available
7Do not know
Sub-question of Q27.
1
12 (12%) — Almost Always
2
6 (6%) — Frequently
3
7 (7%) — Sometimes
4
9 (9%) — Infrequently
5
32 (33%) — Almost Never
6
9 (9%) — Not Available
7
23 (24%) — Don't know
Q32Clerical: Stretcher BearerAlmost Never (27%)How often are clerical staff available as stretcher bearers?P_Clerical_Stretcher
1Almost Always
2Frequently
3Sometimes
4Infrequently
5Almost Never
6Not Available
7Do not know
Sub-question of Q27.
1
25 (26%) — Almost Always
2
21 (21%) — Frequently
3
8 (8%) — Sometimes
4
3 (3%) — Infrequently
5
26 (27%) — Almost Never
6
9 (9%) — Not Available
7
6 (6%) — Don't know
Q33Clerical Scope of WorkFree textWhat additional tasks or activities are part of the scope of work for a clerical healthcare worker at the PHO service?P_Tasks_Clerical
Free-text response.
Q34Total New Cancer PatientsNumber (48.9)Total number of newly diagnosed cancer patients at the facilityP_TotalNewPatients
N=118 responses. Mean=48.9, Median=24, Range=0-1200.
Q35Ambulatory Visits per DayNumber (12.5)Average number of PHO ambulatory care visits per clinic dayP_NoAmbuVisits
N=118 responses. Mean=12.5, Median=7, Range=0-140.
Q36Ward ScenarioDedicated PHO ward (59%)Which of the previous scenarios best describes the ward used to calculate nurse:patient ratios?P_Scenarios
1Scenario a: Dedicated PHO inpatient ward
2Scenario b: Shared ward, dedicated PHO area
3Scenario c: Shared ward, no dedicated PHO area
1
69 (59%) — Dedicated PHO ward
2
37 (31%) — Shared, dedicated area
3
12 (10%) — Shared, no dedicated
Q37Number of BedsNumber (17.3)Number of beds in the PHO ward/areaP_Numberofbeds
N=118 responses. Mean=17.3, Median=14, Range=2-85.
Core Consultants & AccessibilityQ38-Q68 · max 93 pts
Q38IntensivistAlmost Always (68%)Accessibility of intensivist for the PHO serviceP_Accessibility_Intensivist
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
80 (68%) — Almost Always [3 pts]
2
13 (11%) — Frequently [2 pts]
3
4 (3%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
5 (4%) — Almost Never [0 pts]
6
13 (11%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q39Clinical PharmacistAlmost Always (37%)Accessibility of clinical pharmacist for the PHO serviceP_Accessibility_Pharmacist
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
44 (37%) — Almost Always [3 pts]
2
14 (12%) — Frequently [2 pts]
3
6 (5%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
7 (6%) — Almost Never [0 pts]
6
39 (33%) — Not available [0 pts]
7
5 (4%) — Don't know [0 pts]
Q40Anatomic PathologistAlmost Always (64%)Accessibility of anatomic pathologist for the PHO serviceP_Accessibility_AnaPathologist
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
75 (64%) — Almost Always [3 pts]
2
25 (21%) — Frequently [2 pts]
3
7 (6%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
7 (6%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q41HematopathologistNot available (57%)Accessibility of hematopathologist for the PHO serviceP_Accessibility_HemaPathologist
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
11 (23%) — Almost Always [3 pts]
2
2 (4%) — Frequently [2 pts]
3
3 (6%) — Sometimes [1 pt]
4
1 (2%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
27 (57%) — Not available [0 pts]
7
3 (6%) — Don't know [0 pts]
Q42RadiologistAlmost Always (72%)Accessibility of radiologist for the PHO serviceP_Accessibility_Radiologist
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
85 (72%) — Almost Always [3 pts]
2
23 (20%) — Frequently [2 pts]
3
7 (6%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
2 (2%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q43Pediatric SurgeonAlmost Always (78%)Accessibility of pediatric surgeon for the PHO serviceP_Accessibility_Surgeon
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
92 (78%) — Almost Always [3 pts]
2
19 (16%) — Frequently [2 pts]
3
2 (2%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
3 (3%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q44Orthopedic SurgeonAlmost Always (59%)Accessibility of orthopedic surgeon for the PHO serviceP_Accessibility_Orthopedic
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
70 (59%) — Almost Always [3 pts]
2
15 (13%) — Frequently [2 pts]
3
11 (9%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
14 (12%) — Not available [0 pts]
7
3 (3%) — Don't know [0 pts]
Q45NeurosurgeonAlmost Always (56%)Accessibility of neurosurgeon for the PHO serviceP_Accessibility_Neurosurgeon
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
66 (56%) — Almost Always [3 pts]
2
20 (17%) — Frequently [2 pts]
3
15 (13%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
12 (10%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q46Ophthalmology SurgeonAlmost Always (48%)Accessibility of ophthalmology surgeon for the PHO serviceP_Accessibility_Ophthalmology
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
56 (48%) — Almost Always [3 pts]
2
24 (20%) — Frequently [2 pts]
3
8 (7%) — Sometimes [1 pt]
4
9 (8%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
18 (15%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q47Ocular Prosthesis SpecialistNot available (62%)Accessibility of ocular prosthesis specialist for the PHO serviceP_Accessibility_Ocular
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
12 (10%) — Almost Always [3 pts]
2
4 (3%) — Frequently [2 pts]
3
5 (4%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
8 (7%) — Almost Never [0 pts]
6
73 (62%) — Not available [0 pts]
7
11 (9%) — Don't know [0 pts]
Q48Interventional RadiologistAlmost Always (33%)Accessibility of interventional radiologist for the PHO serviceP_Accessibility_Intervention
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
39 (33%) — Almost Always [3 pts]
2
19 (16%) — Frequently [2 pts]
3
13 (11%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
39 (33%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q49Nuclear Medicine SpecialistNot available (40%)Accessibility of nuclear medicine specialist for the PHO serviceP_Accessibility_Nuclear
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
35 (30%) — Almost Always [3 pts]
2
13 (11%) — Frequently [2 pts]
3
13 (11%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
47 (40%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q50AnesthesiologistAlmost Always (82%)Accessibility of anesthesiologist for the PHO serviceP_Accessibility_Anesthesiologist
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
97 (82%) — Almost Always [3 pts]
2
12 (10%) — Frequently [2 pts]
3
6 (5%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
2 (2%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q51Pain SpecialistAlmost Always (48%)Accessibility of pain specialist for the PHO serviceP_Accessibility_Pain
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
57 (48%) — Almost Always [3 pts]
2
14 (12%) — Frequently [2 pts]
3
18 (15%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
25 (21%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q52Palliative Care SpecialistAlmost Always (41%)Accessibility of palliative care specialist for the PHO serviceP_Accessibility_Palliative
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
48 (41%) — Almost Always [3 pts]
2
16 (14%) — Frequently [2 pts]
3
5 (4%) — Sometimes [1 pt]
4
8 (7%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
40 (34%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q53Respiratory TherapistAlmost Always (33%)Accessibility of respiratory therapist for the PHO serviceP_Accessibility_Respiratory
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
39 (33%) — Almost Always [3 pts]
2
17 (14%) — Frequently [2 pts]
3
17 (14%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
34 (29%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q54Child Life SpecialistNot available (56%)Accessibility of child life (play) specialist for the PHO serviceP_Accessibility_ChildLife
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
21 (18%) — Almost Always [3 pts]
2
6 (5%) — Frequently [2 pts]
3
12 (10%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
66 (56%) — Not available [0 pts]
7
6 (5%) — Don't know [0 pts]
Q55Dietician/NutritionistAlmost Always (65%)Accessibility of dietician/nutritionist for the PHO serviceP_Accessibility_Dietician
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
77 (65%) — Almost Always [3 pts]
2
18 (15%) — Frequently [2 pts]
3
8 (7%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
7 (6%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q56PsychologistAlmost Always (55%)Accessibility of psychologist for the PHO serviceP_Accessibility_Psychologist
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
65 (55%) — Almost Always [3 pts]
2
17 (14%) — Frequently [2 pts]
3
16 (14%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
11 (9%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q57PsychiatristAlmost Always (33%)Accessibility of psychiatrist for the PHO serviceP_Accessibility_Psychiatrist
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
39 (33%) — Almost Always [3 pts]
2
28 (24%) — Frequently [2 pts]
3
21 (18%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
18 (15%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q58PT/OT/Rehab ProviderAlmost Always (48%)Accessibility of physical therapist/occupational therapist/rehabilitation provider for the PHO serviceP_Accessibility_Therapist
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
57 (48%) — Almost Always [3 pts]
2
25 (21%) — Frequently [2 pts]
3
17 (14%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
9 (8%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q59Legal/Child ProtectionNot available (38%)Accessibility of legal (child protection) team member for the PHO serviceP_Accessibility_Legal
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
30 (25%) — Almost Always [3 pts]
2
7 (6%) — Frequently [2 pts]
3
9 (8%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
6 (5%) — Almost Never [0 pts]
6
45 (38%) — Not available [0 pts]
7
16 (14%) — Don't know [0 pts]
Q60Infection Prevention SpecialistAlmost Always (44%)Accessibility of infection prevention specialist for the PHO serviceP_Accessibility_Infection
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
52 (44%) — Almost Always [3 pts]
2
12 (10%) — Frequently [2 pts]
3
12 (10%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
5 (4%) — Almost Never [0 pts]
6
28 (24%) — Not available [0 pts]
7
3 (3%) — Don't know [0 pts]
Q61Pediatric CardiologistAlmost Always (65%)Accessibility of pediatric cardiologist for the PHO serviceP_Accessibility_Cardio
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
77 (65%) — Almost Always [3 pts]
2
21 (18%) — Frequently [2 pts]
3
7 (6%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
9 (8%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q62Pediatric EndocrinologistAlmost Always (56%)Accessibility of pediatric endocrinologist for the PHO serviceP_Accessibility_Endo
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
66 (56%) — Almost Always [3 pts]
2
13 (11%) — Frequently [2 pts]
3
11 (9%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
23 (20%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q63Pediatric NephrologistAlmost Always (57%)Accessibility of pediatric nephrologist for the PHO serviceP_Accessibility_Nephro
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
67 (57%) — Almost Always [3 pts]
2
11 (9%) — Frequently [2 pts]
3
9 (8%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
24 (20%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q64Pediatric PulmonologistAlmost Always (51%)Accessibility of pediatric pulmonologist for the PHO serviceP_Accessibility_Pulmon
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
60 (51%) — Almost Always [3 pts]
2
13 (11%) — Frequently [2 pts]
3
6 (5%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
33 (28%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q65Radiation OncologistAlmost Always (42%)Accessibility of radiation oncologist for the PHO serviceP_Accessibility_RadOnco
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
50 (42%) — Almost Always [3 pts]
2
15 (13%) — Frequently [2 pts]
3
10 (9%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
38 (32%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q66Radiation TherapistAlmost Always (44%)Accessibility of radiation therapist for the PHO serviceP_Accessibility_RadTherapist
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
52 (44%) — Almost Always [3 pts]
2
15 (13%) — Frequently [2 pts]
3
10 (9%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
33 (28%) — Not available [0 pts]
7
4 (3%) — Don't know [0 pts]
Q67Medical Radiation PhysicistNot available (42%)Accessibility of medical radiation physicist for the PHO serviceP_Accessibility_RadPhysic
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
37 (31%) — Almost Always [3 pts]
2
11 (9%) — Frequently [2 pts]
3
2 (2%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
50 (42%) — Not available [0 pts]
7
12 (10%) — Don't know [0 pts]
Q68DosimetristsNot available (51%)Accessibility of dosimetrists for the PHO serviceP_Accessibility_Dosimet
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
34 (29%) — Almost Always [3 pts]
2
5 (4%) — Frequently [2 pts]
3
3 (3%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
60 (51%) — Not available [0 pts]
7
12 (10%) — Don't know [0 pts]
Level of TrainingQ69-Q82 · max 70 pts
Q69Responsibility: LeukemiaPHO-trained (98%)Who is primarily responsible for the management of children with leukemia?P_Responsibility_Leukemia
1[5 pts]PHO-trained provider
2[3 pts]Adult H/O-trained provider
3[1 pt]Pediatrician
4[0 pts]General practitioner
5[0 pts]Dedicated H/O staff not available
6[0 pts]Other
1
116 (98%) — PHO-trained [5 pts]
2
0 (0%) — Adult H/O [3 pts]
3
2 (2%) — Pediatrician [1 pt]
4
0 (0%) — GP [0 pts]
5
0 (0%) — Not available [0 pts]
6
0 (0%) — Other [0 pts]
Q70Responsibility: LymphomaPHO-trained (97%)Who is primarily responsible for the management of children with lymphoma?P_Responsibility_Lymphoma
1[5 pts]PHO-trained provider
2[3 pts]Adult H/O-trained provider
3[1 pt]Pediatrician
4[0 pts]General practitioner
5[0 pts]Dedicated H/O staff not available
6[0 pts]Other
1
114 (97%) — PHO-trained [5 pts]
2
2 (2%) — Adult H/O [3 pts]
3
1 (1%) — Pediatrician [1 pt]
4
0 (0%) — GP [0 pts]
5
1 (1%) — Not available [0 pts]
6
0 (0%) — Other [0 pts]
Q71Responsibility: Non-CNS Solid TumorPHO-trained (94%)Who is primarily responsible for the management of children with non-CNS solid tumors?P_Responsibility_Solid
1[5 pts]PHO-trained provider
2[3 pts]Adult H/O-trained provider
3[1 pt]Pediatrician
4[0 pts]General practitioner
5[0 pts]Dedicated H/O staff not available
6[0 pts]Other
1
111 (94%) — PHO-trained [5 pts]
2
1 (1%) — Adult H/O [3 pts]
3
1 (1%) — Pediatrician [1 pt]
4
0 (0%) — GP [0 pts]
5
3 (3%) — Not available [0 pts]
6
2 (2%) — Other [0 pts]
Q72Responsibility: Brain TumorPHO-trained (92%)Who is primarily responsible for the management of children with brain tumors?P_Responsibility_Brain
1[5 pts]PHO-trained provider
2[3 pts]Adult H/O-trained provider
3[1 pt]Pediatrician
4[0 pts]General practitioner
5[0 pts]Dedicated H/O staff not available
6[0 pts]Other
1
109 (92%) — PHO-trained [5 pts]
2
0 (0%) — Adult H/O [3 pts]
3
2 (2%) — Pediatrician [1 pt]
4
0 (0%) — GP [0 pts]
5
5 (4%) — Not available [0 pts]
6
2 (2%) — Other [0 pts]
Q73Surgical Training: General SurgeonPed surgery (56%)What is the highest level of training for the general surgeon managing PHO patients?P_Training_Surgeon
1[5 pts]Pediatric oncologic surgery
2[3 pts]Pediatric surgery
3[3 pts]Oncologic surgery
4[1 pt]General surgery
5[0 pts]Dedicated surgical staff not available
6[0 pts]Not applicable
1
39 (33%) — Ped onco surgery [5 pts]
2
66 (56%) — Ped surgery [3 pts]
3
3 (3%) — Onco surgery [3 pts]
4
5 (4%) — General surgery [1 pt]
5
1 (1%) — Not available [0 pts]
6
4 (3%) — N/A [0 pts]
Q74Surgical Training: Orthopedic SurgeonPed surgery (40%)What is the highest level of training for the orthopedic surgeon managing PHO patients?P_Training_Orthopedic
1[5 pts]Pediatric oncologic surgery
2[3 pts]Pediatric surgery
3[3 pts]Oncologic surgery
4[1 pt]General surgery
5[0 pts]Dedicated surgical staff not available
6[0 pts]Not applicable
1
17 (14%) — Ped onco surgery [5 pts]
2
47 (40%) — Ped surgery [3 pts]
3
7 (6%) — Onco surgery [3 pts]
4
25 (21%) — General surgery [1 pt]
5
13 (11%) — Not available [0 pts]
6
9 (8%) — N/A [0 pts]
Q75Surgical Training: NeurosurgeonPed surgery (33%)What is the highest level of training for the neurosurgeon managing PHO patients?P_Training_Neurosurgeon
1[5 pts]Pediatric oncologic surgery
2[3 pts]Pediatric surgery
3[3 pts]Oncologic surgery
4[1 pt]General surgery
5[0 pts]Dedicated surgical staff not available
6[0 pts]Not applicable
1
13 (11%) — Ped onco surgery [5 pts]
2
39 (33%) — Ped surgery [3 pts]
3
5 (4%) — Onco surgery [3 pts]
4
37 (31%) — General surgery [1 pt]
5
14 (12%) — Not available [0 pts]
6
10 (9%) — N/A [0 pts]
Q76Surgical Training: Head & Neck SurgeonNot available (28%)What is the highest level of training for the head & neck surgeon managing PHO patients?P_Training_HNSurgeon
1[5 pts]Pediatric oncologic surgery
2[3 pts]Pediatric surgery
3[3 pts]Oncologic surgery
4[1 pt]General surgery
5[0 pts]Dedicated surgical staff not available
6[0 pts]Not applicable
1
8 (7%) — Ped onco surgery [5 pts]
2
14 (12%) — Ped surgery [3 pts]
3
19 (16%) — Onco surgery [3 pts]
4
23 (20%) — General surgery [1 pt]
5
33 (28%) — Not available [0 pts]
6
21 (18%) — N/A [0 pts]
Q77Surgical Training: Ophthalmology SurgeonGeneral surgery (41%)What is the highest level of training for the ophthalmology surgeon managing PHO patients?P_Training_Ophthalmology
1[5 pts]Pediatric oncologic surgery
2[3 pts]Pediatric surgery
3[3 pts]Oncologic surgery
4[1 pt]General surgery
5[0 pts]Dedicated surgical staff not available
6[0 pts]Not applicable
1
13 (11%) — Ped onco surgery [5 pts]
2
20 (17%) — Ped surgery [3 pts]
3
2 (2%) — Onco surgery [3 pts]
4
48 (41%) — General surgery [1 pt]
5
23 (20%) — Not available [0 pts]
6
12 (10%) — N/A [0 pts]
Q78Training: PathologistAdult provider (49%)What is the level of training of the pathologist managing PHO patients?P_Training_Pathologist
1[5 pts]Provider is formally trained in childhood cancer
2[4 pts]Provider has special interest in childhood cancer
3[2 pts]Provider is trained in childhood diseases
4[1 pt]Provider is available for children, but is an adult provider
5[0 pts]Provider not available
1
20 (17%) — Formal childhood cancer [5 pts]
2
24 (20%) — Special interest [4 pts]
3
11 (9%) — Childhood diseases [2 pts]
4
58 (49%) — Adult provider [1 pt]
5
5 (4%) — Not available [0 pts]
Q79Training: Radiation OncologistAdult provider (35%)What is the level of training of the radiation oncologist managing PHO patients?P_Training_Radiation
1[5 pts]Provider is formally trained in childhood cancer
2[4 pts]Provider has special interest in childhood cancer
3[2 pts]Provider is trained in childhood diseases
4[1 pt]Provider is available for children, but is an adult provider
5[0 pts]Provider not available
1
22 (19%) — Formal childhood cancer [5 pts]
2
15 (13%) — Special interest [4 pts]
3
1 (1%) — Childhood diseases [2 pts]
4
41 (35%) — Adult provider [1 pt]
5
39 (33%) — Not available [0 pts]
Q80Training: RadiologistAdult provider (55%)What is the level of training of the radiologist managing PHO patients?P_Training_Radiologist
1[5 pts]Provider is formally trained in childhood cancer
2[4 pts]Provider has special interest in childhood cancer
3[2 pts]Provider is trained in childhood diseases
4[1 pt]Provider is available for children, but is an adult provider
5[0 pts]Provider not available
1
9 (8%) — Formal childhood cancer [5 pts]
2
19 (16%) — Special interest [4 pts]
3
16 (14%) — Childhood diseases [2 pts]
4
65 (55%) — Adult provider [1 pt]
5
9 (8%) — Not available [0 pts]
Q81Training: Interventional RadiologistNot available (46%)What is the level of training of the interventional radiologist managing PHO patients?P_Training_Interventional
1[5 pts]Provider is formally trained in childhood cancer
2[4 pts]Provider has special interest in childhood cancer
3[2 pts]Provider is trained in childhood diseases
4[1 pt]Provider is available for children, but is an adult provider
5[0 pts]Provider not available
1
6 (5%) — Formal childhood cancer [5 pts]
2
14 (12%) — Special interest [4 pts]
3
3 (3%) — Childhood diseases [2 pts]
4
41 (35%) — Adult provider [1 pt]
5
54 (46%) — Not available [0 pts]
Q82Training: Palliative Care ProviderNot available (43%)What is the level of training of the palliative care provider managing PHO patients?P_Training_Palliative
1[5 pts]Provider is formally trained in childhood cancer
2[4 pts]Provider has special interest in childhood cancer
3[2 pts]Provider is trained in childhood diseases
4[1 pt]Provider is available for children, but is an adult provider
5[0 pts]Provider not available
1
25 (21%) — Formal childhood cancer [5 pts]
2
9 (8%) — Special interest [4 pts]
3
9 (8%) — Childhood diseases [2 pts]
4
24 (20%) — Adult provider [1 pt]
5
51 (43%) — Not available [0 pts]
Planning & ImprovementQ83-Q84 · max 10 pts
Q83Overall Status RatingScale (6.7)Overall, how would you rate the current status of personnel and staffing for delivery of PHO care at your facility (1=Weak and 10=Strong)?P_Impression
Self-assessment scale 1-10. N=118 responses. Mean=6.7, Median=7. Not scored.
7
33 (28%)
8
27 (23%)
6
18 (15%)
9
12 (10%)
4
9 (8%)
5
8 (7%)
3
6 (5%)
10
3 (3%)
1
1 (1%)
2
1 (1%)
Q84Improvement PlansYes (47%)Are there plans and committed resources to improve the current status of your personnel and staffing for delivery of PHO care in the next 12 months?P_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
55 (47%) — Yes [10 pts]
2
32 (27%) — No [0 pts]
3
31 (26%) — Don't know [0 pts]
Module 5: Service Capacity (Capacidad de Servicio)71 questions · max 205 pts
Inpatient InfrastructureQ1-Q19 · max 10 pts
Q1Total Facility BedsNumber (194.4)Total # of inpatient beds in the facilitySC_AllBeds
N=118 responses. Mean=194.4, Median=150.5, Range=0-1200. Not scored.
Q2Pediatric BedsNumber (47.1)Total # of general pediatric inpatient bedsSC_BedsPed
N=118 responses. Mean=47.1, Median=29, Range=0-427. Not scored.
Q3PICU BedsNumber (5.1)Total # of pediatric intensive care bedsSC_BedsPICU
N=118 responses. Mean=5.1, Median=4, Range=0-28. Not scored.
Q4PHO BedsNumber (14.6)Total # of inpatient PHO bedsSC_BedsPHO
N=118 responses. Mean=14.6, Median=10, Range=0-163. Not scored.
Q5Isolation RoomsNumber (3.4)Total # of single-person infection isolation rooms available for PHO patientsSC_IsoRooms
N=118 responses. Mean=3.4, Median=2, Range=0-29. Not scored.
Q6BMT BedsNumber (0.7)Total # of bone marrow/stem cell transplant beds available for PHO patientsSC_SCBMBeds
N=118 responses. Mean=0.7, Median=0, Range=0-14. Not scored.
Q7Avg Patients/RoomNumber (5.9)Average number of PHO patients in a roomSC_AvePerRoom
N=118 responses. Mean=5.9, Median=5, Range=0-35. Not scored.
Q8Min Patients/RoomNumber (2.4)Minimum number of PHO patients in a roomSC_MinPerRoom
N=118 responses. Mean=2.4, Median=1, Range=0-30. Not scored.
Q9Max Patients/RoomNumber (8.4)Maximum number of PHO patients in a roomSC_MaxPerRoom
N=118 responses. Mean=8.4, Median=6, Range=0-40. Not scored.
Q10Avg Patients/BedNumber (1.0)Average number of PHO patients in a bedSC_AvePerBed
N=118 responses. Mean=1.0, Median=1, Range=1-2. Not scored.
Q11Min Patients/BedNumber (1.0)Minimum number of PHO patients in a bedSC_MinPerBed
N=118 responses. Mean=1.0, Median=1, Range=0-1. Not scored.
Q12Max Patients/BedNumber (1.0)Maximum number of PHO patients in a bedSC_MaxPerBed
N=118 responses. Mean=1.0, Median=1, Range=1-2. Not scored.
Q13PHO Inpatients/DayNumber (9.3)What is the average number of PHO inpatients on a typical day?SC_PatientsPerDay
N=118 responses. Mean=9.3, Median=6, Range=0-90. Not scored.
Q14Physicians/DayNumber (3.9)What is the number of physicians assigned to the inpatient area per day?SC_PhysiciansPerDay
N=118 responses. Mean=3.9, Median=2.5, Range=0-45. Not scored.
Q15Patients per PHO PhysicianNumber (7.4)What is the average number of PHO and non-PHO patients per PHO physician on a typical weekday shift?SC_PatientPerPHO
N=118 responses. Mean=7.4, Median=6, Range=0-24. Not scored.
Q16Patients per GPNumber (12.6)What is the average number of PHO and non-PHO patients per in-house physician (general practitioner) on a typical night/weekend shift?SC_PatientPerGP
N=118 responses. Mean=12.6, Median=10, Range=0-90. Not scored.
Q17Specialized NursesNo (73%)Are most inpatient bedside nurses specialized in pediatric oncology (as opposed to generalists)?SC_NurseSpec
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
32 (27%) — Yes [5 pts]
2
86 (73%) — No [0 pts]
3
0 (0%) — Don't know [0 pts]
Q18Designated NursesYes (57%)Are nurses designated to the pediatric oncology unit (as opposed to float nurses who rotate assignments)?SC_NurseDesign
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
67 (57%) — Yes [5 pts]
2
49 (42%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
Q19Nurse Rotation Duration> 3 months (65%)How long are generalist nurses assigned to a service/unit before they rotate again?SC_NurseAssign
1[0 pts]Monthly
2[0 pts]Every 2 months
3[0 pts]Every 3 months
4[1 pt]Interval > 3 months
Sub-question of Q18. Only answered when SC_NurseDesign = No.
1
15 (31%) — Monthly [0 pts]
2
0 (0%) — Every 2 mo [0 pts]
3
2 (4%) — Every 3 mo [0 pts]
4
32 (65%) — > 3 months [1 pt]
Ambulatory CareQ20-Q26 · descriptive
Q20Ambulatory Visits/DayNumber (12.5)Average number of PHO ambulatory care visits per clinic daySC_AmbuVisits
N=118 responses. Mean=12.5, Median=7, Range=0-140. Not scored.
Q21Ambulatory Days/WeekNumber (5.4)Number of days per week PHO patients may be seen in ambulatory care areaSC_AmbuDays
N=118 responses. Mean=5.4, Median=5, Range=0-7. Not scored.
Q22Procedure Days/WeekNumber (3.8)Number of days per week ambulatory PHO procedures are performedSC_AmbuProced
N=118 responses. Mean=3.8, Median=5, Range=0-7. Not scored.
Q23Procedure RoomsNumber (1.1)Number of procedure rooms in PHO ambulatory care areaSC_AmbuRooms
N=118 responses. Mean=1.1, Median=1, Range=0-15. Not scored.
Q24Ambulatory Isolation RoomsNumber (1.0)Number of single-patient isolation rooms in PHO ambulatory care areaSC_AmbuIso
N=118 responses. Mean=1.0, Median=0, Range=0-25. Not scored.
Q25Day Chemo Chairs/BedsNumber (7.4)Number of Day Chemotherapy chairs/beds/cots in the PHO ambulatory care areaSC_AmbuChemo
N=118 responses. Mean=7.4, Median=6, Range=0-25. Not scored.
Q26Ambulatory PhysiciansNumber (1.1)Number of physicians assigned to the ambulatory care area per daySC_AmbuPhysicians
N=118 responses. Mean=1.1, Median=1, Range=0-12. Not scored.
Specialty Services OpinionQ27a-l · max 60 pts
Q27aPICU OpinionState of the art (24%)Rate the following: a. Pediatric Intensive Care UnitSC_Opinion_IntenCU
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
27 (23%) — Not available [0 pts]
1
4 (3%) — Inadequate [0 pts]
2
7 (6%) — Basic [1 pt]
3
10 (9%) — Adequate [2 pts]
4
16 (14%) — Good [3 pts]
5
26 (22%) — Very good [4 pts]
6
28 (24%) — State of the art [5 pts]
Q27bIntermediate Care OpinionNot available (63%)Rate the following: b. Pediatric Intermediate Care UnitSC_Opinion_InterCU
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
74 (63%) — Not available [0 pts]
1
2 (2%) — Inadequate [0 pts]
2
4 (3%) — Basic [1 pt]
3
6 (5%) — Adequate [2 pts]
4
5 (4%) — Good [3 pts]
5
9 (8%) — Very good [4 pts]
6
18 (15%) — State of the art [5 pts]
Q27cBMT Unit OpinionNot available (76%)Rate the following: c. Bone Marrow Transplant UnitSC_Opinion_BM
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
90 (76%) — Not available [0 pts]
1
0 (0%) — Inadequate [0 pts]
2
3 (3%) — Basic [1 pt]
3
5 (4%) — Adequate [2 pts]
4
1 (1%) — Good [3 pts]
5
8 (7%) — Very good [4 pts]
6
11 (9%) — State of the art [5 pts]
Q27dOR OpinionGood (25%)Rate the following: d. Surgical Suite / Operating RoomSC_Opinion_OR
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
1 (1%) — Not available [0 pts]
1
5 (4%) — Inadequate [0 pts]
2
8 (7%) — Basic [1 pt]
3
22 (19%) — Adequate [2 pts]
4
30 (25%) — Good [3 pts]
5
30 (25%) — Very good [4 pts]
6
22 (19%) — State of the art [5 pts]
Q27ePost-op Recovery OpinionGood (24%)Rate the following: e. Post-operative Recovery RoomSC_Opinion_PostOp
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
4 (3%) — Not available [0 pts]
1
4 (3%) — Inadequate [0 pts]
2
16 (14%) — Basic [1 pt]
3
21 (18%) — Adequate [2 pts]
4
28 (24%) — Good [3 pts]
5
27 (23%) — Very good [4 pts]
6
18 (15%) — State of the art [5 pts]
Q27fInterventional Radiology OpinionNot available (48%)Rate the following: f. Interventional Radiology DepartmentSC_Opinion_Xray
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
56 (48%) — Not available [0 pts]
1
4 (3%) — Inadequate [0 pts]
2
17 (14%) — Basic [1 pt]
3
5 (4%) — Adequate [2 pts]
4
8 (7%) — Good [3 pts]
5
19 (16%) — Very good [4 pts]
6
9 (8%) — State of the art [5 pts]
Q27gPharmacy OpinionGood (27%)Rate the following: g. Pharmacy DepartmentSC_Opinion_Pharm
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
3 (3%) — Not available [0 pts]
1
8 (7%) — Inadequate [0 pts]
2
13 (11%) — Basic [1 pt]
3
26 (22%) — Adequate [2 pts]
4
32 (27%) — Good [3 pts]
5
15 (13%) — Very good [4 pts]
6
21 (18%) — State of the art [5 pts]
Q27hBlood Bank OpinionVery good (22%)Rate the following: h. Blood BankSC_Opinion_Blood
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
9 (8%) — Not available [0 pts]
1
4 (3%) — Inadequate [0 pts]
2
12 (10%) — Basic [1 pt]
3
24 (20%) — Adequate [2 pts]
4
24 (20%) — Good [3 pts]
5
26 (22%) — Very good [4 pts]
6
19 (16%) — State of the art [5 pts]
Q27iInfection Control OpinionGood (19%)Rate the following: i. Infection Control DepartmentSC_Opinion_ICD
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
19 (16%) — Not available [0 pts]
1
7 (6%) — Inadequate [0 pts]
2
15 (13%) — Basic [1 pt]
3
21 (18%) — Adequate [2 pts]
4
22 (19%) — Good [3 pts]
5
19 (16%) — Very good [4 pts]
6
15 (13%) — State of the art [5 pts]
Q27jNutrition OpinionGood (21%)Rate the following: j. Nutrition / Dietary Support ServicesSC_Opinion_Nutrition
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
4 (3%) — Not available [0 pts]
1
9 (8%) — Inadequate [0 pts]
2
24 (20%) — Basic [1 pt]
3
15 (13%) — Adequate [2 pts]
4
25 (21%) — Good [3 pts]
5
25 (21%) — Very good [4 pts]
6
16 (14%) — State of the art [5 pts]
Q27kLaboratory OpinionGood (25%)Rate the following: k. Laboratory DepartmentSC_Opinion_Lab
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
0 (0%) — Not available [0 pts]
1
1 (1%) — Inadequate [0 pts]
2
17 (14%) — Basic [1 pt]
3
16 (14%) — Adequate [2 pts]
4
30 (25%) — Good [3 pts]
5
28 (24%) — Very good [4 pts]
6
26 (22%) — State of the art [5 pts]
Q27lMicrobiology OpinionGood (22%)Rate the following: l. Microbiology DepartmentSC_Opinion_Micro
0[0 pts]Not available
1[0 pts]Inadequate
2[1 pt]Basic
3[2 pts]Adequate
4[3 pts]Good
5[4 pts]Very good
6[5 pts]State of the art
0
8 (7%) — Not available [0 pts]
1
4 (3%) — Inadequate [0 pts]
2
17 (14%) — Basic [1 pt]
3
18 (15%) — Adequate [2 pts]
4
26 (22%) — Good [3 pts]
5
24 (20%) — Very good [4 pts]
6
21 (18%) — State of the art [5 pts]
Acute Care & EmergencyQ28-Q33 · max 40 pts
Q28After-Hours ManagementPeds ER (68%)Where are PHO patients coming from home with a fever (or other acute issue) managed after hours?SC_AfterHours
1[1 pt]General Emergency Room / Urgent Care Area (Adult and Pediatrics)
2[2 pts]General Pediatrics Emergency Room / Urgent Care Area
3[5 pts]Dedicated PHO Emergency Room / Urgent Care Area
4[3 pts]Directly on the PHO inpatient care area
5Other
1
16 (14%) — General ER [1 pt]
2
80 (68%) — Peds ER [2 pts]
3
11 (9%) — PHO ER [5 pts]
4
11 (9%) — PHO inpatient [3 pts]
5
0 (0%) — Other
Q29ICU Transfer Time1-3hrs (37%)How long does it typically take for a PHO patient with clinical deterioration to be transferred to the ICU?SC_Transfer
1[5 pts]<1hr
2[3 pts]1-3hrs
3[2 pts]4-8hrs
4[1 pt]>8hrs
1
28 (24%) — <1hr [5 pts]
2
44 (37%) — 1-3hrs [3 pts]
3
26 (22%) — 4-8hrs [2 pts]
4
20 (17%) — >8hrs [1 pt]
Q30F&N AlgorithmYes (86%)Do you have a fever and neutropenia algorithm?SC_FNLog
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
102 (86%) — Yes [5 pts]
2
15 (13%) — No [0 pts]
3
1 (1%) — Don't know [0 pts]
Q31F&N Algorithm AccessibilityYes (97%)If you have a fever and neutropenia algorithm, is it easily accessible to nursing staff, general practitioners, and residents?SC_FNLogAccess
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
Sub-question of Q30. Only answered when SC_FNLog = Yes.
1
99 (97%) — Yes [5 pts]
2
2 (2%) — No [0 pts]
3
1 (1%) — Don't know [0 pts]
Q32Antibiotic AvailabilityYes (88%)Do you have a process to ensure stock for rapid availability of antibiotics for PHO patients presenting with fever and neutropenia?SC_FNAntibiotics
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
104 (88%) — Yes [5 pts]
2
12 (10%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
Q33aVasopressors in PHO AreaAlmost Never (35%)How frequently: a. Vasopressors are administered for >24hrs in the PHO inpatient care area due to lack of ICU bed availabilitySC_Practices_Vaso
1[0 pts]Almost Always
2[0 pts]Frequently
3[1 pt]Sometimes
4[3 pts]Infrequently
5[5 pts]Almost Never
6[0 pts]Do not know
Reverse-scored: less frequent = better.
1
19 (16%) — Almost Always [0 pts]
2
10 (9%) — Frequently [0 pts]
3
31 (26%) — Sometimes [1 pt]
4
17 (14%) — Infrequently [3 pts]
5
41 (35%) — Almost Never [5 pts]
6
0 (0%) — Don't know [0 pts]
Q33bMechanical Ventilation in PHO AreaAlmost Never (45%)How frequently: b. Mechanical ventilation is provided for >2hrs in the PHO inpatient care area due to lack of ICU bed availabilitySC_Practices_MV
1[0 pts]Almost Always
2[0 pts]Frequently
3[1 pt]Sometimes
4[3 pts]Infrequently
5[5 pts]Almost Never
6[0 pts]Do not know
Reverse-scored: less frequent = better.
1
18 (15%) — Almost Always [0 pts]
2
12 (10%) — Frequently [0 pts]
3
22 (19%) — Sometimes [1 pt]
4
13 (11%) — Infrequently [3 pts]
5
53 (45%) — Almost Never [5 pts]
6
0 (0%) — Don't know [0 pts]
Q33cCrash Cart AvailabilityAlmost Never (90%)How frequently: c. An emergency cart (crash cart) with resuscitation supplies is not available or easily accessible in the PHO inpatient care areaSC_Practices_Cart
1[0 pts]Almost Always
2[0 pts]Frequently
3[1 pt]Sometimes
4[3 pts]Infrequently
5[5 pts]Almost Never
6[0 pts]Do not know
Reverse-scored: less frequent = better.
1
3 (3%) — Almost Always [0 pts]
2
0 (0%) — Frequently [0 pts]
3
3 (3%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [3 pts]
5
106 (90%) — Almost Never [5 pts]
6
0 (0%) — Don't know [0 pts]
Data ManagementQ34 · max 5 pts
Q34Medical Records StorageElectronic (62%)Where are medical records stored?SC_MedicalRecords
1[5 pts]Hospital-based electronic
2[3 pts]Hospital-based paper
3[0 pts]Family-maintained
4[0 pts]Other
1
73 (62%) — Electronic [5 pts]
2
42 (36%) — Paper [3 pts]
3
0 (0%) — Family [0 pts]
4
3 (3%) — Other [0 pts]
Infection Prevention & ControlQ35-Q40 · max 30 pts
Q35IPC PoliciesYes (90%)Does your facility have established infection prevention and control policies and procedures?SC_IDSOP
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
106 (90%) — Yes [5 pts]
2
5 (4%) — No [0 pts]
3
7 (6%) — Don't know [0 pts]
Q36WHO Hand Hygiene LevelIntermediate (37%)What is your WHO Hand Hygiene Facility Level?SC_HHLevel
1[0 pts]Inadequate (0-125)
2[1 pt]Basic (126-250)
3[3 pts]Intermediate (251-375)
4[5 pts]Advanced (376-500)
5[0 pts]Do not know
1
3 (3%) — Inadequate [0 pts]
2
17 (14%) — Basic [1 pt]
3
44 (37%) — Intermediate [3 pts]
4
40 (34%) — Advanced [5 pts]
5
14 (12%) — Don't know [0 pts]
Q37Environmental Services PoliciesYes (52%)Does your facility have established environmental services policies and procedures?SC_Environment
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
61 (52%) — Yes [5 pts]
2
24 (20%) — No [0 pts]
3
33 (28%) — Don't know [0 pts]
Q38Sinks in PHO AreaNumber (8.1)How many sinks are located in the PHO inpatient care area?SC_Sinks
Scored by ratio to beds. N=118 responses. Mean=8.1, Median=6, Range=0-65. Max 5 pts.
Q39Hand Sanitizer DispensersNumber (10.1)How many alcohol-based hand sanitizer dispensers are in the PHO inpatient care area?SC_Alcohol
Scored by ratio to beds. N=118 responses. Mean=10.1, Median=7, Range=0-48. Max 5 pts.
Q40Biohazard Waste SeparationYes (93%)Are infectious and contaminated waste stored separately from routine waste?SC_BioWaste
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
110 (93%) — Yes [5 pts]
2
3 (3%) — No [0 pts]
3
5 (4%) — Don't know [0 pts]
Patient SafetyQ41-Q46 · max 50 pts
Q41aPPE: GlovesAlmost Always (67%)How often is the following PPE available when required? a. GlovesSC_PPE_Glove
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
79 (67%) — Almost Always [5 pts]
2
22 (19%) — Frequently [3 pts]
3
11 (9%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
0 (0%) — Don't know [0 pts]
Q41bPPE: Chemo GlovesAlmost Always (74%)How often is the following PPE available when required? b. Gloves for handling chemotherapy (nitrile or other approved material)SC_PPE_ChemoGloves
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
87 (74%) — Almost Always [5 pts]
2
16 (14%) — Frequently [3 pts]
3
6 (5%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
6 (5%) — Almost Never [0 pts]
6
2 (2%) — Don't know [0 pts]
Q41cPPE: GownsAlmost Always (68%)How often is the following PPE available when required? c. GownsSC_PPE_Gowns
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
80 (68%) — Almost Always [5 pts]
2
19 (16%) — Frequently [3 pts]
3
12 (10%) — Sometimes [1 pt]
4
7 (6%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — Don't know [0 pts]
Q41dPPE: Chemo GownsAlmost Always (67%)How often is the following PPE available when required? d. Gowns for handling chemotherapy (lint-free, non-permeable)SC_PPE_ChemoGowns
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
79 (67%) — Almost Always [5 pts]
2
12 (10%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
8 (7%) — Infrequently [0 pts]
5
13 (11%) — Almost Never [0 pts]
6
3 (3%) — Don't know [0 pts]
Q41ePPE: MasksAlmost Always (64%)How often is the following PPE available when required? e. MasksSC_PPE_Masks
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
75 (64%) — Almost Always [5 pts]
2
19 (16%) — Frequently [3 pts]
3
14 (12%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
8 (7%) — Almost Never [0 pts]
6
0 (0%) — Don't know [0 pts]
Q41fPPE: Eye/Splash GuardsAlmost Always (38%)How often is the following PPE available when required? f. Eye shields or masks with splash guard (if risk of splash)SC_PPE_Splash
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
45 (38%) — Almost Always [5 pts]
2
21 (18%) — Frequently [3 pts]
3
22 (19%) — Sometimes [1 pt]
4
11 (9%) — Infrequently [0 pts]
5
18 (15%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q42IV Pumps AdequacyYes (80%)Do you have an adequate number of IV pumps to meet your needs?SC_IVPumps
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
94 (80%) — Yes [5 pts]
2
24 (20%) — No [0 pts]
3
0 (0%) — Don't know [0 pts]
Q43aVascular Access: PIVAlmost Always (43%)How often is the following vascular access used? a. Peripheral Intravenous (PIV)SC_VA_PIV
1Almost Always
2Frequently
3Sometimes
4Infrequently
5Almost Never
6Do not know
Descriptive only, not scored.
1
51 (43%) — Almost Always
2
32 (27%) — Frequently
3
14 (12%) — Sometimes
4
11 (9%) — Infrequently
5
10 (9%) — Almost Never
6
0 (0%) — Don't know
Q43bVascular Access: Mid-lineAlmost Never (46%)How often is the following vascular access used? b. Mid-line CatheterSC_VA_Midline
1Almost Always
2Frequently
3Sometimes
4Infrequently
5Almost Never
6Do not know
Descriptive only, not scored.
1
12 (10%) — Almost Always
2
14 (12%) — Frequently
3
17 (14%) — Sometimes
4
12 (10%) — Infrequently
5
54 (46%) — Almost Never
6
9 (8%) — Don't know
Q43cVascular Access: Temp Central LineSometimes (33%)How often is the following vascular access used? c. Temporary Central LineSC_VA_Nontunneled
1Almost Always
2Frequently
3Sometimes
4Infrequently
5Almost Never
6Do not know
Descriptive only, not scored.
1
19 (16%) — Almost Always
2
28 (24%) — Frequently
3
39 (33%) — Sometimes
4
23 (20%) — Infrequently
5
8 (7%) — Almost Never
6
1 (1%) — Don't know
Q43dVascular Access: PICCAlmost Never (40%)How often is the following vascular access used? d. Peripherally Inserted Central Catheter (PICC)SC_VA_PICC
1Almost Always
2Frequently
3Sometimes
4Infrequently
5Almost Never
6Do not know
Descriptive only, not scored.
1
12 (10%) — Almost Always
2
15 (13%) — Frequently
3
26 (22%) — Sometimes
4
15 (13%) — Infrequently
5
47 (40%) — Almost Never
6
3 (3%) — Don't know
Q43eVascular Access: TunneledAlmost Never (57%)How often is the following vascular access used? e. Tunneled Permanent Central LineSC_VA_Tunneled
1Almost Always
2Frequently
3Sometimes
4Infrequently
5Almost Never
6Do not know
Descriptive only, not scored.
1
13 (11%) — Almost Always
2
9 (8%) — Frequently
3
12 (10%) — Sometimes
4
11 (9%) — Infrequently
5
67 (57%) — Almost Never
6
6 (5%) — Don't know
Q43fVascular Access: PortAlmost Always (52%)How often is the following vascular access used? f. Implanted Permanent Central Line (Port)SC_VA_Port
1Almost Always
2Frequently
3Sometimes
4Infrequently
5Almost Never
6Do not know
Descriptive only, not scored.
1
61 (52%) — Almost Always
2
36 (31%) — Frequently
3
12 (10%) — Sometimes
4
3 (3%) — Infrequently
5
6 (5%) — Almost Never
6
0 (0%) — Don't know
Q44Patient IdentificationYes (98%)Do you routinely confirm the identity of your patients through a unique patient identifier prior to administering treatments?SC_PatientID
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
115 (98%) — Yes [5 pts]
2
3 (3%) — No [0 pts]
3
0 (0%) — Don't know [0 pts]
Q45Patient-Treatment Matching SOPYes (96%)Does your facility have a standardized process and a written policy to match correct patients with correct treatments?SC_SOPCare
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
113 (96%) — Yes [5 pts]
2
5 (4%) — No [0 pts]
3
0 (0%) — Don't know [0 pts]
Q46Vascular Access TeamYes (85%)Does your facility have a vascular access team?SC_Vateam
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
100 (85%) — Yes [5 pts]
2
16 (14%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
Planning & ImprovementQ47-Q48 · max 10 pts
Q47Overall Status RatingScale (7.5)Overall, how would you rate the assessed components of service capacity for delivery of PHO care at your facility (1=Weak and 10=Strong)?SC_Impression
Self-assessment scale 1-10. N=118 responses. Mean=7.5, Median=8. Not scored.
8
41 (35%)
7
29 (25%)
9
21 (18%)
6
9 (8%)
5
6 (5%)
10
6 (5%)
4
3 (3%)
2
2 (2%)
3
1 (1%)
Q48Improvement PlansYes (57%)Are there plans and committed resources to improve the components of service capacity for delivery of PHO care in the next 12 months?SC_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
67 (57%) — Yes [10 pts]
2
26 (22%) — No [0 pts]
3
25 (21%) — Don't know [0 pts]
Module 6: Supportive Infrastructure (Integración de Servicios)33 questions · max 154 pts
Interdisciplinary CareQ1-Q17 · max 94 pts
Q1Multidisciplinary Care MeetingYes (50%)Does the institution hold a multidisciplinary care meeting in which all new and established PHO patients who could benefit from interdisciplinary care and decision-making are discussed?SI_MultiCare
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
59 (50%) — Yes [5 pts]
2
59 (50%) — No [0 pts]
3
0 (0%) — Don't know [0 pts]
Q2MDC Meeting FrequencyWeekly (42%)How frequently are these multidisciplinary care meetings held?SI_MultiCareFreq
1[3 pts]Weekly
2[3 pts]Twice monthly
3[2 pts]Monthly
4[1 pt]Quarterly
5[0 pts]Less than quarterly
Sub-question of Q1. Only answered when SI_MultiCare = Yes.
1
25 (42%) — Weekly [3 pts]
2
11 (19%) — Twice/month [3 pts]
3
15 (25%) — Monthly [2 pts]
4
4 (7%) — Quarterly [1 pt]
5
4 (7%) — < Quarterly [0 pts]
Q3MDC Meeting AttendeesHematology/Oncology (48%)Who attends these multidisciplinary care meetings on a regular basis? (check all that apply)SI_MulticareAttend___*
Check all that apply. Core specialties score 2 pts, others 1 pt each. Max 23 pts. {N} facilities responded.
48%
Hematology/Oncology (56)
22%
General Surgery (26)
22%
Pathology (26)
21%
Nursing (25)
20%
Palliative Care (24)
20%
Psychosocial (23)
20%
Radiology (23)
18%
Trainees (21)
15%
Neurosurgery (18)
14%
Radiation Oncology (17)
14%
Other (16)
13%
Orthopedics (15)
11%
Dietician (13)
10%
Pharmacists (12)
6%
Ophthalmology (7)
5%
ENT (6)
3%
Chaplain (3)
3%
Genetic Expertise (3)
Q4Pediatric Tumor BoardNo (82%)Does the institution hold a formal educational multi-disciplinary pediatric tumor board?SI_PTB
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
21 (18%) — Yes [5 pts]
2
97 (82%) — No [0 pts]
3
0 (0%) — Don't know [0 pts]
Q5Tumor Board FrequencyWeekly (52%)How frequently were these pediatric tumor board meetings held during the past 12 months?SI_PTBFreq
1[3 pts]Weekly
2[3 pts]Twice monthly
3[2 pts]Monthly
4[1 pt]Quarterly
5[0 pts]Less than quarterly
Sub-question of Q4. Only answered when SI_PTB = Yes.
1
11 (52%) — Weekly [3 pts]
2
4 (19%) — Twice/month [3 pts]
3
2 (10%) — Monthly [2 pts]
4
3 (14%) — Quarterly [1 pt]
5
1 (5%) — < Quarterly [0 pts]
Q6Tumor Board SpecialtiesHematology/Oncology (18%)Which of the following specialties participate in the pediatric tumor board? (check all that apply)SI_PTBSpec___*
Check all that apply. Core specialties score 2 pts, others 1 pt each. Max 22 pts. {N} facilities responded.
18%
Hematology/Oncology (21)
13%
Pathology (15)
9%
General Surgery (11)
9%
Radiology (11)
9%
Palliative Care (10)
8%
Neurosurgery (9)
8%
Radiation Oncology (9)
6%
Orthopedics (7)
5%
Trainees (6)
4%
Nursing (5)
4%
Other (5)
4%
Psychosocial (5)
3%
Genetic Expertise (4)
3%
Ophthalmology (4)
3%
Pharmacists (4)
3%
Dietician (3)
3%
ENT (3)
Q7Daily RoundsAlmost Always (89%)Patient care rounds occur dailySI_Comm_Rounds
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
105 (89%) — Almost Always [3 pts]
2
8 (7%) — Frequently [2 pts]
3
0 (0%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
2 (2%) — N/A [0 pts]
Q8Interdisciplinary RoundsAlmost Always (63%)An interdisciplinary team conducts daily rounds (physicians, nurses, pharmacy, nutrition...)SI_Comm_Team
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
74 (63%) — Almost Always [3 pts]
2
12 (10%) — Frequently [2 pts]
3
8 (7%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
16 (14%) — Almost Never [0 pts]
6
2 (2%) — N/A [0 pts]
Q9Difficult Cases DiscussionAlmost Always (54%)Difficult cases are discussed in a group settingSI_Comm_Cases1
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
64 (54%) — Almost Always [3 pts]
2
24 (20%) — Frequently [2 pts]
3
15 (13%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
5 (4%) — N/A [0 pts]
Q10Interesting Cases DiscussionAlmost Always (45%)Interesting cases are discussed in a group settingSI_Comm_Cases2
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
53 (45%) — Almost Always [3 pts]
2
26 (22%) — Frequently [2 pts]
3
18 (15%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
10 (9%) — Almost Never [0 pts]
6
6 (5%) — N/A [0 pts]
Q11New Cases DiscussionAlmost Always (23%)All new cases are discussed in a group settingSI_Comm_Cases3
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
27 (23%) — Almost Always [3 pts]
2
23 (20%) — Frequently [2 pts]
3
25 (21%) — Sometimes [1 pt]
4
14 (12%) — Infrequently [0 pts]
5
21 (18%) — Almost Never [0 pts]
6
8 (7%) — N/A [0 pts]
Q12Hospital Deaths DiscussionSometimes (26%)Hospital deaths are discussed in a group settingSI_Comm_Deaths
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
27 (23%) — Almost Always [3 pts]
2
18 (15%) — Frequently [2 pts]
3
31 (26%) — Sometimes [1 pt]
4
11 (9%) — Infrequently [0 pts]
5
27 (23%) — Almost Never [0 pts]
6
4 (3%) — N/A [0 pts]
Q13Errors DiscussionSometimes (26%)Errors are openly discussed in a group settingSI_Comm_Errors
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
30 (25%) — Almost Always [3 pts]
2
22 (19%) — Frequently [2 pts]
3
31 (26%) — Sometimes [1 pt]
4
10 (9%) — Infrequently [0 pts]
5
19 (16%) — Almost Never [0 pts]
6
6 (5%) — N/A [0 pts]
Q14Core Disciplines InputSometimes (24%)All core disciplines attend and provide inputSI_Comm_Input
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
20 (17%) — Almost Always [3 pts]
2
22 (19%) — Frequently [2 pts]
3
28 (24%) — Sometimes [1 pt]
4
17 (14%) — Infrequently [0 pts]
5
21 (18%) — Almost Never [0 pts]
6
10 (9%) — N/A [0 pts]
Q15Test Results Available at MDCAlmost Always (81%)Relevant test results, reports, and studies are available during MDC meetingsSI_Comm_Results
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
Only answered by facilities with multidisciplinary care meetings (Q1 = Yes).
1
48 (81%) — Almost Always [3 pts]
2
10 (17%) — Frequently [2 pts]
3
1 (2%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q16Urgent Team AssemblyAlmost Always (49%)When urgent needs arise, I am able to bring together the team for synchronous multi-disciplinary case discussion and communication in a timely mannerSI_Comm_Urgent
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
58 (49%) — Almost Always [3 pts]
2
21 (18%) — Frequently [2 pts]
3
16 (14%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
13 (11%) — Almost Never [0 pts]
6
6 (5%) — N/A [0 pts]
Q17Patient Preferences in MDCAlmost Always (71%)Patient preferences are discussed when making decisions in the MDC meetingsSI_Comm_Preferences
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
Only answered by facilities with multidisciplinary care meetings (Q1 = Yes).
1
42 (71%) — Almost Always [3 pts]
2
12 (20%) — Frequently [2 pts]
3
3 (5%) — Sometimes [1 pt]
4
1 (2%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (2%) — N/A [0 pts]
CommunicationQ18-Q27 · max 30 pts
Q18Pre-Op CommunicationAlmost Always (64%)Oncologists and surgeons communicate directly prior to a scheduled surgical procedure to discuss the planSI_Comm_PreOp
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
75 (64%) — Almost Always [3 pts]
2
23 (20%) — Frequently [2 pts]
3
11 (9%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
2 (2%) — N/A [0 pts]
Q19Post-Op CommunicationAlmost Always (62%)Oncologists and surgeons communicate directly after a scheduled surgical procedure to discuss events, margins, and the extent of the resection achievedSI_Comm_PostOp
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
73 (62%) — Almost Always [3 pts]
2
27 (23%) — Frequently [2 pts]
3
8 (7%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
2 (2%) — N/A [0 pts]
Q20Pre-Radiation CommunicationAlmost Always (42%)Oncologists and radiation oncologists communicate directly prior to the initiation of radiation therapy to determine therapeutic plan (dose, fractions, fields)SI_Comm_PreRad
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
50 (42%) — Almost Always [3 pts]
2
22 (19%) — Frequently [2 pts]
3
15 (13%) — Sometimes [1 pt]
4
8 (7%) — Infrequently [0 pts]
5
11 (9%) — Almost Never [0 pts]
6
12 (10%) — N/A [0 pts]
Q21Post-Radiation CommunicationAlmost Always (36%)Oncologists and radiation oncologists communicate directly after the completion of therapy to discuss events, toxicity and the treatment deliveredSI_Comm_PostRad
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
43 (36%) — Almost Always [3 pts]
2
25 (21%) — Frequently [2 pts]
3
16 (14%) — Sometimes [1 pt]
4
11 (9%) — Infrequently [0 pts]
5
12 (10%) — Almost Never [0 pts]
6
11 (9%) — N/A [0 pts]
Q22Nurses Share OpinionsAlmost Always (52%)Nurses are encouraged to share their opinion with doctors and others on the care teamSI_Comm_Nurses
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
61 (52%) — Almost Always [3 pts]
2
33 (28%) — Frequently [2 pts]
3
11 (9%) — Sometimes [1 pt]
4
10 (9%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
1 (1%) — N/A [0 pts]
Q23Nurses AdvocateAlmost Always (53%)Nurses are encouraged to advocate for their patientsSI_Comm_NursesAdvo
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
63 (53%) — Almost Always [3 pts]
2
37 (31%) — Frequently [2 pts]
3
11 (9%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
2 (2%) — N/A [0 pts]
Q24Patient Treatment ChoicesAlmost Always (87%)Patients are informed of treatment choicesSI_Comm_Patients
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
103 (87%) — Almost Always [3 pts]
2
14 (12%) — Frequently [2 pts]
3
1 (1%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q25Treatment Plan ExplainedAlmost Always (91%)A physician or nurse explains the treatment plan to parents in detailSI_Comm_TxPlan
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
107 (91%) — Almost Always [3 pts]
2
8 (7%) — Frequently [2 pts]
3
2 (2%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q26Parent Input During RoundsAlmost Always (70%)Parents are encouraged to provide input during patient roundsSI_Comm_Parents
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
83 (70%) — Almost Always [3 pts]
2
23 (20%) — Frequently [2 pts]
3
7 (6%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q27Aggressive Surgery ExplainedAlmost Always (54%)An interdisciplinary team explains the need for aggressive surgery (such as amputation) to familiesSI_Comm_Sx
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not applicable for my role
1
64 (54%) — Almost Always [3 pts]
2
15 (13%) — Frequently [2 pts]
3
16 (14%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
10 (9%) — Almost Never [0 pts]
6
8 (7%) — N/A [0 pts]
Scheduling & CallbackQ28-Q31 · max 20 pts
Q28Appointment Scheduling SystemYes (65%)Does your facility have an appointment scheduling system to identify patients who have missed an appointment?SI_Scheduling
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
77 (65%) — Yes [5 pts]
2
41 (35%) — No [0 pts]
3
0 (0%) — Don't know [0 pts]
Q29Scheduling System TypeAd hoc (58%)Which of the following best describes your appointment scheduling system?SI_SchedulingDesc
1[2 pts]Ad hoc system (manually identifies missed appointments)
2[1 pt]Electronic system without automated alert
3[3 pts]Electronic system with automated alert
4[5 pts]Electronic system with automated alert integrated to EHR
Sub-question of Q28. Only answered when SI_Scheduling = Yes.
1
45 (58%) — Ad hoc [2 pts]
2
22 (29%) — Electronic, no alert [1 pt]
3
3 (4%) — Electronic + alert [3 pts]
4
7 (9%) — Electronic + alert + EHR [5 pts]
Q30Call-Back SystemYes (55%)Does your facility have a call-back system to track patients who missed an appointment?SI_Callback
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
65 (55%) — Yes [5 pts]
2
51 (43%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
Q31Call-Back System TypeAd hoc (57%)Which of the following best describes your call-back system?SI_CallbackDesc
1[1 pt]Ad hoc follow-up phone calls to some patients
2[1 pt]Monthly follow-up phone calls to all patients
3[3 pts]Weekly follow-up phone calls to all patients
4[4 pts]Twice a week follow-up phone calls to all patients
5[5 pts]Daily follow-up phone calls to all patients
Sub-question of Q30. Only answered when SI_Callback = Yes.
1
37 (57%) — Ad hoc [1 pt]
2
5 (8%) — Monthly [1 pt]
3
5 (8%) — Weekly [3 pts]
4
4 (6%) — Twice/week [4 pts]
5
14 (22%) — Daily [5 pts]
Planning & ImprovementQ32-Q33 · max 10 pts
Q32Overall Status RatingScale (6.8)Overall, how would you rate the assessed components of service integration for delivery of PHO care (communication and interdisciplinary care) at your facility? (1=Weak, 10=Strong)SI_Impression
Self-assessment scale 1-10. N=118 responses. Mean=6.8, Median=7. Not scored.
8
32 (27%)
7
24 (20%)
6
18 (15%)
9
16 (14%)
5
10 (9%)
4
5 (4%)
1
4 (3%)
10
4 (3%)
3
3 (3%)
2
2 (2%)
Q33Improvement PlansNo (43%)Are there plans and committed resources to improve service integration for delivery of PHO care (interdisciplinary care and tumor boards) at your facility in the next 12 months?SI_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
45 (38%) — Yes [10 pts]
2
51 (43%) — No [0 pts]
3
22 (19%) — Don't know [0 pts]
Module 7: Diagnostics (Diagnóstico)67 questions · max 335 pts
Diagnostic CapacityQ1-Q4d · max 35 pts
Q1Clinical Pathology AccessYes, at facility (75%)Does your facility have timely access to clinical pathology services?D_ClinPath
1[5 pts]Yes, at our facility
2[3 pts]Yes, at another facility
3[0 pts]No
1
89 (75%) — Yes, at facility [5 pts]
2
21 (18%) — Yes, another [3 pts]
3
8 (7%) — No [0 pts]
Q2Anatomical Pathology AccessYes, at facility (75%)Does your facility have timely access to anatomical pathology services?D_AnatPath
1[5 pts]Yes, at our facility
2[3 pts]Yes, at another facility
3[0 pts]No
1
88 (75%) — Yes, at facility [5 pts]
2
23 (20%) — Yes, another [3 pts]
3
7 (6%) — No [0 pts]
Q3Critical Results CommunicationYes (74%)Do you have a process to communicate critical results of tests and diagnostic procedures on a timely basis to clinical staff?D_Results
1[5 pts]Yes
2[0 pts]No
1
87 (74%) — Yes [5 pts]
2
31 (26%) — No [0 pts]
Q4aTime to Dx: Leukemia3-7 days (51%)Time from initial presentation to definitive diagnosis: a. LeukemiaD_TTDx_Leuk
1[5 pts]<=48hrs
2[3 pts]3-7 days
3[1 pt]8-21 days
4[0 pts]>=22 days
5[0 pts]Not applicable
6[0 pts]Do not know
1
53 (45%) — <=48hrs [5 pts]
2
60 (51%) — 3-7 days [3 pts]
3
4 (3%) — 8-21 days [1 pt]
4
1 (1%) — >=22 days [0 pts]
5
0 (0%) — N/A [0 pts]
6
0 (0%) — Don't know [0 pts]
Q4bTime to Dx: Lymphoma3-7 days (50%)Time from initial presentation to definitive diagnosis: b. LymphomaD_TTDx_Lymph
1[5 pts]<=48hrs
2[3 pts]3-7 days
3[1 pt]8-21 days
4[0 pts]>=22 days
5[0 pts]Not applicable
6[0 pts]Do not know
1
8 (7%) — <=48hrs [5 pts]
2
59 (50%) — 3-7 days [3 pts]
3
41 (35%) — 8-21 days [1 pt]
4
6 (5%) — >=22 days [0 pts]
5
4 (3%) — N/A [0 pts]
6
0 (0%) — Don't know [0 pts]
Q4cTime to Dx: Solid Tumor8-21 days (51%)Time from initial presentation to definitive diagnosis: c. Solid TumorD_TTDx_Solid
1[5 pts]<=48hrs
2[3 pts]3-7 days
3[1 pt]8-21 days
4[0 pts]>=22 days
5[0 pts]Not applicable
6[0 pts]Do not know
1
4 (3%) — <=48hrs [5 pts]
2
34 (29%) — 3-7 days [3 pts]
3
60 (51%) — 8-21 days [1 pt]
4
13 (11%) — >=22 days [0 pts]
5
7 (6%) — N/A [0 pts]
6
0 (0%) — Don't know [0 pts]
Q4dTime to Dx: Brain Tumor8-21 days (48%)Time from initial presentation to definitive diagnosis: d. Brain TumorD_TTDx_Brain
1[5 pts]<=48hrs
2[3 pts]3-7 days
3[1 pt]8-21 days
4[0 pts]>=22 days
5[0 pts]Not applicable
6[0 pts]Do not know
1
5 (4%) — <=48hrs [5 pts]
2
25 (21%) — 3-7 days [3 pts]
3
57 (48%) — 8-21 days [1 pt]
4
17 (14%) — >=22 days [0 pts]
5
14 (12%) — N/A [0 pts]
6
0 (0%) — Don't know [0 pts]
General LaboratoryQ5a-Q5k · max 55 pts
Q5aRoutine Blood Counts (CBC)Almost Always (98%)Availability of laboratory tests: a. Routine Blood Counts (CBC + differential)D_Lab_CBC
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
115 (98%) — Almost Always [5 pts]
2
3 (3%) — Frequently [3 pts]
3
0 (0%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q5bElectrolytes, Liver/Renal FunctionAlmost Always (95%)Availability of laboratory tests: b. Electrolytes, liver/renal functionD_Lab_Electrolytes
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
112 (95%) — Almost Always [5 pts]
2
6 (5%) — Frequently [3 pts]
3
0 (0%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q5cLDH, FerritinAlmost Always (72%)Availability of laboratory tests: c. LDH, ferritinD_Lab_LDH
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
85 (72%) — Almost Always [5 pts]
2
27 (23%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q5dCoagulation StudiesAlmost Always (95%)Availability of laboratory tests: d. Coagulation studies (INR, PTT)D_Lab_Coagulation
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
112 (95%) — Almost Always [5 pts]
2
4 (3%) — Frequently [3 pts]
3
2 (2%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q5eUrine VMA/HVAAlmost Always (52%)Availability of laboratory tests: e. Urine VMA/HVAD_Lab_Urine
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
61 (52%) — Almost Always [5 pts]
2
9 (8%) — Frequently [3 pts]
3
9 (8%) — Sometimes [1 pt]
4
7 (6%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
26 (22%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q5fTumor Markers (AFP, etc.)Almost Always (72%)Availability of laboratory tests: f. Other tumor markers (such as AFP)D_Lab_Markers
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
85 (72%) — Almost Always [5 pts]
2
22 (19%) — Frequently [3 pts]
3
7 (6%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
2 (2%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q5gBasic MicrobiologyAlmost Always (82%)Availability of laboratory tests: g. Microbiology - basic (species identification in blood, urine, CSF)D_Lab_BasicMicro
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
97 (82%) — Almost Always [5 pts]
2
11 (9%) — Frequently [3 pts]
3
7 (6%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q5hBlood CulturesAlmost Always (86%)Availability of laboratory tests: h. Microbiology - Blood culturesD_Lab_Culture
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
101 (86%) — Almost Always [5 pts]
2
12 (10%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q5iAdvanced MicrobiologyAlmost Always (46%)Availability of laboratory tests: i. Microbiology - advanced (sensitivity analyses, fungal studies)D_Lab_AdvancedMicro
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
54 (46%) — Almost Always [5 pts]
2
23 (20%) — Frequently [3 pts]
3
19 (16%) — Sometimes [1 pt]
4
11 (9%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
7 (6%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q5jAntibiotic LevelsNot available (55%)Availability of laboratory tests: j. Monitoring of antibiotic levels (such as vancomycin levels)D_Lab_Antibiotic
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
14 (12%) — Almost Always [5 pts]
2
4 (3%) — Frequently [3 pts]
3
10 (9%) — Sometimes [1 pt]
4
12 (10%) — Infrequently [0 pts]
5
11 (9%) — Almost Never [0 pts]
6
65 (55%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q5kAntineoplastic Drug LevelsNot available (49%)Availability of laboratory tests: k. Monitoring of antineoplastic drug levels (such as methotrexate levels)D_Lab_Antineoplastic
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
28 (24%) — Almost Always [5 pts]
2
9 (8%) — Frequently [3 pts]
3
11 (9%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
6 (5%) — Almost Never [0 pts]
6
58 (49%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Leukemia/Lymphoma Pathology TurnaroundQ6a-Q6k · max 55 pts
Q6aBlood Smear Morphology<=48hrs (95%)Turnaround time for leukemia/lymphoma pathology: a. Morphologic review of blood smearD_Leuk_Blood
1[5 pts]<=48hrs
2[3 pts]3-7 days
3[0 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
112 (95%) — <=48hrs [5 pts]
2
3 (3%) — 3-7 days [3 pts]
3
2 (2%) — 8-21 days [0 pts]
4
0 (0%) — 22-31 days [0 pts]
5
0 (0%) — >31 days [0 pts]
6
1 (1%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q6bBone Marrow Morphology<=48hrs (93%)Turnaround time for leukemia/lymphoma pathology: b. Morphologic review of bone marrowD_Leuk_Bone
1[5 pts]<=48hrs
2[3 pts]3-7 days
3[0 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
110 (93%) — <=48hrs [5 pts]
2
5 (4%) — 3-7 days [3 pts]
3
2 (2%) — 8-21 days [0 pts]
4
0 (0%) — 22-31 days [0 pts]
5
0 (0%) — >31 days [0 pts]
6
1 (1%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q6cCSF Morphology<=48hrs (70%)Turnaround time for leukemia/lymphoma pathology: c. Morphologic review of CSFD_Leuk_CSF
1[5 pts]<=48hrs
2[3 pts]3-7 days
3[0 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
82 (70%) — <=48hrs [5 pts]
2
26 (22%) — 3-7 days [3 pts]
3
8 (7%) — 8-21 days [0 pts]
4
0 (0%) — 22-31 days [0 pts]
5
0 (0%) — >31 days [0 pts]
6
2 (2%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q6dFlow Cytometry (Immunophenotype)3-7 days (62%)Turnaround time for leukemia/lymphoma pathology: d. Flow Cytometry (immunophenotype)D_Leuk_Flow
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
24 (20%) — <=48hrs [5 pts]
2
73 (62%) — 3-7 days [5 pts]
3
15 (13%) — 8-21 days [3 pts]
4
1 (1%) — 22-31 days [0 pts]
5
1 (1%) — >31 days [0 pts]
6
4 (3%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q6eFlow Cytometry (Flow-MRD)3-7 days (61%)Turnaround time for leukemia/lymphoma pathology: e. Flow Cytometry (Flow-MRD)D_Leuk_Flow1
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
20 (17%) — <=48hrs [5 pts]
2
72 (61%) — 3-7 days [5 pts]
3
18 (15%) — 8-21 days [3 pts]
4
1 (1%) — 22-31 days [0 pts]
5
1 (1%) — >31 days [0 pts]
6
6 (5%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q6fMolecular Studies (PCR)3-7 days (32%)Turnaround time for leukemia/lymphoma pathology: f. Molecular studies (PCR)D_Leuk_PCR
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
10 (9%) — <=48hrs [5 pts]
2
38 (32%) — 3-7 days [5 pts]
3
37 (31%) — 8-21 days [3 pts]
4
8 (7%) — 22-31 days [0 pts]
5
6 (5%) — >31 days [0 pts]
6
16 (14%) — Not available [0 pts]
7
3 (3%) — Don't know [0 pts]
Q6gMolecular Studies (PCR-MRD)8-21 days (29%)Turnaround time for leukemia/lymphoma pathology: g. Molecular studies (PCR-MRD)D_Leuk_PCR1
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
10 (9%) — <=48hrs [5 pts]
2
33 (28%) — 3-7 days [5 pts]
3
34 (29%) — 8-21 days [3 pts]
4
9 (8%) — 22-31 days [0 pts]
5
4 (3%) — >31 days [0 pts]
6
25 (21%) — Not available [0 pts]
7
3 (3%) — Don't know [0 pts]
Q6hFISH8-21 days (35%)Turnaround time for leukemia/lymphoma pathology: h. FISHD_Leuk_FISH
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
2 (2%) — <=48hrs [5 pts]
2
28 (24%) — 3-7 days [5 pts]
3
41 (35%) — 8-21 days [3 pts]
4
7 (6%) — 22-31 days [0 pts]
5
5 (4%) — >31 days [0 pts]
6
33 (28%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q6iCytogenetics8-21 days (42%)Turnaround time for leukemia/lymphoma pathology: i. CytogeneticsD_Leuk_Cytogenetics
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
3 (3%) — <=48hrs [5 pts]
2
22 (19%) — 3-7 days [5 pts]
3
50 (42%) — 8-21 days [3 pts]
4
19 (16%) — 22-31 days [0 pts]
5
5 (4%) — >31 days [0 pts]
6
19 (16%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q6jFinalized Pathology Report8-21 days (53%)Turnaround time for leukemia/lymphoma pathology: j. Finalized pathology reportD_Leuk_FinalPath
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
6 (5%) — <=48hrs [5 pts]
2
28 (24%) — 3-7 days [5 pts]
3
63 (53%) — 8-21 days [3 pts]
4
11 (9%) — 22-31 days [0 pts]
5
4 (3%) — >31 days [0 pts]
6
5 (4%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q6kSecond Opinion Report8-21 days (36%)Turnaround time for leukemia/lymphoma pathology: k. Second opinion reportD_Leuk_SecondOp
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
5 (4%) — <=48hrs [5 pts]
2
22 (19%) — 3-7 days [5 pts]
3
42 (36%) — 8-21 days [3 pts]
4
17 (14%) — 22-31 days [0 pts]
5
4 (3%) — >31 days [0 pts]
6
25 (21%) — Not available [0 pts]
7
3 (3%) — Don't know [0 pts]
Solid Tumor Pathology TurnaroundQ7a-Q7h · max 40 pts
Q7aMorphologic Review3-7 days (51%)Turnaround time for solid tumor pathology: a. Morphologic reviewD_Solid_Morph
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
20 (17%) — <=48hrs [5 pts]
2
60 (51%) — 3-7 days [5 pts]
3
28 (24%) — 8-21 days [3 pts]
4
3 (3%) — 22-31 days [0 pts]
5
1 (1%) — >31 days [0 pts]
6
6 (5%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q7bImmunohistochemistry8-21 days (51%)Turnaround time for solid tumor pathology: b. Immunohistochemistry resultsD_Solid_Immuno
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
2 (2%) — <=48hrs [5 pts]
2
26 (22%) — 3-7 days [5 pts]
3
60 (51%) — 8-21 days [3 pts]
4
15 (13%) — 22-31 days [0 pts]
5
3 (3%) — >31 days [0 pts]
6
12 (10%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q7cSpecial Stains8-21 days (45%)Turnaround time for solid tumor pathology: c. Special stainsD_Solid_Stains
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
4 (3%) — <=48hrs [5 pts]
2
21 (18%) — 3-7 days [5 pts]
3
53 (45%) — 8-21 days [3 pts]
4
16 (14%) — 22-31 days [0 pts]
5
4 (3%) — >31 days [0 pts]
6
19 (16%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q7dCytogeneticsNot available (39%)Turnaround time for solid tumor pathology: d. CytogeneticsD_Solid_Cytogenetics
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
0 (0%) — <=48hrs [5 pts]
2
14 (12%) — 3-7 days [5 pts]
3
38 (32%) — 8-21 days [3 pts]
4
13 (11%) — 22-31 days [0 pts]
5
7 (6%) — >31 days [0 pts]
6
46 (39%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q7eFISHNot available (52%)Turnaround time for solid tumor pathology: e. FISHD_Solid_FISH
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
0 (0%) — <=48hrs [5 pts]
2
14 (12%) — 3-7 days [5 pts]
3
27 (23%) — 8-21 days [3 pts]
4
8 (7%) — 22-31 days [0 pts]
5
8 (7%) — >31 days [0 pts]
6
61 (52%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q7fMolecular Studies (PCR)Not available (48%)Turnaround time for solid tumor pathology: f. Molecular studies (PCR)D_Solid_PCR
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
4 (3%) — <=48hrs [5 pts]
2
13 (11%) — 3-7 days [5 pts]
3
28 (24%) — 8-21 days [3 pts]
4
11 (9%) — 22-31 days [0 pts]
5
6 (5%) — >31 days [0 pts]
6
56 (48%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q7gFinalized Pathology Report8-21 days (57%)Turnaround time for solid tumor pathology: g. Finalized pathology reportD_Solid_FinalPath
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
1 (1%) — <=48hrs [5 pts]
2
22 (19%) — 3-7 days [5 pts]
3
67 (57%) — 8-21 days [3 pts]
4
15 (13%) — 22-31 days [0 pts]
5
6 (5%) — >31 days [0 pts]
6
7 (6%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q7hSecond Opinion Report8-21 days (35%)Turnaround time for solid tumor pathology: h. Second opinion reportD_Solid_SecondOp
1[5 pts]<=48hrs
2[5 pts]3-7 days
3[3 pts]8-21 days
4[0 pts]22-31 days
5[0 pts]> 31 days
6[0 pts]Not available
7[0 pts]Do not know
1
3 (3%) — <=48hrs [5 pts]
2
22 (19%) — 3-7 days [5 pts]
3
41 (35%) — 8-21 days [3 pts]
4
16 (14%) — 22-31 days [0 pts]
5
11 (9%) — >31 days [0 pts]
6
24 (20%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Pathology PracticesQ8a-Q8h · max 40 pts
Q8aCSF Cytospin TechniqueAlmost Always (41%)Pathology practices: a. CSF is evaluated with proper cytospin techniqueD_Path_CSF
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
48 (41%) — Almost Always [5 pts]
2
16 (14%) — Frequently [3 pts]
3
11 (9%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
22 (19%) — Not available [0 pts]
7
7 (6%) — Don't know [0 pts]
Q8bFrozen Sections During SurgeryNot available (31%)Pathology practices: b. Frozen sections are reviewed during surgical procedures (preliminary diagnosis or disease extent at margin)D_Path_Frozen
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
26 (22%) — Almost Always [5 pts]
2
21 (18%) — Frequently [3 pts]
3
16 (14%) — Sometimes [1 pt]
4
7 (6%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
36 (31%) — Not available [0 pts]
7
3 (3%) — Don't know [0 pts]
Q8cTumor Involvement at MarginAlmost Always (58%)Pathology practices: c. The pathology report describes the level of tumor involvement at the resection marginD_Path_TumorInvolve
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
68 (58%) — Almost Always [5 pts]
2
22 (19%) — Frequently [3 pts]
3
12 (10%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
8 (7%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q8dHistologic ClassificationAlmost Always (38%)Pathology practices: d. The pathology report allows full histologic classification of the tumorD_Path_TumorHx
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
45 (38%) — Almost Always [5 pts]
2
39 (33%) — Frequently [3 pts]
3
17 (14%) — Sometimes [1 pt]
4
9 (8%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
7 (6%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q8eNecrosis (Osteosarcoma)Almost Always (48%)Pathology practices: e. Percent of necrosis is reported for patients with osteosarcoma who have received neoadjuvant chemotherapyD_Path_Necrosis
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
57 (48%) — Almost Always [5 pts]
2
25 (21%) — Frequently [3 pts]
3
13 (11%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
12 (10%) — Not available [0 pts]
7
5 (4%) — Don't know [0 pts]
Q8fAnaplasia (Renal Tumors)Almost Always (54%)Pathology practices: f. Degree of anaplasia is reported for patients with renal tumorsD_Path_Anaplasia
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
64 (54%) — Almost Always [5 pts]
2
21 (18%) — Frequently [3 pts]
3
15 (13%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
8 (7%) — Not available [0 pts]
7
5 (4%) — Don't know [0 pts]
Q8gReport Clear & CompleteAlmost Always (38%)Pathology practices: g. The pathology report is clear and completeD_Path_PathReport
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
45 (38%) — Almost Always [5 pts]
2
41 (35%) — Frequently [3 pts]
3
20 (17%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
5 (4%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q8hSecond Opinion AvailableAlmost Always (48%)Pathology practices: h. If there are doubts about diagnosis, sample can be sent to an expert for second opinionD_Path_SecondOp
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
57 (48%) — Almost Always [5 pts]
2
23 (20%) — Frequently [3 pts]
3
18 (15%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
13 (11%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Imaging ModalitiesQ9a-Q9h · max 40 pts
Q9aPlain X-rays<24hrs (96%)Turnaround time for imaging studies: a. Plain X-rays (1 and/or 2 views)D_Imaging_Xray
1[5 pts]<24hrs
2[3 pts]24-48hrs
3[1 pt]3-7 days
4[0 pts]8-14 days
5[0 pts]>14 days
6[0 pts]Not available
7[0 pts]Do not know
1
113 (96%) — <24hrs [5 pts]
2
4 (3%) — 24-48hrs [3 pts]
3
1 (1%) — 3-7 days [1 pt]
4
0 (0%) — 8-14 days [0 pts]
5
0 (0%) — >14 days [0 pts]
6
0 (0%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q9bUltrasound<24hrs (74%)Turnaround time for imaging studies: b. UltrasoundD_Imaging_Ultrasound
1[5 pts]<24hrs
2[3 pts]24-48hrs
3[1 pt]3-7 days
4[0 pts]8-14 days
5[0 pts]>14 days
6[0 pts]Not available
7[0 pts]Do not know
1
87 (74%) — <24hrs [5 pts]
2
23 (20%) — 24-48hrs [3 pts]
3
7 (6%) — 3-7 days [1 pt]
4
0 (0%) — 8-14 days [0 pts]
5
0 (0%) — >14 days [0 pts]
6
1 (1%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q9cCT Scan24-48hrs (48%)Turnaround time for imaging studies: c. Computed Tomography (CT) scanD_Imaging_Ctscan
1[5 pts]<24hrs
2[5 pts]24-48hrs
3[3 pts]3-7 days
4[0 pts]8-14 days
5[0 pts]>14 days
6[0 pts]Not available
7[0 pts]Do not know
1
45 (38%) — <24hrs [5 pts]
2
56 (48%) — 24-48hrs [5 pts]
3
13 (11%) — 3-7 days [3 pts]
4
2 (2%) — 8-14 days [0 pts]
5
1 (1%) — >14 days [0 pts]
6
1 (1%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q9dMRI3-7 days (44%)Turnaround time for imaging studies: d. Magnetic Resonance Imaging (MRI)D_Imaging_MRI
1[5 pts]<24hrs
2[5 pts]24-48hrs
3[3 pts]3-7 days
4[3 pts]8-14 days
5[0 pts]>14 days
6[0 pts]Not available
7[0 pts]Do not know
1
13 (11%) — <24hrs [5 pts]
2
37 (31%) — 24-48hrs [5 pts]
3
52 (44%) — 3-7 days [3 pts]
4
8 (7%) — 8-14 days [3 pts]
5
5 (4%) — >14 days [0 pts]
6
3 (3%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q9eMRA/MRV3-7 days (34%)Turnaround time for imaging studies: e. Magnetic Resonance Angiogram (MRA) / Magnetic Resonance Venography (MRV)D_Imaging_MRA
1[5 pts]<24hrs
2[5 pts]24-48hrs
3[3 pts]3-7 days
4[3 pts]8-14 days
5[0 pts]>14 days
6[0 pts]Not available
7[0 pts]Do not know
1
10 (9%) — <24hrs [5 pts]
2
23 (20%) — 24-48hrs [5 pts]
3
40 (34%) — 3-7 days [3 pts]
4
17 (14%) — 8-14 days [3 pts]
5
8 (7%) — >14 days [0 pts]
6
18 (15%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Q9fBone Scan (Tec99m)3-7 days (33%)Turnaround time for imaging studies: f. Bone Scan (Tec99m)D_Imaging_Bone
1[5 pts]<24hrs
2[5 pts]24-48hrs
3[3 pts]3-7 days
4[3 pts]8-14 days
5[0 pts]>14 days
6[0 pts]Not available
7[0 pts]Do not know
1
5 (4%) — <24hrs [5 pts]
2
13 (11%) — 24-48hrs [5 pts]
3
39 (33%) — 3-7 days [3 pts]
4
26 (22%) — 8-14 days [3 pts]
5
17 (14%) — >14 days [0 pts]
6
18 (15%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q9gPET ScanNot available (28%)Turnaround time for imaging studies: g. Positron-Emission Tomography (PET) Scan (18F-FDG)D_Imaging_PET
1[5 pts]<24hrs
2[5 pts]24-48hrs
3[3 pts]3-7 days
4[3 pts]8-14 days
5[0 pts]>14 days
6[0 pts]Not available
7[0 pts]Do not know
1
3 (3%) — <24hrs [5 pts]
2
10 (9%) — 24-48hrs [5 pts]
3
13 (11%) — 3-7 days [3 pts]
4
27 (23%) — 8-14 days [3 pts]
5
32 (27%) — >14 days [0 pts]
6
33 (28%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q9hMIBG ScanNot available (31%)Turnaround time for imaging studies: h. 131 or 123 Metaiodobenzylguanidine (MIBG) scanD_Imaging_MIBG
1[5 pts]<24hrs
2[5 pts]24-48hrs
3[3 pts]3-7 days
4[3 pts]8-14 days
5[0 pts]>14 days
6[0 pts]Not available
7[0 pts]Do not know
1
4 (3%) — <24hrs [5 pts]
2
8 (7%) — 24-48hrs [5 pts]
3
19 (16%) — 3-7 days [3 pts]
4
20 (17%) — 8-14 days [3 pts]
5
29 (25%) — >14 days [0 pts]
6
36 (31%) — Not available [0 pts]
7
2 (2%) — Don't know [0 pts]
Imaging PracticesQ10a-Q10l · max 60 pts
Q10aIV Contrast AvailableAlmost Always (72%)Imaging practices: a. IV contrast is available when neededD_Xray_Contrast
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
85 (72%) — Almost Always [5 pts]
2
20 (17%) — Frequently [3 pts]
3
11 (9%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q10bIV Contrast Procured by InstitutionAlmost Always (82%)Imaging practices: b. IV contrast is procured by the institutionD_Xray_IVpurchase
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
97 (82%) — Almost Always [5 pts]
2
10 (9%) — Frequently [3 pts]
3
6 (5%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
3 (3%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q10cSedation ProvidedAlmost Always (85%)Imaging practices: c. Sedation is provided when neededD_Xray_Sedation
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
100 (85%) — Almost Always [5 pts]
2
13 (11%) — Frequently [3 pts]
3
2 (2%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q10dIV Contrast Given When IndicatedAlmost Always (88%)Imaging practices: d. IV contrast is given when indicatedD_Xray_IVgiven
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
104 (88%) — Almost Always [5 pts]
2
10 (9%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q10eImage QualityAlmost Always (49%)Imaging practices: e. Images are of excellent quality (adequate resolution, no motion artifact)D_Xray_Image
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
58 (49%) — Almost Always [5 pts]
2
48 (41%) — Frequently [3 pts]
3
10 (9%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q10fStudy Indications StatedAlmost Always (75%)Imaging practices: f. Indications for study are clearly stated (what study? when? and why?)D_Xray_Indications
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
89 (75%) — Almost Always [5 pts]
2
23 (20%) — Frequently [3 pts]
3
5 (4%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q10gImage StorageAlmost Always (72%)Imaging practices: g. Past images are stored (physically or digitally) in facility for future comparisonD_Xray_Storage
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
85 (72%) — Almost Always [5 pts]
2
19 (16%) — Frequently [3 pts]
3
9 (8%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
2 (2%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q10hPast Images AvailableAlmost Always (70%)Imaging practices: h. Past images are available for comparisonD_Xray_Available
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
82 (70%) — Almost Always [5 pts]
2
18 (15%) — Frequently [3 pts]
3
13 (11%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
0 (0%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Q10iReport DetailAlmost Always (44%)Imaging practices: i. Radiology report provides adequate detail (e.g. relevant size dimensions) for clinical decision-makingD_Xray_Detail
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
52 (44%) — Almost Always [5 pts]
2
38 (32%) — Frequently [3 pts]
3
18 (15%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
2 (2%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q10jReport in Patient ChartAlmost Always (60%)Imaging practices: j. The radiology report is available in the patient's chartD_Xray_Report
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
71 (60%) — Almost Always [5 pts]
2
21 (18%) — Frequently [3 pts]
3
17 (14%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
2 (2%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q10kRadiologist In-Person ReviewAlmost Always (48%)Imaging practices: k. A radiologist is available to review images in-person when neededD_Xray_Radiologist
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
57 (48%) — Almost Always [5 pts]
2
34 (29%) — Frequently [3 pts]
3
17 (14%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
7
1 (1%) — Don't know [0 pts]
Q10lOncologist-Radiologist ReviewAlmost Always (41%)Imaging practices: l. Oncologists routinely review images with radiologistD_Xray_Oncologist
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
48 (41%) — Almost Always [5 pts]
2
35 (30%) — Frequently [3 pts]
3
23 (20%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
8 (7%) — Almost Never [0 pts]
6
0 (0%) — Not available [0 pts]
7
0 (0%) — Don't know [0 pts]
Planning & ImprovementQ11-Q12 · max 10 pts
Q11Overall Status RatingScale (7.4)Overall, how would you rate the diagnostic capacity for delivery of PHO care at your facility (0=Weak and 10=Strong)?D_Impression
Self-assessment scale 0-10. N=118 responses. Mean=7.4, Median=8. Not scored.
8
36 (31%)
7
27 (23%)
9
22 (19%)
6
14 (12%)
5
7 (6%)
10
6 (5%)
3
3 (3%)
4
3 (3%)
Q12Improvement PlansYes (51%)Are there any plans or committed resources to improve diagnostic capacity for delivery of PHO care at your facility in the next 12 months?D_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
60 (51%) — Yes [10 pts]
2
32 (27%) — No [0 pts]
3
26 (22%) — Don't know [0 pts]
Module 8: Chemotherapy (Quimioterapia)63 questions · max 328 pts
Curative TreatmentQ1-Q6d · max 86 pts
Q1Treatment ProtocolsYes (97%)Does the PHO unit use treatment protocols?C_Protocol
1[5 pts]Yes
2[0 pts]No
1
114 (97%) — Yes [5 pts]
2
4 (3%) — No [0 pts]
Q2Disease-Specific ProtocolsAcute Lymphoblastic Leukemia (ALL) (97%)For which diseases does the PHO unit have specific written treatment protocols?C_DiseaseProtocol___*
Multi-select checkboxes. 1 pt per disease. Max 21 pts. {N} facilities responded.
97%
Acute Lymphoblastic Leukemia (ALL) (114)
92%
Acute Myeloid Leukemia (AML) (109)
92%
Hodgkin Lymphoma (108)
91%
Non-Hodgkin Lymphoma (107)
89%
Acute Promyelocytic Leukemia (APML) (105)
86%
Burkitt Lymphoma (102)
85%
Nephroblastoma (Wilms tumor) (100)
85%
Osteosarcoma (100)
84%
Ewing Sarcoma (99)
83%
Extracranial Germ Cell Tumors (98)
82%
Chronic Myeloid Leukemia (CML) (97)
82%
Neuroblastoma (97)
82%
Rhabdomyosarcoma (97)
81%
High Grade Glioma (95)
81%
Medulloblastoma (95)
81%
Non-Rhabdomyosarcoma Soft Tissue Sarcoma (95)
79%
Intracranial Germ Cell Tumors (93)
79%
Low Grade Glioma (93)
78%
Ependymoma (92)
75%
Retinoblastoma (89)
21%
Other (25)
Q3Outcomes TrackingRetrospective (37%)Does the PHO unit monitor clinical outcomes by protocol or guideline?C_Outcomes
1[5 pts]Prospective collection and monitoring of clinical outcomes
2[2 pts]Retrospective collection of clinical outcomes
3[0 pts]Not applicable (no monitoring being conducted)
1
34 (30%) — Prospective [5 pts]
2
42 (37%) — Retrospective [2 pts]
3
38 (33%) — Not applicable [0 pts]
Q4Clinical TrialsNo (87%)Does the PHO unit participate in clinical trials?C_Trial
1[5 pts]Yes
2[0 pts]No
1
15 (13%) — Yes [5 pts]
2
99 (87%) — No [0 pts]
Q5aProtocol: Risk StratificationAlmost Always (90%)How often does the treatment protocol include risk stratification?C_Protocol_Risk
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
106 (90%) — Almost Always [5 pts]
2
8 (7%) — Frequently [3 pts]
3
0 (0%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q5bProtocol: Treatment FlowAlmost Always (72%)How often does the treatment protocol include treatment flow?C_Protocol_Flow
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
85 (72%) — Almost Always [5 pts]
2
16 (14%) — Frequently [3 pts]
3
9 (8%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
5 (4%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q5cProtocol: Toxicity ManagementAlmost Always (57%)How often does the treatment protocol include toxicity management?C_Protocol_Toxic
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
67 (57%) — Almost Always [5 pts]
2
18 (15%) — Frequently [3 pts]
3
11 (9%) — Sometimes [1 pt]
4
10 (9%) — Infrequently [0 pts]
5
11 (9%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q5dProtocol: Dose ModificationsAlmost Always (59%)How often does the treatment protocol include dose modifications?C_Protocol_Dose
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
70 (59%) — Almost Always [5 pts]
2
18 (15%) — Frequently [3 pts]
3
16 (14%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
6 (5%) — Almost Never [0 pts]
6
2 (2%) — Don't know [0 pts]
Q5eProtocol: Complication ManagementAlmost Always (58%)How often does the treatment protocol include complication management?C_Protocol_Manage
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
68 (58%) — Almost Always [5 pts]
2
19 (16%) — Frequently [3 pts]
3
15 (13%) — Sometimes [1 pt]
4
7 (6%) — Infrequently [0 pts]
5
6 (5%) — Almost Never [0 pts]
6
3 (3%) — Don't know [0 pts]
Q5fProtocol: Follow-up PlansAlmost Always (64%)How often does the treatment protocol include follow-up plans?C_Protocol_Followup
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
76 (64%) — Almost Always [5 pts]
2
15 (13%) — Frequently [3 pts]
3
12 (10%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
8 (7%) — Almost Never [0 pts]
6
2 (2%) — Don't know [0 pts]
Q6aTx Plan: Clear OrdersAlmost Always (81%)How often are treatment plan orders written clearly?C_TxPlan_Clear
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
96 (81%) — Almost Always [5 pts]
2
16 (14%) — Frequently [3 pts]
3
2 (2%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q6bTx Plan: Documented in ChartAlmost Always (81%)How often is the treatment plan documented in the patient chart?C_TxPlan_Chart
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
95 (81%) — Almost Always [5 pts]
2
18 (15%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q6cTx Plan: Schema/DiagramAlmost Always (59%)How often does the treatment plan include a schema or diagram?C_TxPlan_Schema
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
70 (59%) — Almost Always [5 pts]
2
24 (20%) — Frequently [3 pts]
3
14 (12%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
8 (7%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q6dTx Plan: Changes DocumentedAlmost Always (76%)How often are treatment plan changes documented?C_TxPlan_Change
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
90 (76%) — Almost Always [5 pts]
2
23 (20%) — Frequently [3 pts]
3
1 (1%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
2 (2%) — Don't know [0 pts]
Essential MedicinesQ7-Q9d · max 160 pts
Q7Medicine AccessSometimes (43%)How often are medication shortages affecting treatment plans for PHO patients?C_MedAccess
1[5 pts]Never (0%)
2[3 pts]Rarely (<1%)
3[1 pt]Sometimes (2-25%)
4[0 pts]Mostly (>25%)
6[0 pts]Do not know
1
20 (17%) — Never [5 pts]
2
40 (34%) — Rarely [3 pts]
3
51 (43%) — Sometimes [1 pt]
4
6 (5%) — Mostly [0 pts]
6
1 (1%) — Don't know [0 pts]
Q8aAsparaginaseAlmost Always (77%)Availability of Asparaginase for PHO patientsC_Med_Aspar
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
91 (77%) — Almost Always [5 pts]
2
23 (20%) — Frequently [3 pts]
3
1 (1%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
Q8bBleomycinAlmost Always (61%)Availability of Bleomycin for PHO patientsC_Med_Bleo
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
72 (61%) — Almost Always [5 pts]
2
31 (26%) — Frequently [3 pts]
3
9 (8%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
3 (3%) — Not available [0 pts]
Q8cCarboplatinAlmost Always (75%)Availability of Carboplatin for PHO patientsC_Med_Carbon
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
89 (75%) — Almost Always [5 pts]
2
22 (19%) — Frequently [3 pts]
3
4 (3%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
2 (2%) — Not available [0 pts]
Q8dCarmustineNot available (43%)Availability of Carmustine for PHO patientsC_Med_Carm
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
23 (20%) — Almost Always [5 pts]
2
6 (5%) — Frequently [3 pts]
3
17 (14%) — Sometimes [1 pt]
4
7 (6%) — Infrequently [0 pts]
5
14 (12%) — Almost Never [0 pts]
6
51 (43%) — Not available [0 pts]
Q8eCisplatinAlmost Always (75%)Availability of Cisplatin for PHO patientsC_Med_Cisp
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
88 (75%) — Almost Always [5 pts]
2
21 (18%) — Frequently [3 pts]
3
4 (3%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
4 (3%) — Not available [0 pts]
Q8fCyclophosphamideAlmost Always (82%)Availability of Cyclophosphamide for PHO patientsC_Med_Cyclo
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
97 (82%) — Almost Always [5 pts]
2
18 (15%) — Frequently [3 pts]
3
2 (2%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
Q8gCytarabineAlmost Always (76%)Availability of Cytarabine for PHO patientsC_Med_Cytar
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
90 (76%) — Almost Always [5 pts]
2
19 (16%) — Frequently [3 pts]
3
6 (5%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
3 (3%) — Not available [0 pts]
Q8hDacarbazineAlmost Always (59%)Availability of Dacarbazine for PHO patientsC_Med_Dacar
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
69 (59%) — Almost Always [5 pts]
2
22 (19%) — Frequently [3 pts]
3
15 (13%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
6 (5%) — Not available [0 pts]
Q8iDactinomycinAlmost Always (53%)Availability of Dactinomycin for PHO patientsC_Med_Dactino
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
62 (53%) — Almost Always [5 pts]
2
24 (20%) — Frequently [3 pts]
3
19 (16%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
8 (7%) — Not available [0 pts]
Q8jDasatinibAlmost Always (37%)Availability of Dasatinib for PHO patientsC_Med_Dasat
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
44 (37%) — Almost Always [5 pts]
2
16 (14%) — Frequently [3 pts]
3
20 (17%) — Sometimes [1 pt]
4
10 (9%) — Infrequently [0 pts]
5
10 (9%) — Almost Never [0 pts]
6
18 (15%) — Not available [0 pts]
Q8kDaunorubicinAlmost Always (69%)Availability of Daunorubicin for PHO patientsC_Med_Dauno
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
81 (69%) — Almost Always [5 pts]
2
24 (20%) — Frequently [3 pts]
3
8 (7%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
2 (2%) — Not available [0 pts]
Q8lDocetaxelAlmost Always (46%)Availability of Docetaxel for PHO patientsC_Med_Doce
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
54 (46%) — Almost Always [5 pts]
2
16 (14%) — Frequently [3 pts]
3
13 (11%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
22 (19%) — Not available [0 pts]
Q8mDoxorubicinAlmost Always (81%)Availability of Doxorubicin for PHO patientsC_Med_Doxo
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
95 (81%) — Almost Always [5 pts]
2
18 (15%) — Frequently [3 pts]
3
4 (3%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
Q8nEtoposideAlmost Always (85%)Availability of Etoposide for PHO patientsC_Med_Etop
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
100 (85%) — Almost Always [5 pts]
2
14 (12%) — Frequently [3 pts]
3
2 (2%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
2 (2%) — Not available [0 pts]
Q8oEpirubicinAlmost Always (47%)Availability of Epirubicin for PHO patientsC_Med_Epir
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
55 (47%) — Almost Always [5 pts]
2
21 (18%) — Frequently [3 pts]
3
15 (13%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
18 (15%) — Not available [0 pts]
Q8pIfosfamideAlmost Always (82%)Availability of Ifosfamide for PHO patientsC_Med_Ifos
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
97 (82%) — Almost Always [5 pts]
2
14 (12%) — Frequently [3 pts]
3
4 (3%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
3 (3%) — Not available [0 pts]
Q8qImatinibAlmost Always (60%)Availability of Imatinib for PHO patientsC_Med_Imat
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
71 (60%) — Almost Always [5 pts]
2
27 (23%) — Frequently [3 pts]
3
12 (10%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
7 (6%) — Not available [0 pts]
Q8rIrinotecanAlmost Always (57%)Availability of Irinotecan for PHO patientsC_Med_Irino
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
67 (57%) — Almost Always [5 pts]
2
17 (14%) — Frequently [3 pts]
3
12 (10%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
12 (10%) — Not available [0 pts]
Q8sLomustineNot available (46%)Availability of Lomustine for PHO patientsC_Med_Lomu
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
19 (16%) — Almost Always [5 pts]
2
8 (7%) — Frequently [3 pts]
3
14 (12%) — Sometimes [1 pt]
4
11 (9%) — Infrequently [0 pts]
5
12 (10%) — Almost Never [0 pts]
6
54 (46%) — Not available [0 pts]
Q8tMercaptopurineAlmost Always (83%)Availability of Mercaptopurine for PHO patientsC_Med_Mercap
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
98 (83%) — Almost Always [5 pts]
2
15 (13%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
Q8uMethotrexateAlmost Always (80%)Availability of Methotrexate for PHO patientsC_Med_Metho
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
94 (80%) — Almost Always [5 pts]
2
16 (14%) — Frequently [3 pts]
3
5 (4%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
2 (2%) — Not available [0 pts]
Q8vPaclitaxelAlmost Always (47%)Availability of Paclitaxel for PHO patientsC_Med_Pac
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
55 (47%) — Almost Always [5 pts]
2
20 (17%) — Frequently [3 pts]
3
10 (9%) — Sometimes [1 pt]
4
8 (7%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
16 (14%) — Not available [0 pts]
Q8wTemozolomideAlmost Always (62%)Availability of Temozolomide for PHO patientsC_Med_Temozo
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
73 (62%) — Almost Always [5 pts]
2
20 (17%) — Frequently [3 pts]
3
5 (4%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
12 (10%) — Not available [0 pts]
Q8xThioguanineNot available (61%)Availability of Thioguanine for PHO patientsC_Med_Tio
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
13 (11%) — Almost Always [5 pts]
2
4 (3%) — Frequently [3 pts]
3
7 (6%) — Sometimes [1 pt]
4
12 (10%) — Infrequently [0 pts]
5
10 (9%) — Almost Never [0 pts]
6
72 (61%) — Not available [0 pts]
Q8yTopotecanNot available (31%)Availability of Topotecan for PHO patientsC_Med_Topo
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
34 (29%) — Almost Always [5 pts]
2
15 (13%) — Frequently [3 pts]
3
16 (14%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
11 (9%) — Almost Never [0 pts]
6
36 (31%) — Not available [0 pts]
Q8zVinblastineAlmost Always (70%)Availability of Vinblastine for PHO patientsC_Med_Vinblast
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
82 (70%) — Almost Always [5 pts]
2
25 (21%) — Frequently [3 pts]
3
6 (5%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
4 (3%) — Not available [0 pts]
Q8aaVincristineAlmost Always (84%)Availability of Vincristine for PHO patientsC_Med_Vincrist
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
99 (84%) — Almost Always [5 pts]
2
13 (11%) — Frequently [3 pts]
3
5 (4%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
Q9aDexamethasoneAlmost Always (84%)Availability of Dexamethasone for PHO patientsC_Med_Dexa
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
99 (84%) — Almost Always [5 pts]
2
12 (10%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
2 (2%) — Not available [0 pts]
Q9bHydrocortisoneAlmost Always (91%)Availability of Hydrocortisone for PHO patientsC_Med_Hydro
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
107 (91%) — Almost Always [5 pts]
2
10 (9%) — Frequently [3 pts]
3
1 (1%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — Not available [0 pts]
Q9cMethylprednisoloneAlmost Always (88%)Availability of Methylprednisolone for PHO patientsC_Med_Methyl
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
104 (88%) — Almost Always [5 pts]
2
10 (9%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — Not available [0 pts]
Q9dPrednisone/PrednisoloneAlmost Always (74%)Availability of Prednisone/Prednisolone for PHO patientsC_Med_Predni
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
87 (74%) — Almost Always [5 pts]
2
13 (11%) — Frequently [3 pts]
3
5 (4%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
9 (8%) — Not available [0 pts]
Safe ChemotherapyQ10-Q17g · max 72 pts
Q10Cytotoxic Medication ProcurementSecure (overcome) (41%)What is the status of cytotoxic medication procurement at your facility?C_CytotoxicMed
3[5 pts]Secure procurement, <1% of treatment plans affected, through established mechanisms
2[5 pts]Secure procurement, can overcome most shortages and market failures
1[1 pt]Improved, <25% affected but dependent on third sector funding
0[0 pts]Erratic, >25% of treatment plans affected by lack of medications
3
24 (20%) — Secure (<1%) [5 pts]
2
48 (41%) — Secure (overcome) [5 pts]
1
39 (33%) — Improved (<25%) [1 pt]
0
7 (6%) — Erratic (>25%) [0 pts]
Q11Stock-out OccurrenceNo (65%)Has there been a stock-out of essential chemotherapy medications in the past 12 months?C_Stockout
1[5 pts]No
2[0 pts]Yes
3[0 pts]Do not know
1
77 (65%) — No [5 pts]
2
26 (22%) — Yes [0 pts]
3
15 (13%) — Don't know [0 pts]
Q12Quality ControlYes (51%)Does the facility have a quality control program for cytotoxic medications?C_QC
1[5 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
60 (51%) — Yes [5 pts]
2
29 (25%) — No [0 pts]
3
29 (25%) — Don't know [0 pts]
Q13QC Program ComponentsTrustworthy (33%)Which quality control program characteristics apply?C_QCProgram___*
Multi-select checkboxes. 1 pt each for Reliable and Trustworthy. Max 2 pts. {N} facilities responded.
33%
Trustworthy (39)
24%
Reliable (28)
21%
None of the above (25)
Q14Flow Hood AvailabilityAvailable (85%)Is a biological safety cabinet (flow hood) available for cytotoxic drug preparation?C_FlowHood
1[5 pts]Available
2[0 pts]Not available
1
100 (85%) — Available [5 pts]
2
18 (15%) — Not available [0 pts]
Q15Chemo Preparation AreaAvailable (86%)Is a dedicated chemotherapy preparation area available?C_ChemoPrep
1[5 pts]Available
2[0 pts]Not available
1
102 (86%) — Available [5 pts]
2
16 (14%) — Not available [0 pts]
Q16IV Chemo PreparationProfessional Nurse (33%)Who is primarily responsible for IV chemotherapy preparation?C_ChemoIVPrep
6[5 pts]Pharmacy
4[3 pts]Specialist Nurse
3[3 pts]Professional Nurse
7[0 pts]Other
6
35 (30%) — Pharmacy [5 pts]
4
36 (31%) — Specialist Nurse [3 pts]
3
39 (33%) — Professional Nurse [3 pts]
7
8 (7%) — Other [0 pts]
Q16bIV Chemo AdministrationSpecialist Nurse (53%)Who is primarily responsible for IV chemotherapy administration?C_ChemoIVAdmin
3[5 pts]Professional Nurse
4[5 pts]Specialist Nurse
1[1 pt]PHO Physician
3
54 (46%) — Professional Nurse [5 pts]
4
63 (53%) — Specialist Nurse [5 pts]
1
1 (1%) — PHO Physician [1 pt]
Q17aPractice: Standardized TemplatesAlmost Always (85%)How often are standardized chemotherapy order templates used?C_Practices_Template
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
100 (85%) — Almost Always [5 pts]
2
6 (5%) — Frequently [3 pts]
3
4 (3%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
8 (7%) — Almost Never [0 pts]
6
0 (0%) — Don't know [0 pts]
Q17bPractice: Order VerificationAlmost Always (74%)How often are chemotherapy orders independently verified before preparation?C_Practices_OrderCheck
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
87 (74%) — Almost Always [5 pts]
2
11 (9%) — Frequently [3 pts]
3
6 (5%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
10 (9%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q17cPractice: Preparation Verification (1)Almost Always (55%)How often is a second person verifying correct preparation of chemotherapy?C_Practices_Prep1
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
65 (55%) — Almost Always [5 pts]
2
10 (9%) — Frequently [3 pts]
3
16 (14%) — Sometimes [1 pt]
4
9 (8%) — Infrequently [0 pts]
5
18 (15%) — Almost Never [0 pts]
6
0 (0%) — Don't know [0 pts]
Q17dPractice: Preparation Verification (2)Almost Never (45%)How often is correct labeling of prepared chemotherapy verified?C_Practices_Prep2
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
45 (38%) — Almost Always [5 pts]
2
13 (11%) — Frequently [3 pts]
3
2 (2%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
53 (45%) — Almost Never [0 pts]
6
2 (2%) — Don't know [0 pts]
Q17ePractice: Patient ID WristbandAlmost Always (70%)How often are patient identification wristbands used during chemotherapy administration?C_Practices_WristBand
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
82 (70%) — Almost Always [5 pts]
2
17 (14%) — Frequently [3 pts]
3
5 (4%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
2 (2%) — Don't know [0 pts]
Q17fPractice: Infusion Pump UseAlmost Always (82%)How often are infusion pumps used for chemotherapy administration?C_Practices_Infusion
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
97 (82%) — Almost Always [5 pts]
2
16 (14%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
0 (0%) — Don't know [0 pts]
Q17gPractice: Nurse Double-CheckAlmost Always (60%)How often does a second nurse verify patient, drug, dose, and route before administration?C_Practices_NurseCheck
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
71 (60%) — Almost Always [5 pts]
2
30 (25%) — Frequently [3 pts]
3
11 (9%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
4 (3%) — Don't know [0 pts]
Planning & ImprovementQ18-Q19 · max 10 pts
Q18Overall Status RatingScale (8.0)Rate the current status of chemotherapy at your facility (0=Weak, 10=Strong)?C_Impression
Self-assessment scale 0-10. N=118 responses. Mean=8.0, Median=8. Not scored.
8
39 (33%)
9
35 (30%)
7
23 (20%)
10
11 (9%)
5
4 (3%)
6
4 (3%)
1
1 (1%)
4
1 (1%)
Q1912-Month Improvement PlansYes (54%)Does the PHO unit have plans to improve chemotherapy services in the next 12 months?C_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
64 (54%) — Yes [10 pts]
2
38 (32%) — No [0 pts]
3
16 (14%) — Don't know [0 pts]
Module 9: Supportive Care (Cuidados de Soporte)98 questions · max 335 pts
Supportive Care GuidelinesQ1-Q2 · max 19 pts
Q1Guidelines AvailabilityYes (88%)Does the PHO unit have written guidelines/policies related to supportive care?Supp_Guidelines
1[5 pts]Yes
2[0 pts]No
1
104 (88%) — Yes [5 pts]
2
14 (12%) — No [0 pts]
Q2Guidelines SpecificationsFebrile Neutropenia (85%)Which of the following supportive care guidelines does the PHO unit have? (check all that apply)Supp_GuidelinesSpec___*
Check all that apply. 1 pt each (max 14 pts). {N} facilities responded.
85%
Febrile Neutropenia (100)
65%
Nausea/Vomiting (77)
59%
Pain (69)
56%
Discharge Planning (66)
56%
Psychosocial Support (66)
53%
New Patient Education (63)
51%
Patient Handoff (60)
48%
Initiation of Palliative Care (56)
46%
Growth and Nutrition (54)
45%
Diarrhea (53)
44%
Constipation (52)
42%
End-of-Life Care (49)
36%
Behavioral Problems (42)
11%
Other (13)
Blood ProductsQ3-Q3f · max 35 pts
Q3Blood Product AccessYes 24/7 (81%)Does the PHO unit have reliable access to blood products?Supp_BloodAccess
1[5 pts]Yes, 24/7 access
2[3 pts]Yes, but limited hours
3[0 pts]No reliable access
1
96 (81%) — Yes 24/7 [5 pts]
2
19 (16%) — Limited [3 pts]
3
3 (3%) — No [0 pts]
Q3aWhole BloodAlmost Always (42%)Availability of whole blood for PHO patientsSupp_Blood_Whole
1[5 pts]Almost Always
2[4 pts]Frequently
3[3 pts]Sometimes
4[2 pts]Infrequently
5[1 pt]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
49 (42%) — Almost Always [5 pts]
2
31 (26%) — Frequently [4 pts]
3
4 (3%) — Sometimes [3 pts]
4
1 (1%) — Infrequently [2 pts]
5
0 (0%) — Almost Never [1 pt]
6
28 (24%) — N/A [0 pts]
7
5 (4%) — Don't know [0 pts]
Q3bRed Blood Cells (RBC)Almost Always (70%)Availability of packed red blood cells for PHO patientsSupp_Blood_RBC
1[5 pts]Almost Always
2[4 pts]Frequently
3[3 pts]Sometimes
4[2 pts]Infrequently
5[1 pt]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
82 (70%) — Almost Always [5 pts]
2
33 (28%) — Frequently [4 pts]
3
1 (1%) — Sometimes [3 pts]
4
2 (2%) — Infrequently [2 pts]
5
0 (0%) — Almost Never [1 pt]
6
0 (0%) — N/A [0 pts]
7
0 (0%) — Don't know [0 pts]
Q3cPlateletsAlmost Always (50%)Availability of platelets for PHO patientsSupp_Blood_Platelets
1[5 pts]Almost Always
2[4 pts]Frequently
3[3 pts]Sometimes
4[2 pts]Infrequently
5[1 pt]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
59 (50%) — Almost Always [5 pts]
2
42 (36%) — Frequently [4 pts]
3
12 (10%) — Sometimes [3 pts]
4
3 (3%) — Infrequently [2 pts]
5
2 (2%) — Almost Never [1 pt]
6
0 (0%) — N/A [0 pts]
7
0 (0%) — Don't know [0 pts]
Q3dFresh Frozen PlasmaAlmost Always (70%)Availability of fresh frozen plasma for PHO patientsSupp_Blood_Plasma
1[5 pts]Almost Always
2[4 pts]Frequently
3[3 pts]Sometimes
4[2 pts]Infrequently
5[1 pt]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
83 (70%) — Almost Always [5 pts]
2
29 (25%) — Frequently [4 pts]
3
4 (3%) — Sometimes [3 pts]
4
1 (1%) — Infrequently [2 pts]
5
1 (1%) — Almost Never [1 pt]
6
0 (0%) — N/A [0 pts]
7
0 (0%) — Don't know [0 pts]
Q3eCryoprecipitateAlmost Always (53%)Availability of cryoprecipitate for PHO patientsSupp_Blood_Cryo
1[5 pts]Almost Always
2[4 pts]Frequently
3[3 pts]Sometimes
4[2 pts]Infrequently
5[1 pt]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
63 (53%) — Almost Always [5 pts]
2
26 (22%) — Frequently [4 pts]
3
5 (4%) — Sometimes [3 pts]
4
1 (1%) — Infrequently [2 pts]
5
3 (3%) — Almost Never [1 pt]
6
20 (17%) — N/A [0 pts]
7
0 (0%) — Don't know [0 pts]
Q3fLeuco-depleted ProductsN/A (42%)Availability of leuco-depleted blood products for PHO patientsSupp_Blood_Leuco
1[5 pts]Almost Always
2[4 pts]Frequently
3[3 pts]Sometimes
4[2 pts]Infrequently
5[1 pt]Almost Never
6[0 pts]Not available
7[0 pts]Do not know
1
23 (20%) — Almost Always [5 pts]
2
21 (18%) — Frequently [4 pts]
3
11 (9%) — Sometimes [3 pts]
4
3 (3%) — Infrequently [2 pts]
5
4 (3%) — Almost Never [1 pt]
6
50 (42%) — N/A [0 pts]
7
6 (5%) — Don't know [0 pts]
Pain & Symptom MedicationsQ4a-Q4x · max 72 pts
Q4aIbuprofenAlmost Always (48%)Availability of Ibuprofen for PHO patientsSupp_Med_Ibu
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
57 (48%) — Almost Always [3 pts]
2
14 (12%) — Frequently [2 pts]
3
7 (6%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
5 (4%) — Almost Never [0 pts]
6
33 (28%) — N/A [0 pts]
Q4bParacetamol/AcetaminophenAlmost Always (86%)Availability of Paracetamol/Acetaminophen for PHO patientsSupp_Med_Parace
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
102 (86%) — Almost Always [3 pts]
2
15 (13%) — Frequently [2 pts]
3
1 (1%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q4cMorphine (Oral)N/A (34%)Availability of Morphine (Oral) for PHO patientsSupp_Med_MorphOral
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
27 (23%) — Almost Always [3 pts]
2
16 (14%) — Frequently [2 pts]
3
16 (14%) — Sometimes [1 pt]
4
12 (10%) — Infrequently [0 pts]
5
7 (6%) — Almost Never [0 pts]
6
40 (34%) — N/A [0 pts]
Q4dMorphine (Injectable)Almost Always (41%)Availability of Morphine (Injectable) for PHO patientsSupp_Med_MorphInject
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
48 (41%) — Almost Always [3 pts]
2
17 (14%) — Frequently [2 pts]
3
17 (14%) — Sometimes [1 pt]
4
8 (7%) — Infrequently [0 pts]
5
5 (4%) — Almost Never [0 pts]
6
23 (20%) — N/A [0 pts]
Q4eAmitriptylineAlmost Always (32%)Availability of Amitriptyline for PHO patientsSupp_Med_Amitri
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
38 (32%) — Almost Always [3 pts]
2
27 (23%) — Frequently [2 pts]
3
8 (7%) — Sometimes [1 pt]
4
14 (12%) — Infrequently [0 pts]
5
12 (10%) — Almost Never [0 pts]
6
19 (16%) — N/A [0 pts]
Q4fCyclizineN/A (56%)Availability of Cyclizine for PHO patientsSupp_Med_Cycli
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
15 (13%) — Almost Always [3 pts]
2
5 (4%) — Frequently [2 pts]
3
6 (5%) — Sometimes [1 pt]
4
8 (7%) — Infrequently [0 pts]
5
18 (15%) — Almost Never [0 pts]
6
66 (56%) — N/A [0 pts]
Q4gDexamethasoneAlmost Always (85%)Availability of Dexamethasone for PHO patientsSupp_Med_Dexa
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
100 (85%) — Almost Always [3 pts]
2
12 (10%) — Frequently [2 pts]
3
2 (2%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
2 (2%) — N/A [0 pts]
Q4hDocusate SodiumN/A (65%)Availability of Docusate Sodium for PHO patientsSupp_Med_DocSodium
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
11 (9%) — Almost Always [3 pts]
2
3 (3%) — Frequently [2 pts]
3
6 (5%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
15 (13%) — Almost Never [0 pts]
6
77 (65%) — N/A [0 pts]
Q4iFluoxetineAlmost Always (65%)Availability of Fluoxetine for PHO patientsSupp_Med_Fluox
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
77 (65%) — Almost Always [3 pts]
2
16 (14%) — Frequently [2 pts]
3
8 (7%) — Sometimes [1 pt]
4
7 (6%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
8 (7%) — N/A [0 pts]
Q4jHyoscine/HydromorphineAlmost Always (38%)Availability of Hyoscine/Hydromorphine for PHO patientsSupp_Med_HyoHydro
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
45 (38%) — Almost Always [3 pts]
2
13 (11%) — Frequently [2 pts]
3
12 (10%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
34 (29%) — N/A [0 pts]
Q4kLactuloseAlmost Always (57%)Availability of Lactulose for PHO patientsSupp_Med_Lactu
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
67 (57%) — Almost Always [3 pts]
2
14 (12%) — Frequently [2 pts]
3
7 (6%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
24 (20%) — N/A [0 pts]
Q4lOndansetronAlmost Always (90%)Availability of Ondansetron for PHO patientsSupp_Med_Ondan
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
106 (90%) — Almost Always [3 pts]
2
9 (8%) — Frequently [2 pts]
3
2 (2%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — N/A [0 pts]
Q4mSennaAlmost Always (44%)Availability of Senna for PHO patientsSupp_Med_Senna
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
52 (44%) — Almost Always [3 pts]
2
14 (12%) — Frequently [2 pts]
3
0 (0%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
5 (4%) — Almost Never [0 pts]
6
45 (38%) — N/A [0 pts]
Q4nMetoclopramideAlmost Always (86%)Availability of Metoclopramide for PHO patientsSupp_Med_Metoclo
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
101 (86%) — Almost Always [3 pts]
2
15 (13%) — Frequently [2 pts]
3
2 (2%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q4oOmeprazoleAlmost Always (86%)Availability of Omeprazole for PHO patientsSupp_Med_Omepra
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
102 (86%) — Almost Always [3 pts]
2
11 (9%) — Frequently [2 pts]
3
2 (2%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
1 (1%) — N/A [0 pts]
Q4pRanitidineN/A (72%)Availability of Ranitidine for PHO patientsSupp_Med_Ranit
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
22 (19%) — Almost Always [3 pts]
2
2 (2%) — Frequently [2 pts]
3
2 (2%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
6 (5%) — Almost Never [0 pts]
6
85 (72%) — N/A [0 pts]
Q4qCarbamazepineAlmost Always (68%)Availability of Carbamazepine for PHO patientsSupp_Med_Carba
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
80 (68%) — Almost Always [3 pts]
2
20 (17%) — Frequently [2 pts]
3
8 (7%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
5 (4%) — N/A [0 pts]
Q4rDiazepamAlmost Always (75%)Availability of Diazepam for PHO patientsSupp_Med_DiazAnti
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
88 (75%) — Almost Always [3 pts]
2
22 (19%) — Frequently [2 pts]
3
5 (4%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
2 (2%) — N/A [0 pts]
Q4sLorazepamAlmost Always (52%)Availability of Lorazepam for PHO patientsSupp_Med_Loraz
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
61 (52%) — Almost Always [3 pts]
2
10 (9%) — Frequently [2 pts]
3
14 (12%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
6 (5%) — Almost Never [0 pts]
6
22 (19%) — N/A [0 pts]
Q4tMidazolamAlmost Always (81%)Availability of Midazolam for PHO patientsSupp_Med_Midaz
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
95 (81%) — Almost Always [3 pts]
2
19 (16%) — Frequently [2 pts]
3
1 (1%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
3 (3%) — N/A [0 pts]
Q4uPhenobarbitalAlmost Always (47%)Availability of Phenobarbital for PHO patientsSupp_Med_Phenobarb
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
55 (47%) — Almost Always [3 pts]
2
21 (18%) — Frequently [2 pts]
3
14 (12%) — Sometimes [1 pt]
4
8 (7%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
18 (15%) — N/A [0 pts]
Q4vPhenytoinAlmost Always (77%)Availability of Phenytoin for PHO patientsSupp_Med_Pheny
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
91 (77%) — Almost Always [3 pts]
2
21 (18%) — Frequently [2 pts]
3
3 (3%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
2 (2%) — N/A [0 pts]
Q4wValproic AcidAlmost Always (73%)Availability of Valproic Acid for PHO patientsSupp_Med_ValAcid
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
86 (73%) — Almost Always [3 pts]
2
18 (15%) — Frequently [2 pts]
3
8 (7%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
4 (3%) — N/A [0 pts]
Q4xHaloperidolAlmost Always (62%)Availability of Haloperidol for PHO patientsSupp_Med_Halo
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
73 (62%) — Almost Always [3 pts]
2
21 (18%) — Frequently [2 pts]
3
8 (7%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
10 (9%) — N/A [0 pts]
Toxicity MedicationsQ5a-Q5f · max 18 pts
Q5aAllopurinolAlmost Always (86%)Availability of Allopurinol for PHO patientsSupp_Toxic_Allo
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
102 (86%) — Almost Always [3 pts]
2
10 (9%) — Frequently [2 pts]
3
3 (3%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
1 (1%) — N/A [0 pts]
Q5bCalcium LeucovorinAlmost Always (70%)Availability of Calcium Leucovorin for PHO patientsSupp_Toxic_Calcium
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
83 (70%) — Almost Always [3 pts]
2
7 (6%) — Frequently [2 pts]
3
1 (1%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
21 (18%) — N/A [0 pts]
Q5cFilgrastim (G-CSF)Almost Always (90%)Availability of Filgrastim (G-CSF) for PHO patientsSupp_Toxic_Filgra
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
106 (90%) — Almost Always [3 pts]
2
9 (8%) — Frequently [2 pts]
3
1 (1%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — N/A [0 pts]
Q5dPegfilgrastimAlmost Always (39%)Availability of Pegfilgrastim for PHO patientsSupp_Toxic_Pegfil
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
46 (39%) — Almost Always [3 pts]
2
12 (10%) — Frequently [2 pts]
3
14 (12%) — Sometimes [1 pt]
4
8 (7%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
29 (25%) — N/A [0 pts]
Q5eGM-CSFN/A (44%)Availability of GM-CSF for PHO patientsSupp_Toxic_GMCSF
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
38 (32%) — Almost Always [3 pts]
2
7 (6%) — Frequently [2 pts]
3
7 (6%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
12 (10%) — Almost Never [0 pts]
6
52 (44%) — N/A [0 pts]
Q5fMesnaAlmost Always (85%)Availability of Mesna for PHO patientsSupp_Toxic_Mesna
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
100 (85%) — Almost Always [3 pts]
2
16 (14%) — Frequently [2 pts]
3
1 (1%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Essential AntimicrobialsQ6a-Q6ab · max 84 pts
Q6aAmoxicillin/ClavulanateAlmost Always (79%)Availability of Amoxicillin/Clavulanate for PHO patientsSupp_Med_AmoxiClav
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
93 (79%) — Almost Always [3 pts]
2
17 (14%) — Frequently [2 pts]
3
4 (3%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
1 (1%) — N/A [0 pts]
Q6bAmikacinAlmost Always (89%)Availability of Amikacin for PHO patientsSupp_Med_Amik
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
105 (89%) — Almost Always [3 pts]
2
12 (10%) — Frequently [2 pts]
3
1 (1%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q6cAzithromycinAlmost Always (65%)Availability of Azithromycin for PHO patientsSupp_Med_Azithro
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
77 (65%) — Almost Always [3 pts]
2
13 (11%) — Frequently [2 pts]
3
12 (10%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
14 (12%) — N/A [0 pts]
Q6dCefiximeAlmost Always (47%)Availability of Cefixime for PHO patientsSupp_Med_Cefix
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
55 (47%) — Almost Always [3 pts]
2
8 (7%) — Frequently [2 pts]
3
12 (10%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
5 (4%) — Almost Never [0 pts]
6
34 (29%) — N/A [0 pts]
Q6eCefotaximeAlmost Always (74%)Availability of Cefotaxime for PHO patientsSupp_Med_Cefot
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
87 (74%) — Almost Always [3 pts]
2
24 (20%) — Frequently [2 pts]
3
5 (4%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
1 (1%) — N/A [0 pts]
Q6fCeftazidimeAlmost Always (75%)Availability of Ceftazidime for PHO patientsSupp_Med_Ceftaz
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
89 (75%) — Almost Always [3 pts]
2
21 (18%) — Frequently [2 pts]
3
7 (6%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — N/A [0 pts]
Q6gCeftriaxoneAlmost Always (86%)Availability of Ceftriaxone for PHO patientsSupp_Med_Ceftriax
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
102 (86%) — Almost Always [3 pts]
2
15 (13%) — Frequently [2 pts]
3
1 (1%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q6hCefuroximeAlmost Always (59%)Availability of Cefuroxime for PHO patientsSupp_Med_Cefurox
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
69 (59%) — Almost Always [3 pts]
2
15 (13%) — Frequently [2 pts]
3
12 (10%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
16 (14%) — N/A [0 pts]
Q6iCiprofloxacinAlmost Always (70%)Availability of Ciprofloxacin for PHO patientsSupp_Med_Cipro
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
82 (70%) — Almost Always [3 pts]
2
20 (17%) — Frequently [2 pts]
3
6 (5%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
8 (7%) — N/A [0 pts]
Q6jClindamycinAlmost Always (79%)Availability of Clindamycin for PHO patientsSupp_Med_Clind
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
93 (79%) — Almost Always [3 pts]
2
20 (17%) — Frequently [2 pts]
3
2 (2%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q6kColistinAlmost Always (33%)Availability of Colistin for PHO patientsSupp_Med_Colistin
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
39 (33%) — Almost Always [3 pts]
2
15 (13%) — Frequently [2 pts]
3
19 (16%) — Sometimes [1 pt]
4
12 (10%) — Infrequently [0 pts]
5
8 (7%) — Almost Never [0 pts]
6
25 (21%) — N/A [0 pts]
Q6lFosfomycinN/A (32%)Availability of Fosfomycin for PHO patientsSupp_Med_Fosfo
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
33 (28%) — Almost Always [3 pts]
2
12 (10%) — Frequently [2 pts]
3
19 (16%) — Sometimes [1 pt]
4
10 (9%) — Infrequently [0 pts]
5
6 (5%) — Almost Never [0 pts]
6
38 (32%) — N/A [0 pts]
Q6mGentamicinAlmost Always (59%)Availability of Gentamicin for PHO patientsSupp_Med_Genta
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
69 (59%) — Almost Always [3 pts]
2
19 (16%) — Frequently [2 pts]
3
14 (12%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
8 (7%) — N/A [0 pts]
Q6nLinezolidAlmost Always (53%)Availability of Linezolid for PHO patientsSupp_Med_Linez
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
63 (53%) — Almost Always [3 pts]
2
25 (21%) — Frequently [2 pts]
3
18 (15%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
6 (5%) — N/A [0 pts]
Q6oMeropenemAlmost Always (78%)Availability of Meropenem for PHO patientsSupp_Med_Mero
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
92 (78%) — Almost Always [3 pts]
2
23 (20%) — Frequently [2 pts]
3
2 (2%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q6pPiperacillin/TazobactamAlmost Always (72%)Availability of Piperacillin/Tazobactam for PHO patientsSupp_Med_Piptaz
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
85 (72%) — Almost Always [3 pts]
2
20 (17%) — Frequently [2 pts]
3
9 (8%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
3 (3%) — N/A [0 pts]
Q6qPolymyxin BAlmost Always (52%)Availability of Polymyxin B for PHO patientsSupp_Med_PolyB
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
61 (52%) — Almost Always [3 pts]
2
13 (11%) — Frequently [2 pts]
3
6 (5%) — Sometimes [1 pt]
4
12 (10%) — Infrequently [0 pts]
5
6 (5%) — Almost Never [0 pts]
6
20 (17%) — N/A [0 pts]
Q6rTrimethoprim/SulfamethoxazoleAlmost Always (82%)Availability of Trimethoprim/Sulfamethoxazole for PHO patientsSupp_Med_Trisulfa
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
97 (82%) — Almost Always [3 pts]
2
19 (16%) — Frequently [2 pts]
3
1 (1%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q6sVancomycin (IV)Almost Always (81%)Availability of Vancomycin (IV) for PHO patientsSupp_Med_Vanco
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
96 (81%) — Almost Always [3 pts]
2
18 (15%) — Frequently [2 pts]
3
3 (3%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q6tAmphotericin B (Deoxycholate)Almost Always (48%)Availability of Amphotericin B (Deoxycholate) for PHO patientsSupp_Med_AmphoDeoxy
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
56 (48%) — Almost Always [3 pts]
2
27 (23%) — Frequently [2 pts]
3
19 (16%) — Sometimes [1 pt]
4
3 (3%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
9 (8%) — N/A [0 pts]
Q6uAmphotericin B (Liposomal)Almost Always (40%)Availability of Amphotericin B (Liposomal) for PHO patientsSupp_Med_AmphoLipo
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
47 (40%) — Almost Always [3 pts]
2
12 (10%) — Frequently [2 pts]
3
20 (17%) — Sometimes [1 pt]
4
7 (6%) — Infrequently [0 pts]
5
7 (6%) — Almost Never [0 pts]
6
25 (21%) — N/A [0 pts]
Q6vFluconazoleAlmost Always (84%)Availability of Fluconazole for PHO patientsSupp_Med_Flucon
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
99 (84%) — Almost Always [3 pts]
2
17 (14%) — Frequently [2 pts]
3
1 (1%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
1 (1%) — N/A [0 pts]
Q6wItraconazoleAlmost Always (54%)Availability of Itraconazole for PHO patientsSupp_Med_Itracon
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
64 (54%) — Almost Always [3 pts]
2
19 (16%) — Frequently [2 pts]
3
12 (10%) — Sometimes [1 pt]
4
9 (8%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
12 (10%) — N/A [0 pts]
Q6xVoriconazoleAlmost Always (46%)Availability of Voriconazole for PHO patientsSupp_Med_Voricon
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
54 (46%) — Almost Always [3 pts]
2
18 (15%) — Frequently [2 pts]
3
19 (16%) — Sometimes [1 pt]
4
9 (8%) — Infrequently [0 pts]
5
8 (7%) — Almost Never [0 pts]
6
10 (9%) — N/A [0 pts]
Q6yAcyclovirAlmost Always (76%)Availability of Acyclovir for PHO patientsSupp_Med_Acyclo
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
90 (76%) — Almost Always [3 pts]
2
22 (19%) — Frequently [2 pts]
3
5 (4%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q6zOseltamivirAlmost Always (66%)Availability of Oseltamivir for PHO patientsSupp_Med_Oselt
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
78 (66%) — Almost Always [3 pts]
2
26 (22%) — Frequently [2 pts]
3
10 (9%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
4 (3%) — N/A [0 pts]
Q6aaValganciclovirAlmost Always (31%)Availability of Valganciclovir for PHO patientsSupp_Med_Valgan
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
37 (31%) — Almost Always [3 pts]
2
18 (15%) — Frequently [2 pts]
3
17 (14%) — Sometimes [1 pt]
4
15 (13%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
27 (23%) — N/A [0 pts]
Q6abMetronidazoleAlmost Always (84%)Availability of Metronidazole for PHO patientsSupp_Med_Metro
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
99 (84%) — Almost Always [3 pts]
2
16 (14%) — Frequently [2 pts]
3
1 (1%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
2 (2%) — N/A [0 pts]
Complementary AntimicrobialsQ7a-Q7x · max 72 pts
Q7aAmpicillin/SulbactamAlmost Always (36%)Availability of Ampicillin/Sulbactam for PHO patientsSupp_Med_AmpiSulb
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
42 (36%) — Almost Always [3 pts]
2
7 (6%) — Frequently [2 pts]
3
16 (14%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
8 (7%) — Almost Never [0 pts]
6
39 (33%) — N/A [0 pts]
Q7bCefepimeAlmost Always (78%)Availability of Cefepime for PHO patientsSupp_Med_Cefepime
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
92 (78%) — Almost Always [3 pts]
2
16 (14%) — Frequently [2 pts]
3
8 (7%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — N/A [0 pts]
Q7cCeftolozane/TazobactamN/A (61%)Availability of Ceftolozane/Tazobactam for PHO patientsSupp_Med_Ceftoloz
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
16 (14%) — Almost Always [3 pts]
2
1 (1%) — Frequently [2 pts]
3
10 (9%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
13 (11%) — Almost Never [0 pts]
6
72 (61%) — N/A [0 pts]
Q7dCiprofloxacin (PO)Almost Always (69%)Availability of Ciprofloxacin (PO) for PHO patientsSupp_Med_CiproPO
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
81 (69%) — Almost Always [3 pts]
2
20 (17%) — Frequently [2 pts]
3
6 (5%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
7 (6%) — N/A [0 pts]
Q7eDaptomycinN/A (57%)Availability of Daptomycin for PHO patientsSupp_Med_Dapto
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
16 (14%) — Almost Always [3 pts]
2
1 (1%) — Frequently [2 pts]
3
15 (13%) — Sometimes [1 pt]
4
10 (9%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
67 (57%) — N/A [0 pts]
Q7fImipenemAlmost Always (69%)Availability of Imipenem for PHO patientsSupp_Med_Imipen
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
81 (69%) — Almost Always [3 pts]
2
16 (14%) — Frequently [2 pts]
3
8 (7%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
7 (6%) — N/A [0 pts]
Q7gLevofloxacin (IV)Almost Always (66%)Availability of Levofloxacin (IV) for PHO patientsSupp_Med_LevoIV
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
78 (66%) — Almost Always [3 pts]
2
13 (11%) — Frequently [2 pts]
3
10 (9%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
2 (2%) — Almost Never [0 pts]
6
10 (9%) — N/A [0 pts]
Q7hLevofloxacin (PO)Almost Always (66%)Availability of Levofloxacin (PO) for PHO patientsSupp_Med_LevoPO
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
78 (66%) — Almost Always [3 pts]
2
13 (11%) — Frequently [2 pts]
3
5 (4%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
15 (13%) — N/A [0 pts]
Q7iMeropenem/VaborbactamN/A (59%)Availability of Meropenem/Vaborbactam for PHO patientsSupp_Med_MeroVab
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
24 (20%) — Almost Always [3 pts]
2
1 (1%) — Frequently [2 pts]
3
5 (4%) — Sometimes [1 pt]
4
7 (6%) — Infrequently [0 pts]
5
12 (10%) — Almost Never [0 pts]
6
69 (59%) — N/A [0 pts]
Q7jMoxifloxacin (IV)N/A (42%)Availability of Moxifloxacin (IV) for PHO patientsSupp_Med_MoxiIV
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
31 (26%) — Almost Always [3 pts]
2
4 (3%) — Frequently [2 pts]
3
7 (6%) — Sometimes [1 pt]
4
13 (11%) — Infrequently [0 pts]
5
13 (11%) — Almost Never [0 pts]
6
50 (42%) — N/A [0 pts]
Q7kMoxifloxacin (PO)N/A (46%)Availability of Moxifloxacin (PO) for PHO patientsSupp_Med_MoxiPO
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
31 (26%) — Almost Always [3 pts]
2
2 (2%) — Frequently [2 pts]
3
9 (8%) — Sometimes [1 pt]
4
9 (8%) — Infrequently [0 pts]
5
13 (11%) — Almost Never [0 pts]
6
54 (46%) — N/A [0 pts]
Q7lTeicoplaninN/A (33%)Availability of Teicoplanin for PHO patientsSupp_Med_Teico
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
37 (31%) — Almost Always [3 pts]
2
5 (4%) — Frequently [2 pts]
3
13 (11%) — Sometimes [1 pt]
4
13 (11%) — Infrequently [0 pts]
5
11 (9%) — Almost Never [0 pts]
6
39 (33%) — N/A [0 pts]
Q7mTicarcillin/ClavulanateN/A (56%)Availability of Ticarcillin/Clavulanate for PHO patientsSupp_Med_TicarClav
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
21 (18%) — Almost Always [3 pts]
2
2 (2%) — Frequently [2 pts]
3
10 (9%) — Sometimes [1 pt]
4
10 (9%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
66 (56%) — N/A [0 pts]
Q7nTigecyclineAlmost Always (34%)Availability of Tigecycline for PHO patientsSupp_Med_Tige
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
40 (34%) — Almost Always [3 pts]
2
8 (7%) — Frequently [2 pts]
3
13 (11%) — Sometimes [1 pt]
4
11 (9%) — Infrequently [0 pts]
5
8 (7%) — Almost Never [0 pts]
6
38 (32%) — N/A [0 pts]
Q7oTobramycinAlmost Always (49%)Availability of Tobramycin for PHO patientsSupp_Med_Tobra
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
58 (49%) — Almost Always [3 pts]
2
8 (7%) — Frequently [2 pts]
3
10 (9%) — Sometimes [1 pt]
4
9 (8%) — Infrequently [0 pts]
5
7 (6%) — Almost Never [0 pts]
6
26 (22%) — N/A [0 pts]
Q7pVancomycin (PO)N/A (70%)Availability of Vancomycin (PO) for PHO patientsSupp_Med_VancoPO
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
17 (14%) — Almost Always [3 pts]
2
4 (3%) — Frequently [2 pts]
3
3 (3%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
7 (6%) — Almost Never [0 pts]
6
83 (70%) — N/A [0 pts]
Q7qAnidulafunginN/A (73%)Availability of Anidulafungin for PHO patientsSupp_Med_Anidula
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
11 (9%) — Almost Always [3 pts]
2
1 (1%) — Frequently [2 pts]
3
6 (5%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
86 (73%) — N/A [0 pts]
Q7rCaspofunginAlmost Always (48%)Availability of Caspofungin for PHO patientsSupp_Med_Caspo
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
57 (48%) — Almost Always [3 pts]
2
20 (17%) — Frequently [2 pts]
3
19 (16%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
12 (10%) — N/A [0 pts]
Q7sMicafunginN/A (77%)Availability of Micafungin for PHO patientsSupp_Med_Mica
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
7 (6%) — Almost Always [3 pts]
2
1 (1%) — Frequently [2 pts]
3
5 (4%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
91 (77%) — N/A [0 pts]
Q7tPosaconazoleN/A (56%)Availability of Posaconazole for PHO patientsSupp_Med_Posa
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
11 (9%) — Almost Always [3 pts]
2
7 (6%) — Frequently [2 pts]
3
16 (14%) — Sometimes [1 pt]
4
8 (7%) — Infrequently [0 pts]
5
10 (9%) — Almost Never [0 pts]
6
66 (56%) — N/A [0 pts]
Q7uGanciclovirAlmost Always (37%)Availability of Ganciclovir for PHO patientsSupp_Med_Ganc
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
44 (37%) — Almost Always [3 pts]
2
17 (14%) — Frequently [2 pts]
3
13 (11%) — Sometimes [1 pt]
4
12 (10%) — Infrequently [0 pts]
5
5 (4%) — Almost Never [0 pts]
6
27 (23%) — N/A [0 pts]
Q7vSulfadoxineN/A (74%)Availability of Sulfadoxine for PHO patientsSupp_Med_Sulfadox
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
8 (7%) — Almost Always [3 pts]
2
2 (2%) — Frequently [2 pts]
3
6 (5%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
10 (9%) — Almost Never [0 pts]
6
87 (74%) — N/A [0 pts]
Q7wPentamidineN/A (74%)Availability of Pentamidine for PHO patientsSupp_Med_Pentamid
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
9 (8%) — Almost Always [3 pts]
2
2 (2%) — Frequently [2 pts]
3
6 (5%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
87 (74%) — N/A [0 pts]
Q7xPyrimethamineN/A (64%)Availability of Pyrimethamine for PHO patientsSupp_Med_Pyrimeth
1[3 pts]Almost Always
2[2 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available
1
16 (14%) — Almost Always [3 pts]
2
1 (1%) — Frequently [2 pts]
3
12 (10%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
75 (64%) — N/A [0 pts]
Supportive Care NeedsQ8a-Q8e · max 25 pts
Q8aAntibiotic StewardshipAlmost Always (88%)Does the facility have an antibiotic stewardship program?Supp_Other_Abx
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
104 (88%) — Almost Always [5 pts]
2
11 (9%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — Don't know [0 pts]
Q8bSecure Venous AccessAlmost Always (75%)How often is secure venous access available for PHO patients?Supp_Other_SVA
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
89 (75%) — Almost Always [5 pts]
2
26 (22%) — Frequently [3 pts]
3
2 (2%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
0 (0%) — Almost Never [0 pts]
6
0 (0%) — Don't know [0 pts]
Q8cPain ManagementAlmost Always (39%)How well are pain management needs met for PHO patients?Supp_Other_Pain
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
46 (39%) — Almost Always [5 pts]
2
15 (13%) — Frequently [3 pts]
3
15 (13%) — Sometimes [1 pt]
4
10 (9%) — Infrequently [0 pts]
5
7 (6%) — Almost Never [0 pts]
6
25 (21%) — Don't know [0 pts]
Q8dSymptom ManagementAlmost Always (36%)How well are symptom management needs met for PHO patients?Supp_Other_Symptoms
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
42 (36%) — Almost Always [5 pts]
2
31 (26%) — Frequently [3 pts]
3
14 (12%) — Sometimes [1 pt]
4
9 (8%) — Infrequently [0 pts]
5
5 (4%) — Almost Never [0 pts]
6
17 (14%) — Don't know [0 pts]
Q8eEnd-of-Life CareAlmost Always (42%)How well are end-of-life care needs met for PHO patients?Supp_Other_EOL
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
49 (42%) — Almost Always [5 pts]
2
16 (14%) — Frequently [3 pts]
3
19 (16%) — Sometimes [1 pt]
4
4 (3%) — Infrequently [0 pts]
5
6 (5%) — Almost Never [0 pts]
6
24 (20%) — Don't know [0 pts]
Planning & ImprovementQ9-Q10 · max 10 pts
Q9Overall Status RatingScaleOverall, how would you rate the current status of supportive care for delivery of PHO care at your facility? (0=Weak, 10=Strong)Supp_Impression
Self-assessment scale 0-10. N=118 responses. Mean={mean}, Median={median}. Not scored.
8
33 (28%)
7
25 (21%)
6
17 (14%)
9
17 (14%)
10
10 (9%)
5
8 (7%)
4
5 (4%)
1
1 (1%)
2
1 (1%)
3
1 (1%)
Q10Improvement PlansYes (47%)Are there plans and committed resources to improve supportive care for delivery of PHO care at your facility in the next 12 months?Supp_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
55 (47%) — Yes [10 pts]
2
35 (30%) — No [0 pts]
3
28 (24%) — Don't know [0 pts]
Module 10: Surgery (Cirugía)19 questions · max 85 pts
Surgical ServicesQ1-Q5 · max 15 pts
Q1Surgical ProceduresNumber (16.8)Approximate number of surgical procedures performed annually for PHO patients at this facilitySx_Number
N=118 responses. Mean=16.8, Median=5, Range=0-215. Not scored.
Q2Operating Room AvailabilityYes (99%)Does your facility have a dedicated operating room (OR) for use by PHO patients?Sx_OR
1[5 pts]Yes
2[0 pts]No
1
117 (99%) — Yes [5 pts]
2
1 (1%) — No [0 pts]
Q3Number of Operating RoomsNumber (4.7)How many operating rooms are available for use by PHO patients?Sx_ORCount
N=117 responses. Mean=4.7, Median=4, Range=0-18. Not scored.
Q4Surgical SubspecialtiesGeneral Surgery (75%)Which of the following surgical subspecialties are available at your facility for PHO patients?Sx_Subspec___*
Check all that apply. Each subspecialty scores 1 pt (max 5 pts; 'None' scores 0). {N} facilities responded.
75%
General Surgery (89)
61%
Neurosurgery (72)
59%
Orthopedic Surgery (70)
45%
Ophthalmic Surgery (53)
42%
Otolaryngology (ENT) (50)
17%
None (20)
Q5OR LocationWithin facility (92%)Where is the operating room located in relation to your facility?Sx_ORLocation
1[5 pts]Within this facility
2[3 pts]In a nearby facility (same campus)
3[0 pts]In a distant facility (different campus)
1
108 (92%) — Within facility [5 pts]
2
6 (5%) — Same campus [3 pts]
3
3 (3%) — Different campus [0 pts]
Surgical OperationsQ6a-Q6f · max 30 pts
Q6aPriority SchedulingAlmost Always (43%)PHO patients are given priority for surgical schedulingSx_Services_Priority
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
51 (43%) — Almost Always [5 pts]
2
39 (33%) — Frequently [3 pts]
3
21 (18%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
2 (2%) — Don't know [0 pts]
Q6bTimely Surgical AccessAlmost Always (36%)PHO patients receive timely access to surgery when neededSx_Services_Time
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
43 (36%) — Almost Always [5 pts]
2
34 (29%) — Frequently [3 pts]
3
22 (19%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
8 (7%) — Almost Never [0 pts]
6
5 (4%) — Don't know [0 pts]
Q6cTrained Surgical StaffAlmost Always (35%)Surgeons trained in pediatric oncology surgical techniques are availableSx_Services_Staff
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
41 (35%) — Almost Always [5 pts]
2
18 (15%) — Frequently [3 pts]
3
22 (19%) — Sometimes [1 pt]
4
10 (9%) — Infrequently [0 pts]
5
21 (18%) — Almost Never [0 pts]
6
6 (5%) — Don't know [0 pts]
Q6dIntraoperative HistopathologyAlmost Never (35%)Intraoperative histopathology (frozen section) is availableSx_Services_Histo
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
21 (18%) — Almost Always [5 pts]
2
17 (14%) — Frequently [3 pts]
3
16 (14%) — Sometimes [1 pt]
4
11 (9%) — Infrequently [0 pts]
5
41 (35%) — Almost Never [0 pts]
6
12 (10%) — Don't know [0 pts]
Q6eIntraoperative Blood ProductsAlmost Always (76%)Intraoperative blood product support is availableSx_Services_Blood
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
90 (76%) — Almost Always [5 pts]
2
18 (15%) — Frequently [3 pts]
3
6 (5%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
2 (2%) — Don't know [0 pts]
Q6fLimb Salvage SurgeryAlmost Never (32%)Limb salvage surgery is available for PHO patientsSx_Services_Limb
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
28 (24%) — Almost Always [5 pts]
2
12 (10%) — Frequently [3 pts]
3
15 (13%) — Sometimes [1 pt]
4
5 (4%) — Infrequently [0 pts]
5
38 (32%) — Almost Never [0 pts]
6
20 (17%) — Don't know [0 pts]
Post-Operative CareQ7a-Q7f · max 30 pts
Q7aOperative ReportAlmost Always (81%)An operative report is completed immediately following each surgical procedureSx_Postop_Report
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
96 (81%) — Almost Always [5 pts]
2
17 (14%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q7bLegible ReportAlmost Always (63%)The operative report is legible and accessible to those involved in the patient's careSx_Postop_Legible
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
74 (63%) — Almost Always [5 pts]
2
30 (25%) — Frequently [3 pts]
3
11 (9%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q7cReport DetailAlmost Always (63%)The operative report includes details of surgical findings, margins, and extent of resectionSx_Postop_Detail
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
74 (63%) — Almost Always [5 pts]
2
25 (21%) — Frequently [3 pts]
3
11 (9%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
3 (3%) — Almost Never [0 pts]
6
3 (3%) — Don't know [0 pts]
Q7dMechanical VentilationAlmost Always (85%)Post-operative mechanical ventilation is available when neededSx_Postop_MV
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
100 (85%) — Almost Always [5 pts]
2
14 (12%) — Frequently [3 pts]
3
0 (0%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q7ePain ManagementAlmost Always (69%)Post-operative pain management is routinely providedSx_Postop_Pain
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
81 (69%) — Almost Always [5 pts]
2
30 (25%) — Frequently [3 pts]
3
5 (4%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Q7fComplications MonitoringAlmost Always (62%)Post-operative surgical complications are monitored and managedSx_Postop_Complications
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Do not know
1
73 (62%) — Almost Always [5 pts]
2
40 (34%) — Frequently [3 pts]
3
3 (3%) — Sometimes [1 pt]
4
0 (0%) — Infrequently [0 pts]
5
1 (1%) — Almost Never [0 pts]
6
1 (1%) — Don't know [0 pts]
Planning & ImprovementQ8-Q9 · max 10 pts
Q8Overall Status RatingScale (7.1)Overall, how would you rate the assessed components of surgical services for delivery of PHO care at your facility? (0=Weak, 10=Strong)Sx_Impressions
Self-assessment scale 0-10. N=118 responses. Mean=7.1, Median=8. Not scored.
8
34 (29%)
7
22 (19%)
9
18 (15%)
6
12 (10%)
5
10 (9%)
4
8 (7%)
10
8 (7%)
3
3 (3%)
0
1 (1%)
1
1 (1%)
2
1 (1%)
Q9Improvement PlansNo (40%)Are there plans and committed resources to improve surgical services for delivery of PHO care at your facility in the next 12 months?Sx_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
45 (38%) — Yes [10 pts]
2
47 (40%) — No [0 pts]
3
26 (22%) — Don't know [0 pts]
Module 11: Radiation Therapy (Radioterapia)15 questions · max 64 pts
Radiation ServicesQ1-Q9 · max 34 pts
Q1Radiation SourcesLinear accelerator (74%)Which of the following sources of radiation are available for the treatment of pediatric cancer patients? (check all that apply)R_Sources___*
Check all that apply. Cobalt 2 pts, Linear accelerator 5 pts, Protons 2 pts. Max 9 pts. {N} facilities responded.
74%
Linear accelerator (87)
25%
None of the above (29)
8%
Cobalt (9)
3%
Other (4)
2%
Protons (2)
Q2Radiation CentersScale (32.7)How many dedicated radiation treatment centers are available for the treatment of pediatric cancer patients in your country?R_Centers
Number of radiation centers in country. N=118 responses. Mean=32.7, Median=10. Not scored.
10
16 (14%)
0
13 (11%)
20
12 (10%)
3
9 (8%)
4
7 (6%)
2
6 (5%)
30
6 (5%)
50
6 (5%)
1
5 (4%)
15
5 (4%)
25
3 (3%)
103
3 (3%)
173
3 (3%)
40
2 (2%)
80
2 (2%)
141
2 (2%)
170
2 (2%)
5
1 (1%)
6
1 (1%)
7
1 (1%)
8
1 (1%)
12
1 (1%)
26
1 (1%)
29
1 (1%)
32
1 (1%)
35
1 (1%)
60
1 (1%)
64
1 (1%)
98
1 (1%)
120
1 (1%)
150
1 (1%)
200
1 (1%)
212
1 (1%)
Q3Radiation FacilitiesScale (2.9)How many facilities provide radiation treatment services to your pediatric cancer patients?R_Facilities
Number of facilities providing radiation. N=118 responses. Mean=2.9, Median=1. Not scored.
1
57 (48%)
2
33 (28%)
3
10 (9%)
0
6 (5%)
4
4 (3%)
5
2 (2%)
50
2 (2%)
10
1 (1%)
12
1 (1%)
20
1 (1%)
25
1 (1%)
Q4Wait TimeScale (16.2)Average wait time (in days) from the time radiation therapy is prescribed to the time it is startedR_WaitTime
Wait time in days. N=118 responses. Mean=16.2, Median=10. Not scored.
7
26 (22%)
15
18 (15%)
30
11 (9%)
5
10 (9%)
14
9 (8%)
3
8 (7%)
10
8 (7%)
0
5 (4%)
20
4 (3%)
1
3 (3%)
2
3 (3%)
60
2 (2%)
90
2 (2%)
120
2 (2%)
4
1 (1%)
17
1 (1%)
21
1 (1%)
28
1 (1%)
40
1 (1%)
45
1 (1%)
70
1 (1%)
Q5aEmergency RadiationAlmost Never (47%)Emergency radiation therapy can be arranged in a timely fashionR_Services_Emergency
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available / Don't know
1
20 (17%) — Almost Always [5 pts]
2
11 (9%) — Frequently [3 pts]
3
14 (12%) — Sometimes [1 pt]
4
11 (9%) — Infrequently [0 pts]
5
55 (47%) — Almost Never [0 pts]
6
7 (6%) — N/A [0 pts]
Q5bUpfront Radiation ConsultationAlmost Always (35%)Upfront radiation therapy consultation is provided for patients with solid tumorsR_Services_Upfront
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available / Don't know
1
41 (35%) — Almost Always [5 pts]
2
24 (20%) — Frequently [3 pts]
3
15 (13%) — Sometimes [1 pt]
4
16 (14%) — Infrequently [0 pts]
5
21 (18%) — Almost Never [0 pts]
6
1 (1%) — N/A [0 pts]
Q5cScheduling TimelinessAlmost Always (35%)Radiation therapy is started in a timely fashion once scheduledR_Services_Schedule
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available / Don't know
1
41 (35%) — Almost Always [5 pts]
2
36 (31%) — Frequently [3 pts]
3
22 (19%) — Sometimes [1 pt]
4
10 (9%) — Infrequently [0 pts]
5
7 (6%) — Almost Never [0 pts]
6
2 (2%) — N/A [0 pts]
Q5dSedation/Anesthesia AvailabilityAlmost Always (64%)Sedation/anesthesia is available for radiation therapy when requiredR_Services_Sedation
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available / Don't know
1
75 (64%) — Almost Always [5 pts]
2
20 (17%) — Frequently [3 pts]
3
7 (6%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
11 (9%) — Almost Never [0 pts]
6
3 (3%) — N/A [0 pts]
Q5eLinear Accelerator AvailabilityAlmost Always (85%)Linear accelerator-based treatment is available when indicatedR_Services_LinAcc
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available / Don't know
1
100 (85%) — Almost Always [5 pts]
2
7 (6%) — Frequently [3 pts]
3
1 (1%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
4 (3%) — Almost Never [0 pts]
6
5 (4%) — N/A [0 pts]
Radiation ReportingQ6-Q9 · max 20 pts
Q6aReport in ChartAlmost Always (68%)A radiation report is placed in the patient's chartR_Report_Chart
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available / Don't know
1
80 (68%) — Almost Always [5 pts]
2
15 (13%) — Frequently [3 pts]
3
5 (4%) — Sometimes [1 pt]
4
6 (5%) — Infrequently [0 pts]
5
9 (8%) — Almost Never [0 pts]
6
3 (3%) — N/A [0 pts]
Q6bReport LegibilityAlmost Always (70%)The radiation report is legibleR_Report_Legible
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available / Don't know
1
83 (70%) — Almost Always [5 pts]
2
16 (14%) — Frequently [3 pts]
3
8 (7%) — Sometimes [1 pt]
4
1 (1%) — Infrequently [0 pts]
5
7 (6%) — Almost Never [0 pts]
6
3 (3%) — N/A [0 pts]
Q6cReport DetailAlmost Always (68%)The radiation report contains sufficient detail (fields, dose per fraction, total dose, number of fractions)R_Report_Detail
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available / Don't know
1
80 (68%) — Almost Always [5 pts]
2
20 (17%) — Frequently [3 pts]
3
6 (5%) — Sometimes [1 pt]
4
2 (2%) — Infrequently [0 pts]
5
7 (6%) — Almost Never [0 pts]
6
3 (3%) — N/A [0 pts]
Q6dCumulative Dose TrackingAlmost Always (45%)Cumulative dose of radiation is tracked and available in the patient chartR_Report_Dose
1[5 pts]Almost Always
2[3 pts]Frequently
3[1 pt]Sometimes
4[0 pts]Infrequently
5[0 pts]Almost Never
6[0 pts]Not available / Don't know
1
53 (45%) — Almost Always [5 pts]
2
15 (13%) — Frequently [3 pts]
3
14 (12%) — Sometimes [1 pt]
4
8 (7%) — Infrequently [0 pts]
5
23 (20%) — Almost Never [0 pts]
6
5 (4%) — N/A [0 pts]
Planning & ImprovementQ7-Q8 · max 10 pts
Q7Overall Status RatingScale (7.0)Overall, how would you rate radiation therapy services available for the care of pediatric cancer patients at your facility? (0=Weak, 10=Strong)R_Impression
Self-assessment scale 0-10. N=118 responses. Mean=7.0, Median=8. Not scored.
8
32 (27%)
9
23 (20%)
7
20 (17%)
6
14 (12%)
10
10 (9%)
0
7 (6%)
5
6 (5%)
1
2 (2%)
2
2 (2%)
3
2 (2%)
Q8Improvement PlansNo (41%)Are there plans and committed resources to improve radiation therapy services at your facility in the next 12 months?R_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
44 (37%) — Yes [10 pts]
2
48 (41%) — No [0 pts]
3
26 (22%) — Don't know [0 pts]
Module 12: Patients & Outcomes (Pacientes y Resultados)28 questions · max 70 pts
New DiagnosesQ1-Q9 · max 4 pts
Q1Total Diagnosed (All)Number (48.9)Total number of children diagnosed with cancer (all types) in the past 12 monthsPO_TotalDxAll
Raw count. N=118 responses. Mean=48.9, Median=24, Range=0-1200. Not scored directly.
Q2Total Benign DiagnosesNumber (65.3)Total number of children diagnosed with benign tumors in the past 12 monthsPO_TotalDxBenign
Raw count. N=118 responses. Mean=65.3, Median=21, Range=0-1060. Not scored directly.
Q3Leukemia CasesNumber (17.3)Number of children newly diagnosed with leukemia in the past 12 monthsPO_TotalDx_Leuk
Raw count. N=118 responses. Mean=17.3, Median=10, Range=0-120. [1 pt if reported]
Q4Other Hematologic CasesNumber (7.2)Number of children newly diagnosed with other hematologic malignancies in the past 12 monthsPO_TotalDx_Other
Raw count. N=118 responses. Mean=7.2, Median=3, Range=0-180. [1 pt if reported]
Q5Solid Tumor CasesNumber (18.7)Number of children newly diagnosed with solid tumors (excluding brain) in the past 12 monthsPO_TotalDx_Solid
Raw count. N=118 responses. Mean=18.7, Median=6, Range=0-840. [1 pt if reported]
Q6Brain Tumor CasesNumber (5.7)Number of children newly diagnosed with brain/CNS tumors in the past 12 monthsPO_TotalDx_Brain
Raw count. N=118 responses. Mean=5.7, Median=3, Range=0-60. [1 pt if reported]
Q7Total Newly DiagnosedNumber (48.9)Total number of newly diagnosed pediatric cancer patients in the past 12 monthsPO_TotalNewlyDx
Raw count (sum of leukemia + other + solid + brain). N=118 responses. Mean=48.9, Median=24, Range=0-1200. Not scored directly.
Q8New Diagnosis ReportingInitiated treatment with curative intent (99%)Which of the following does your new diagnosis number include? (check all that apply)PO_NewDiag_Report___*
Check all that apply. {N} facilities responded.
99%
Initiated treatment with curative intent (117)
98%
Histopathologically confirmed diagnosis (116)
88%
Initiated treatment exclusively with palliative intent (104)
82%
Refused treatment (97)
Q95-Year ALL Survival TrackingYes (81%)Does your facility track 5-year survival for ALL (Acute Lymphoblastic Leukemia)?PO_Survival_5yALL_track
1Yes
2No
3Do not know
1
95 (81%) — Yes
2
19 (16%) — No
3
4 (3%) — Don't know
Initial TreatmentQ10-Q16 · max 20 pts
Q105-Year ALL Survival RateNumber (69.9%)What is the 5-year event-free survival rate for ALL at your facility?PO_Survival_5yALL
Percentage (0-100). N=95 responses. Mean=69.9%, Median=70%, Range=0-100%. Only answered when tracking = Yes.
Q115-Year Overall Survival TrackingYes (74%)Does your facility track 5-year overall survival for all pediatric cancers?PO_surival5y_track
1Yes
2No
3Do not know
1
87 (74%) — Yes
2
23 (20%) — No
3
8 (7%) — Don't know
Q125-Year Overall Survival RateNumber (63.1%)What is the 5-year overall survival rate for all pediatric cancers at your facility?PO_Survival5y
Percentage (0-100). N=87 responses. Mean=63.1%, Median=63%, Range=0-100%. Only answered when tracking = Yes.
Q13Histopathologic DiagnosisNumber (44.6)Number of newly diagnosed patients with histopathologically confirmed diagnosis in the past 12 monthsPO_HistoPathDx
Raw count. N=116 responses. Mean=44.6, Median=23, Range=0-1200. Scored by % of total newly diagnosed: >=95%=[5 pts], >=85%=[3 pts], >=75%=[1 pt], <75%=[0 pts].
Q14Curative Intent TreatmentNumber (46.4)Number of newly diagnosed patients who initiated treatment with curative intent in the past 12 monthsPO_CurativeIntent
Raw count. N=117 responses. Mean=46.4, Median=22, Range=0-1140. Scored by % of total newly diagnosed: >=95%=[5 pts], >=85%=[3 pts], >=75%=[1 pt], <75%=[0 pts].
Q15Palliative Intent TreatmentNumber (2.3)Number of newly diagnosed patients who initiated treatment exclusively with palliative intent in the past 12 monthsPO_PalliativeIntent
Raw count. N=104 responses. Mean=2.3, Median=1, Range=0-59. Scored by % of total: <=5%=[5 pts], <=10%=[3 pts], <=15%=[1 pt], >15%=[0 pts].
Q16Treatment RefusalNumber (0.6)Number of newly diagnosed patients who refused treatment in the past 12 monthsPO_RefusedTx
Raw count. N=97 responses. Mean=0.6, Median=0, Range=0-10. Scored by % of total: <=5%=[5 pts], <=10%=[3 pts], <=15%=[1 pt], >15%=[0 pts].
Treatment & Follow-upQ17-Q18 · max 10 pts
Q17Treatment AbandonmentNumber (1.5)Number of patients who abandoned treatment in the past 12 monthsPO_AbandonTx
Raw count. N=118 responses. Mean=1.5, Median=0, Range=0-30. Scored by % of total: <=5%=[5 pts], <=10%=[3 pts], <=15%=[1 pt], >15%=[0 pts].
Q18ALL Treatment OutcomeNumber (1.7)Number of ALL patients who died during treatment or within 30 days of treatment completion in the past 12 monthsPO_OutcomeALL
Raw count. N=118 responses. Mean=1.7, Median=1, Range=0-50. Scored by % of total: <=5%=[5 pts], <=15%=[3 pt], >15%=[0 pts].
EvaluationQ19-Q26 · max 26 pts
Q19Data Quality EstimateBest estimate (45%)Which of the following best describes how your data were estimated?PO_Estimate
1[5 pts]Estimates from a cancer registry
2[2 pts]Estimates from an electronic medical record system
3[0 pts]Best estimate from the PHO unit
4[0 pts]Other
1
20 (17%) — Cancer registry [5 pts]
2
44 (37%) — EMR system [2 pts]
3
53 (45%) — Best estimate [0 pts]
4
1 (1%) — Other [0 pts]
Q20Quality Indicator: FallsYes (89%)Does your facility track inpatient falls as a quality indicator?PO_Indicators_Fall
1[3 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
105 (89%) — Yes [3 pts]
2
11 (9%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
Q21Quality Indicator: IV InfectionsYes (56%)Does your facility track IV line infections as a quality indicator?PO_Indicators_IV
1[3 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
66 (56%) — Yes [3 pts]
2
42 (36%) — No [0 pts]
3
10 (9%) — Don't know [0 pts]
Q22Quality Indicator: Febrile NeutropeniaYes (76%)Does your facility track time to antibiotics for febrile neutropenia as a quality indicator?PO_Indicators_Fever
1[3 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
90 (76%) — Yes [3 pts]
2
28 (24%) — No [0 pts]
3
0 (0%) — Don't know [0 pts]
Q23Quality Indicator: Blood ProductsYes (86%)Does your facility track timely availability of blood products as a quality indicator?PO_Indicators_Blood
1[3 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
101 (86%) — Yes [3 pts]
2
15 (13%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
Q24Outcome EvaluationYes (75%)Does your facility evaluate patient outcomes on a regular basis?PO_OutcomeEval
1[3 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
88 (75%) — Yes [3 pts]
2
28 (24%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
Q25National Journal PublicationNo (73%)Has your facility published results in a national journal in the past 5 years?PO_NatJournal
1[3 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
29 (25%) — Yes [3 pts]
2
86 (73%) — No [0 pts]
3
3 (3%) — Don't know [0 pts]
Q26International Journal PublicationNo (79%)Has your facility published results in an international journal in the past 5 years?PO_InternatJournal
1[3 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
23 (20%) — Yes [3 pts]
2
93 (79%) — No [0 pts]
3
2 (2%) — Don't know [0 pts]
Planning & ImprovementQ27-Q28 · max 10 pts
Q27Overall Status RatingScale (6.7)Overall, how would you rate the current status of patients and outcomes for delivery of PHO care at your facility? (1=Weak, 10=Strong)PO_Impression
Self-assessment scale 1-10. N=118 responses. Mean=6.7, Median=7. Not scored.
8
35 (30%)
7
23 (20%)
6
18 (15%)
5
17 (14%)
9
9 (8%)
2
4 (3%)
4
4 (3%)
10
4 (3%)
3
2 (2%)
0
1 (1%)
1
1 (1%)
Q28Improvement PlansYes (56%)Are there plans and committed resources to improve patients and outcomes for delivery of PHO care at your facility in the next 12 months?PO_Planning
1[10 pts]Yes
2[0 pts]No
3[0 pts]Do not know
1
66 (56%) — Yes [10 pts]
2
38 (32%) — No [0 pts]
3
14 (12%) — Don't know [0 pts]